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Abstract 
This thesis is a summary of the work carried out exploring the properties and applications of 
calix[4]arene ligands. Particular attention is given to the flexibility and encapsulation 
capabilities of these species. Initially synthetic methodology for the incorporation of bis-
imidazolinium and imidaolium groups was targeted. The synthesis of imidazolinium 
functionalised species proved problematic, however pro-ligand 2a·2HI was readily prepared 
via a six-step synthetic procedure.  
 
The coordination chemistry of 2a·2HI with [Rh(COD)Cl]2 and [Rh(CO)2Cl]2, via generation of 
the free carbene (2a) or transmetallation from an isolated silver complex (6a) was explored. 
Both routes resulted in the formation of bimetallic species. The isolation of these complexes 
highlights the flexibility of the calix[4]arene scaffold. The role of the calix[4]arene was probed 
though comparison to complexes of the monodentate I iPr2Me2 ligand.  
Based on these results, the imidazole-2-thione (NHCS) ligand 3 was derived from 2a and 
elemental sulfur. Monodentate rhodium and iridium complexes of 3 were readily prepared 
and found to bind potassium cations within the calix[4]arene cavity. This unusual host-guest 
chemistry was probed by 1H NMR spectroscopy and in the solid state through comparison to 
other calix[4]arene hosts.  
vii 
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1.0 Introduction and scope 
Overview 
This chapter provides a background for the calix[4]arene and N-heterocyclic carbene (NHC) 
chemistry described in this thesis. A short account of the synthesis, structures, selective 
functionalisation and host-guest chemistry of calix[4]arenes is outlined. The discussion 
focuses on previous examples of phosphine- and NHC-based calix[4]arene ligands and their 
corresponding transition metal complexes. An overview of NHC ligands is also provided, 
including common structures and topologies of multidentate variants. 
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1.1 Calixarene synthesis and structure 
Calix[n]arenes are a group of cyclic oligomers, their name derives from the Greek ‘calix’ 
which translates to ‘vase’ or ‘chalice’ due to their characteristic shape. ‘Arene’ refers to the 
phenolic units where n denotes the number of repeat units in the oligomer.1 This naming 
system was introduced in the 1970s and provides a simple alternative to systematic names, 
for example pentacyclo[19.3.1.13,7.19,13.115,19]octacosa-
1(25),3(28),4,6,9(27),10,12,15(26),16,18,21,23-dodecaene is more simply described as p-
tertbutylcalix[4]arene (Figure 1.1). 
 
 
 
 
 
Calixarenes were first synthesised serendipitously as a side product from the Bakelite process 
in the 1900s.2, 3 This process was assumed to yield only linear polymeric products until 1944, 
when Zinke and co-workers postulated that the synthesis yielded semi-rigid cyclic products.4 
This was later confirmed by determination of the molecular weight of the cyclic tetrameric 
product from the condensation of 4-(1,1,3,3-tetramethylbutyl)phenol and formaldehyde. 
Calixarenes have since become known as attractive complexing agents and enzyme mimics 
due to their characteristic ‘basket like’ shape which makes them well suited for the inclusion 
of guest molecules.5-7 
Calix[n]arenes have been isolated in ring sizes ranging from n = 4-16.8-10 Calix[n]arenes with 
n = 4 – 8 have been synthesised on a large scale with good yields.9, 10 This thesis will focus on 
calix[4]arene structures.  
Figure 1.1: Structure of p-tertbutylcalix[4]arene (A1) 
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Calix[4]arenes can be synthesised easily by condensation of p-substituted phenols and 
formaldehyde in the presence of a catalytic amount of base. Several systematic studies have 
been carried out to study the effect of reaction conditions such as reagent ratios, 
temperature and solvent on the product distribution. For example, KOH, RbOH and CsOH are 
shown to favour formation of the hexameric products while NaOH favours formation of the 
tetramers.9, 11, 12 The Zinke-Cornforth procedure has been developed with conditions 
favouring formation of calix[4]arene products and is carried out by heating p-tertbutylphenol 
in formaldehyde solution with NaOH. It was found that ~ 0.03 – 0.04 equivalents NaOH 
favoured formation of calix[4]arenes while higher concentrations (>0.3 equivalents) favour 
the formation of calix[5]arene.12 Generally it has been concluded that calix[4]arenes are the 
thermodynamic products and can be formed easily by pyrolysis of higher order oligomers.13  
Calix[4]arenes with identical substituents in the para-positions are commonly 
synthesised by one-pot procedures.13 Heterofunctionalised calix[4]arenes have been 
prepared from step-wise procedures; these are broadly separated into non-convergent 
stepwise synthesis and fragment condensation.14 Non-convergent syntheses involve 
alternating hydroxymethylation and condensation of o-bromo-p-alkylphenol monomers 
to form linear oligomers which are subsequently cyclised by intramolecular 
condensation in dilute conditions (Scheme 1.1).15  
 
Scheme 1.1: Non-convergent stepwise synthesis of calix[4]arenes 
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Convergent pathways involve a reduced number of steps for the synthesis of 
asymmetrically functionalised calix[4]arenes. The systematic synthesis of asymmetric 
calix[4]arenes by fragment condensation in [3+1] or [2+2] processes (Scheme 1.2) has 
been reported, however, both convergent and fragment condensation methods are 
generally labour intensive and are low yielding.16, 17  
Scheme 1.2: Synthesis of multifunctional calix[4]arenes by fragment condensation; [3+1] (top) and [2+2] 
(bottom) 
 
Selective functionalisation of symmetric calix[4]arene products can provide a more 
efficient synthetic route for the preparation of compounds bearing heterofunctionalised 
products. p-tertButylcalix[4]arene, in particular, is readily synthesised on a large scale and 
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available from most large chemical suppliers, and provided an excellent starting point 
for the preparation of selectively functionalised calix[4]arene products (vide infra).12  
 
Figure 1.2: Conformational isomers of alkylated calix[4]arenes 
 
Conformational isomers of calix[4]arenes are formed by rotation of the aryl substituents 
about the bridging methylene units. The resulting isomers are defined as cone, partial cone, 
1,2-alternate and 1,3-alternate structures (Figure 1.2).18 The four conformers of the hydroxyl 
(R’ = H) calix[4]arenes are in equilibrium in solution at room temperature. The cone 
conformation of the phenolic calix[4]arene is the most thermodynamically stable species due 
to hydrogen bonding between the hydroxyl groups. Interconversion of conformational 
isomers can be followed by observation of the 1H resonances for the methylene protons of 
the calix[4]arene, which appear as a pair of germinal doublets below ambient temperatures 
and a well-defined singlet at elevated temperatures, due to rapid conformational 
interconversion.19 
The most common method for producing a well-defined cavity is by trapping the cone or 
partial cone conformations by substitution of the phenolic hydrogen with a significantly bulky 
group, such as npropyl, to sterically prevent rotation of the aryl groups.20 The nature of p-
subsituent has little effect on conversion of isomers, for example free energy of conversion 
of p-tertbutylcalix[4]arene (A1, R = tBu, R’ = H) is observed at 15.7 kcal/mol in chloroform 
while the unsubstituted calix[4]arene (R, R’ = H) is observed at 14.9 kcal/mol.19 Cone 
conformations can be observed in solution by 1H NMR spectroscopy by the observation of 
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the methylene protons as two geminally coupled doublets at approximately 2.5 and 1.2 ppm 
(Figure 1.3), these have been assigned to the equatorial and axial positions, respectively.21, 
22 
  
  
Figure 1.3: 1H NMR spectra showing methylene bridge resonances of A1 and A2 (CDCl3, 298 K, 400 MHz) 
(Triplet observed at 3.85 ppm is assigned to OCH2.) 
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1.2 Functionalisation of calix[4]arenes 
Synthetic modification of calixarenes is broadly assigned as either upper or lower rim, where 
upper rim refers to substitution at the p-positions and lower rim refers to the incorporation 
through the narrow phenol edge. Modification of both upper and lower rim have been 
extensively investigated.23-25 In particular, Gutche et al. have developed routes for the 
formation of a wide range of selectively functionalised calix[4]arene products.12, 26-30 The 
variety of the appendices and range of ring sizes has led to calixarenes being described as 
having ‘(almost) unlimited possibilities’ as ligands for metal sensing, receptors for neutral 
and charged species and catalysts.31  
As official numbering schemes for calix[4]arene compounds are complex, this thesis will use 
a simpler system where, for example, substitution of opposing aryl rings will be referred to 
as ‘1,3-upper rim substitution’ and appendage of adjacent phenol groups will be referred to 
as ‘1,2-lower rim substitution’ (Figure 1.4).  
 
 
 
 
Figure 1.4: Numbering system adopted for this thesis 
 
1.2.1 Lower rim functionalisation  
The phenolic groups on the lower rim provide an excellent handle for the functionalisation 
of calix[4]arenes. The simplest reactions involve the formation of phenolic ethers, which 
increase the solubility of the scaffold and, as discussed above, can be used to ‘trap’ specific 
calix[4]arene conformations. Alkylation of the lower rim is readily achieved by SN2 reactions 
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with alkyl halides under basic conditions with the selectivity controlled by variation of base 
strength, stoichiometry and reaction conditions (Scheme 1.3).23  
Scheme 1.3: Selective alkylation of the calix[4]arene lower rim 
 
Generally an excess of strong base such as NaH can be used to carry out tetra-O-alkylation 
The selectivity of 1,3-distal and 1,2-proximal products is determined by the relative stabilities 
of Species A and B of the monoalkylated intermediate as shown in Scheme 1.4. Weaker bases 
such as K2CO3 can result in the selective formation of 1,3-disubsituted ‘distal’ products via 
the thermodynamically favoured intermediate, Species A. Stoichiometric addition of 
stronger bases can be exploited for the formation of 1,2-‘proximal’ products.32   
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Scheme 1.4: Mechanism for selective alkylation of the lower rim of calix[4]arenes  
 
The potential to functionalise the lower rim with ether, acetate and ester functionalities 
makes them excellent precursors for the synthesis of biological mimics. For example 
calix[4]arenes bearing amino acid derivatives on the lower rim have been reported by Yong-
bing et al. (Figure 1.5) which are able to selectively extract transition metal ions over alkali 
metals from aqueous solution.33-35 Functionalisation of the lower rim has also been exploited 
for the synthesis of calix[4]arene ligands bearing coordinating groups including thiones, 
phosphine, phosphites and NHCs (Section 1.6).23 
 
 
 
 
 
 
 
 
Figure 1.5 Calix[4]arene bearing amino acid derivatives in the lower rim 
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The synthesis of lower rim-functionalised calix[4]arene complexes has been carried out by 
Matt.36 For example, the synthesis of distal 1,3-bis-phosphite and 1,3-bis-phosphinite 
systems which afford both bimetallic and chelated monometallic rhodium complexes 
(Scheme 1.5). Rhodium complexes A5, A6 and A7 have been synthesised by addition of 
rhodium precursors to the phosphinite ligand A4 and have been and used as effective 
catalysts for the hydroformylation of styrene.36 
 
 
Scheme 1.5: Rhodium complexes bearing phosphite-functionalised calix[4]arene ligands  
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Wieser et al. have prepared platinum complexes of lower-rim functionalised calix[4]arene 
ligands which direct a hydride ligand into the central calix[4]arene cavity (A9 and A10, 
Scheme 1.6). The directed positioning of the hydride has been inferred by ROESY NMR 
experiments, which indicated positioning of the hydride in close contact with the pendant 
methylene OCH2 groups. X-ray crystal analysis of A10 was also used to confirm the projection 
of the hydride into the cavity.37 
 
Scheme 1.6: Platinum complexes prepared by Wieser 
 
Hattori and co-workers have also recently reported a series of palladium complexes from 
ligand A15 (Scheme 1.7).38 This ligand was prepared from an Ullman-type phosphinoylation 
from the 1,3-bis(triflate ester), reduction with HSiCl3 and subsequent methylation of the 
hydroxygroups with alkyl halide in the presence of base. Treatment with two equivalents of 
12 
 
[PdCl2(MeCN)2] resulted in the formation of the bis-µ2-chloro-bridged dinuclear palladium 
complex in benzonitrile, whereas one equivalent of palladium precursor in acetonitrile 
resulted in the formation of the mononuclear palladium complex A16. The square planar 
geometry of the central palladium results in the projection of the acetonitrile ligand into the 
calix[4]arene cavity. The chloride ligand in A16 was easily abstracted by treatment with 
Ag[BF4] in acetonitrile to give A17. The acetonitrile ligand in A16 was easily exchanged with 
the chloride counterion upon reflux in a non-coordinating solvent to give A18. In all cases 
projection of the acetonitrile and chloride ligands into the calix[4]arene cavity was 
corroborated by X-ray analysis. 1H NMR analysis of A17 was particularly notable for the 
contrasting shifts observed for the CH3CN resonances at 3.05 and -1.59 ppm (CDCl3/DMSO-
d6 5:1), indicative of the shielding as a result of π-interaction with the inner walls of the 
calix[4]arene cavity.  
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Scheme 1.7: Preparation of palladium complexes reported by Hattori 
 
A number of lower rim functionalised calix[4]arenes bearing bridged polyether appendages 
or ‘calixcrowns’ have been reported as strong alkali metal binding ligands. These are 
discussed in detail in Chapter 4.  
1.2.2 Upper rim functionalisation 
Typically, synthetic routes for functionalisation of the upper rim of calix[4]arenes involve 
initial dealkylation by reverse Friedel-Crafts reaction of p-alkyl-calix[4]arenes,12 which 
enables further functional group transformation, such as incorporation of bromide by use of 
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N-bromosuccimide (Route A, Scheme 1.8).26 Such halide functionalised calix[4]arenes have 
been readily used in coupling reactions for the incorporation of imidazole or aromatic 
functionalities or addition of donor groups by lithium exchange. Ipso-nitration of the upper 
rim has also been explored by Reinhoudt (Route B, Scheme 1.8) as a route for the synthesis 
of amine, imine, amino and sulfanamido functionalities.30, 39 Use of excess of nitric and acetic 
acids results in the formation of tetranitrocalix[4]arenes, while lower stoichiometries can be 
used to form mixtures which are separable by column chromatography.39 
 
 
 
 
 
 
 
 
 
 
 
Scheme 1.8: Common routes to upper rim functionalisation of calix[4]arenes from 
tertbutylcalix[4]arene 
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Mono-halogenation of calix[4]arenes has been achieved in low yields by the addition of one 
equivalent of a halogenating agent and separation of the product mixture by column 
chromatography.40 Alternatively monobrominated calix[4]arenes can be synthesised by 
protection of upper rim positions by tribenzolylation of the lower rim, followed by addition 
of dibromine (Route C, Scheme 1.8).41, 42 Monobrominated calix[4]arenes have been used 
for the incorporation of coordinating moieties, for example, by lithiation followed by 
phosphination as described by Harvey et al.43 and subsequently used for the synthesis of 
Cp*Rh complexes (Scheme 1.9).44,43  
 
Scheme 1.9: Cp*Rh complexes of phosphine functionalised calix[4]arenes  
 
Matt et al.45 have developed the coordination chemistry of bis-phosphine calix[4]arene 
ligand A27. Reaction of A27 with one equivalent of Ag[BF4] resulted in the formation of silver 
complex A28 (Figure 1.6), the structure of which was confirmed by mass spectrometry, 1H 
and 31P NMR spectroscopy. Notably the 13P resonances displayed characteristic coupling to 
107Ag (1JAgP = 502 Hz) and 109Ag (1J AgP = 580 Hz).  
16 
 
 
Figure 1.6: Complexes of A27 
 
Treatment of A27 with [Pd(Me)(COD)(THF)][BF4], followed by addition of pyridine resulted 
in the formation of A29 (Figure 1.6). The bulky pyridine ligand prevents gyroscopic spinning 
of the pyridine-Pd-Me fragment resulting in the projection of the methyl group inside the 
calix[4]arene cavity as established by NOESY NMR experiments. The methyl group is 
characterised by a triplet 1H NMR signal observed at δ = -0.79 cf. related Pd-CH3 resonances 
observed at δ = -0.60.46 Reaction of A27 with ruthenium trichloride and carbon monoxide 
resulted in a ruthenium(II) complex with cis-carbonyl ligands, which slowly isomerise in 
solution to form trans-carbonyl complex A30. The X-ray diffraction structure of A30 is 
notable for the positioning of the CO ligand within the calix[4]arene cavity. 
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A calix[4]arene bearing phosphinomethyl donor moieties in the 1,3-positions, A31, has been 
developed by Kubas and co workers and the coordination with palladium, platinum and 
rhodium investigated (Scheme 1.10).47 Despite the presence of the potentially chelating 
phosphino groups only polymeric Pd(II) (A32) and Pt(II) (A33) complexes and a dinuclear 
rhodium(I) complex (A34) were isolated in moderate yields (59-82%). A31 was analysed in 
the solid state by X-ray crystallography and the tendency to form bimetallic and polymeric 
products was attributed to the distance observed between the phosphorus atoms (7.01 Å) 
and the directionality of the lone pairs, which are projected away from the calix[4]arene 
centre. However, no detailed analysis was carried out in solution.  
Scheme 1.10: Polymeric and bimetallic complexes of A31 
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Treatment of the relatively bulky 1,3-bisphosphine functionalised calix[4]arene ligand 
bearing tertbutyl functionalities in the 2,4-upper rim positions (A35) also resulted in the 
formation of bimetallic transition metal complexes (A36 to A38) (Scheme 1.11).48 Attempts 
were made to prepare monometallic chelate complexes from A35, however, only polymeric 
products were obtained. 
 
Scheme 1.11: Au, Ru and Rh complexes of A35 
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Reaction of the phosphite ligand, A39, with [Pd(η3-Me-allyl)(THF)2][BF4] was used for the 
preparation of monometallic chelated species, A40, this success was attributed to the 
extension of the coordinating pendant arms (Scheme 1.12).49  
 
Scheme 1.12: Monometallic palladium complexes reported by Matt 
 
Ongoing unpublished work carried out by the Chaplin group† with ligand A31 has shown that 
formation of chelated monomeric complexes is possible, by use of the unusual 
[Rh(biphen)(dtbpm)] precursor. This resulted in the formation of a monometallic complex 
which was characterised by NMR spectroscopy and ESI-MS (Scheme 1.13). 
                                                             
† Ongoing unpublished work by Jack Emerson-King, PhD student and Dr Adrian Chaplin, Associate 
Professor, University of Warwick. 
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Scheme 1.13: Synthesis of monometallic Rh calix[4]arene complexes reported by the Chaplin group 
 
Macrocycles derived from the functionalisation of the calix[4]arene upper rim have also been 
used for the synthesis of transition metal complexes (Figure 1.7). Of particular note is the 
formation of palladium complexes A42 and A43 by Cameron et al. which demonstrated the 
use of an extended cavity resulting in complementarity for large ligands such as pyridine and 
phenylpyridine within the calix[4]arene cavity.50 The upfield shift of the pyridine and 
phenylpyridine resonances, observed by 1H NMR spectroscopy is indicative of an aromatic 
donor-acceptor interaction between the calix[4]arene and the included ligand.  
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Figure 1.7: Palladium complexes of macrocyclic calix[4]arene ligands 
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1.3 Calix[4]arene inclusion complexes 
In addition to intramolecular inclusion complexes, calix[4]arenes have demonstrated an 
ability to form strong and selective intermolecular inclusion complexes (Figure 1.8). This 
includes the ubiquitous p-tertbutyl-calix[4]arene (A1) which has been used to form host-
guest complexes with a variety of small molecules such as chloroform, benzene, 4-
fluorotoluene and toluene.51, 52 Encapsulation of these small molecules was observed by 1H 
NMR spectroscopy by the upfield shift of the guest protons which interact with the ring 
currents of the calix[4]arene cavity walls. X-ray diffraction has also been used to confirm the 
presence of guest molecules within the calix[4]arene cavity.7, 53 In some cases, guests have 
been subsequently removed, however this typically requires prolonged heating at high 
temperatures under vacuum.12  
 
 
Figure 1.8: Schematic of calix[4]arene inclusion complexes 
p-tertButylcalix[4]arene has also been shown to encapsulate anisole in a 2:1 ratio (A44, 
Figure 1.9).54 This host-guest adduct was characterised by X-ray crystallography, indicating 
the presence of the anisole within the closed cage, created by the two calix[4]arene 
macrocycles, although the anisole is observed to be disordered over eight possible 
orientations. 
 
 
 
Figure 1.9: p-tertButlycalix[4]arene-anisole host guest complex reported by Ungaro 
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The encapsulation of xenon within the cavity of A1 has been reported by Ripmeester, by 
vapour diffusion into a saturated solution of the calix[4]arene in nitrobenzene.55  The host-
guest complex was characterised in the solid state by X-ray crystallography (Figure 1.10) and 
by 129Xe NMR spectroscopy. Both techniques showed the presence of Xe in two sites, as 
indicated by disorder in the solid state and the presence of two 129Xe  resonances observed 
at δ 59 and δ 64.  
 
Figure 1.10: X-ray crystal structure of Xe encapsulated within p-tertbutylcalix[4]arene (A1) 
 
In addition to neutral guest molecules, a large number of examples of calix[4]arenes 
appended with donor or acceptor moieties, capable of acting as cation or anion complexation 
agents, have been reported. Calix[4]arenes acting as hosts to alkali metal guests are 
discussed in section 4.1.2.   
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1.4 N-Heterocyclic carbenes  
The growth of the NHC chemistry since the preparation of the first thermally stable NHC by 
Arduengo in 199156 is well established and widely reviewed over the last decade.57-62 This 
section will therefore only provide a brief introduction to their structure, binding 
characteristics and a short discussion of common multidentate NHC topologies.  
 
 
Figure 1.11: General NHC structures 
 
NHCs differ from other carbenes by the presence of heteroatoms, typically nitrogen, in the 
positions adjacent to the carbenic carbon. The most common examples are based around 5-
membered ring structures (Figure 1.11), containing either a saturated (imidazolinylidene) or 
unsaturared backbone (imidazolylidine). N-substituents (R) or variation of the cyclic 
backbone substituents (R’) can be used to tune the properties of the NHC (vide infra). The 
stability of central carbene is thought to be a combination of the steric effects resulting from 
use of bulky R substituents but, more importantly the stability imparted by the electronic 
structure. This is widely accepted to be a result of the inductive σ effect which is a result of 
the electronegativity of the nitrogen resulting in the stabilization of the in-plane pair of 
unshared electrons and simultaneously the electron donation from the nitrogen p-orbitals 
into the vacant p-orbital on the carbenic centre.57, 63 This effect is observed in particular in 
cyclic carbenes where the carbonic carbon is forced into a more bent sp2 like arrangement, 
this favours the formation singlet state carbene structures.57 Coodination to transition 
metals then occurs by strong σ-donation from the carbene with complimentary and 
synergistic π-backbonding from the metal centre (Figure 1.12).58 64, 65 There is also 
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considerable evidence suggesting that NHC ligands can behave as π-donors in the presence 
of electron deficient metal centres (Figure 1.12).66, 67  
 
 
Although 5 membered NHC rings are the most common, 4, 6 and 7 membered structures are 
also known (Figure 1.13, A51-A55). ‘Abnormal’ C4 binding of 5-membered ring systems are 
also well established, for example ligand A47.68-71 Abnormal binding can be prevented by the 
functionalisation of the imidizolylidene backbone, most commonly with relatively inert 
methyl or benzyl groups. Electronic characteristics of NHC ligands can also be altered by the 
inclusion of a heteroatoms, such as sulfur or oxygen, or additional heteroatoms in the C4 or 
C5 positions.71 These electronic differences have a direct effect on the electron-donating 
ability of the carbene and can be quantified using Tolman’s electronic parameter (TEP).72  
 
Figure 1.12: MO diagram showing binding of a singlet NHC to a transition metal 
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Figure 1.13: Selected examples of N-heterocyclic carbene structures 
 
NHCs have been extensively investigated in organometallic chemistry and catalysis in recent 
years, largely due to their structural diversity. As such, a wide range of ligands with 
specifically designed topology including incorporation of bulky, coordinating and chiral 
groups have been prepared.60, 73 Polydentate NHCs have prepared in a wide variety of 
geometries including pincer, tripodal, ring and cage systems (Figure 1.14).62, 74-76 
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Figure 1.14: Pincer, ring and cage NHC structures 
 
Many chelating NHC ligands have been designed to favour strong binding to a metal centre, 
such as pincer ligands (Figure 1.14), which are held in position by a rigid donor group. The 
thermal stability and broad range of transition metal centres supported by pincer structures 
make them excellent systems for catalytic applications.74, 77 In addition to the popular pincer 
based motifs, a wide variety of supramolecular motifs have been described, including 
MOFs,78, 79 polymers80 and cage structures.81 Molecular cylinders from polydentate NHC 
precursurs have been reported by Hahn et al. 82 from a reaction between multidentate 
imidazolium proligands with Ag2O to form tri- or tetra- silver stacked complexes (A56-57, 
Figure 1.15).  
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Figure 1.15: Silver cage structures reported by Hahn 
 
The applications of carbenes can be broadly separated into catalysis, materials and medicinal 
chemistry.57, 58, 83, 84 The most well-known catalytic application of NHC complexes is 
undoubtedly Grubb’s second generation catalyst, which shows increased TOF and greater 
thermal stability than the phosphine bearing first generation catalyst (Figure 1.16).85, 86 
 
Figure 1.16: Grubb’s first and second generation catalysts 
 
Many examples of NHC metal catalysts have also been described in coupling,87 
hydrogenation,88 metathesis reactions58 with good stability in a wide variety of catalytic 
conditions.58 For example,  pyridine-enhanced precatalyst preparation stabilization 
and initiation (PEPPSI) is well reported in palladium catalysed coupling reactions such as  
Negishi and Suzuki coupling reactions (Figure 1.17).87 Ir species have been reported as 
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transfer hydrogenation catalysts e.g. A58 and A59.88, 89 A large number of Rh(I) and Ir(I) NHC 
complexes have also shown activity in the hydrosilation of multiple bonds, for example the 
addition of silanes to alkynes (A60) (Figure 1.17). 
 
Figure 1.17: Selection of NHC-transition metal catalysts 
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1.5  NHC functionalised calix[4]arenes 
Despite the prominence of NHC-based complexes in organometallic chemistry, relatively few 
NHC functionalsed calix[4]arene complexes have been reported. The limited number of 
known examples are introduced in this section.  
Calix[4]arenes bearing NHC substituents on the lower rim have been reported by Katz and 
Solovyov, which were prepared by addition of dibromoalkanes in the presence of a base, to 
1,3-dialkoxylcalix[4]arenes and subsequent alkylation with an excess of 1-alkyl-imidazole 
(Scheme 1.14).90 The Au(I) complexes of these ligands were then formed using 
transmetallation from the isolatied Ag(I) complexes A62.  
 
 
Scheme 1.14: Ag and Au complexes of lower-rim functionalised calix[4]arenes  
 
Pro-ligands bearing methylene bridged imidazolium functionalities on the upper rim have 
been shown to result in a predisposition for subsequently bound metal fragments to be 
projected away, rather than over the calix[4]arene cavity (Scheme 1.15). These complexes 
have been investigated by Schatz et al., who synthesised A65 by addition of Pd(OAc)2 to the 
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bis(imidazolium) salt A64 in low yield (8%) due to simultaneous formation of polymeric 
species and A67 by transmetallation from the isolated complex [A66][AgCl2] with trans-
[Pd(MeCN)2Cl2] in CH2Cl2.91, 92 The cis-palladium complex A65 was found to catalyse Suzuki 
cross-coupling of phenylboronic acid and chlorotoluene to yield 4-methylbiphenyl in yields 
within the range of other chelating NHC systems. The molecular structure of the cis-
palladium complex was confirmed by X-ray diffraction which showed distortion of the NHC 
moieties and projection of the chloride ligands away from the central calix[4]arene cavity.  
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 1.15: Complexes of upper-rim NHC calix[4]arenes 
The structure of the Ag(I) complex [A66][BF4] was confirmed by X-ray diffraction.92 This 
showed Cs  symmetry due to the offset bending of the Ag centre (Scheme 1.16). VT 1H NMR 
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spectroscopy showed time averaged C2v symmetry at ambient temperature due to dynamic 
fluxional behaviour of this unit which was reduced to CS at temperatures below -33°C.92  
 
Sche.: Scheme 1.16: Fluctional structures of [A66][BF4] 
 
1,3-imidazolium functionalised calix[4]arene structures have been investigated by Dinarès 
and co-workers.93 iso-Propyl- and butyl-substituted 1,3-bis(imidazolium)calix[4]arenes 
(A68·2HX) have been used as selective anion receptors for carboxylate ions (Figure 1.18). 
These pro-ligands were also used in the preparation of trans-palladium complexes A69, by 
addition of [Pd(OAc)2]. The Pd adopts a square planar geometry over the calix[4]arene cavity 
enabled by the twisting of the NHC functionalities to a perpendicular position to the aromatic 
calix[4]arene walls. Both A69 complexes were found to be active catalysts in the Suzuki-
Miyaura coupling of 4-bromoacetophenone and phenylboronic acid producing diaryl 
products in good yields.94  
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Figure 1.18: Carboxylate binding and NHC based Pd calix[4]arene complexes  
 
Complexes of mono-substituted and 1,2-bis-substituted imidazolium calix[4]arene pro-
ligands have been described by Brenner and Matt.95 Palladium complexes A70 and A71 were 
produced by addition of Pd(OAc)2 to the imidazolium salts in ca. 37% yield (Figure 1.19). 
These low yields have been attributed to formation of oligometic by-products, however, 
these were not unambiguously identified.  The monosubstituted complex A72 was formed 
from PdCl2 and KBr in the presence of Cs2CO3 in pyridine and was isolated in good yield (75%). 
The trans configuration and the Cs-symmetry of the monomeric A70 and A71 complexes was 
established by 13C NMR spectroscopy (δ 168 (NCN)) and the three environments observed 
for the bridging methylene units. Coordination of the mono-substituted calix[4]arene 
scaffold was also used in the synthesis of a di-calix[4]arene complex A73 under similar 
conditions, but in the absence of pyridine and use of 0.5 equivalents of PdCl2.  
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Figure 1.19: Complexes of mono and 1,2-substituted NHC-calix[4]arene ligands 
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1.6 Thesis scope and objectives 
The development of calix[4]arene scaffolds bearing 1,3-fuctionalised donor groups has been 
identified as a pathway to the formation of chelating NHC ligand systems. With a view of 
exploiting the flexible and encapsulating characteristics of these structures this thesis aims 
to explore the coordination chemistry of calix[4]arene structures bearing 1,3-substituted 
NHC donors on the upper rim. Closely related imidazol-2-thione derivatives were 
subsequently synthesised and studied during the course of this work. The synthesis of 
mononucular organometallic species and formation of host-guest complexes were then 
targeted (Figure 1.20).  
 
 
Figure 1.20: 1,3-substituted calix[4]arenes studied in this thesis 
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2.0  Synthesis of calix[4]arene N-heterocyclic carbene and 
imidazol-2-thione ligands 
Overview 
This chapter discusses the development of the synthetic routes for the preparation of 1,3-
functionalised imidazolinium  (1·2HCl) and imidazolium (2·2HI) calix[4]arene pro-ligands. In 
situ generation of the free carbene 2a (R = Me) is also detailed, the formation of which was 
substantiated by the isolation of the thione adduct 3 by reaction with elemental sulfur. 
Comparisons between 2a, 3 and the monodentate IiPr2Me2 and IiPr2Me2S ligands are also 
made.  
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2.1 Introduction 
2.1.1 Preparation of NHC pro-ligands 
Imidazolinium and imidazolium salts have been described in recent years as efficient NHC 
ligand precursors for the synthesis of transition metal complexes. These robust and bench 
stable salts can be made from a wide range of synthetic routes using commercially available 
starting materials and are readily converted to the free carbene by deprotonation at the C2 
position.1, 2 
2.1.1.1 Imidazolium pro-ligands 
Imidazolium pro-ligands are perhaps the most convenient NHC precursors due, in part, to 
the commercial availability of imidazole (currently available for £112.50/500 g from Sigma 
Aldrich, August 2016). Common synthetic routes to the formation of these precursors  are 
outlined in Scheme 2.1.3 
 
Scheme 2.1: Preparation of imidazolium salts 
 
Synthesis of symmetrically substituted imidazolium salts can be achieved from alkyl 
imidazoles prepared from a reaction between aniline, ammonium salt and aqueous glyoxal 
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in the presence of catalytic quantities of acid to form diazabutadienes which are then cyclised 
by addition of paraformaldehyde in aqueous conditions.4, 5 More simply alkylimidazoles can 
be prepared directly though SN2 substitution of allyl halides or Ullman coupling reaction of 
aryl halides.6-8 Subsequent alkylation of the resulting alkylimidazole readily affords the 
asymmetric N-functionalised imidazolium salts. Symmetric species can be synthesised via 
adaptions of these protocols or by a simple reaction between glyoxal and primary amines 
and cyclisation by addition of a CH+ source such as CH(OEt)3.9 
 
2.1.1.2 Imidazolinium pro-ligands 
Imidazolinium pro-ligands are chiefly synthesised through the formation of N,N’-
disubstituted-1,2-diamines, followed by addition of as CH+ source such as HC(OEt)3 
(Scheme 2.2).10  1,2-diamines are typically prepared by reduction of imines or amides. Other 
common routes include; formation of N,N’-disubstituted formamidines and cyclisation by 
addition of an excess of 1,2-dichloroethane, or reaction of lithium formamidinate with 
biselectrophiles such as 1,3,2-dioxathiolane-2,2-dioxide.9, 11, 12 13, 14 
Scheme 2.2: Preparation of imidizolinium salts 
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2.1.1.3 Other precursors 
While imidazolium and imidazolinium salts are generally considered the primary precursors 
for NHC ligands it is also worth noting other established NHC precursors, such as imidazol-2-
thiones (NHCSs).  These precursors are much more robust than free carbenes and are stable 
in the presence of water and air. The corresponding free NHC ligands can be produced by 
reduction of NHCS with potassium.15 Thione compounds are simply synthesised by 
condensation of N,N’-dialkylthioureas and 3-hydroxy-2-butanone,15  addition of CS2 to 1,2-
diamines,16 or addition of 1,1,3,3-tetrakis-(trifluoromethyl)-1,3-dithiethene to 
alkylimidazoles (although this route is limited NHCSs with (CF3)2CH substituents) 
(Scheme 2.3).17 Formation of imidazole-2-thiones by reaction of a free carbene, isolated or 
generated in situ, with elemental sulfur is another common route, although less useful in this 
context.18, 19 
 
Scheme 2.3: Preparation of NHCS products 
Other masked NHCs involve protection of the C2 position by derivatives of CO2, HCCl3, 
HC6F5 and are discussed in Chapter 3.  
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2.1.2 Preparation of calix[4]arene-based NHC pro-ligands 
Dinarès et al. have reported the synthesis 1,3-bis(imidazolium)-calix[4]arene salts 
[A68]2[PF6] by Ullman-type coupling of 1,3-dibromocalix[4]arene A74 with imidazole 
(Scheme 2.4).6, 20 Use of 20 mol % CuI, 80 mol % DMEDA, Cs2CO3 and heating at 170°C for 2 
days resulted in low yields (11 %) of A75. An increased yield of 89% was achieved by addition 
of equimolar CuI and DMEDA (50 mol %) and heating for 7 days at 170°C. Alkylation of A75 
using 1-bromoalkanes and counterion exchange using HPF6, resulted in the isolation 
of[A68]2[PF6] in good yields R = nBu, 80 %; and R = iPr =53 %. 
 
Scheme 2.4: Synthesis of 1,3-bis(imidazolium)calixarene salts [A68]2[PF6] described by Dinarès et al 
 
Imidazolium salts A68 (a and b) have been examined for their anion binding properties: 
analysis of Job plots for interactions with halides, CN -, acetate and benzoate indicated a 1:1 
receptor: anion binding stoichiometry. The A68 salts have also been used in the synthesis of 
palladium complexes (Figure 1.18, Chapter 1).   
The synthesis of methylene bridged tetrakis(imidazole) and tetrakis(imidazolium) 
calix[4]arenes have been reported by several groups. For example, Willans et al. have 
reported the synthesis of A77 and A78 through reaction of 
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tetrakisbromomethylcalix[4]arene A76 with imidazole or methylimidazole respectively 
(Scheme 2.5).7 Similar alkylation reactions of 1,2-di(chloromethyl)calix[4]arene A79 have 
been used for the preparation of bis(imidazolium) salt A80.21  
 
Scheme 2.5: Synthesis of A77, A78, A79 and A80 reported by Willans et al. 
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2.2 Results and discussion 
2.2.1 Imidazolinium functionalised calix[4]arenes 1·2HCl 
Based on preliminary work by Dr. Adrian Chaplin, the preparation of 1,3-
bis(imidazolinium)calix[4]arene pro-ligands 1·2HCl were initially targeted. These pro-ligands 
were prepared over 5-6 steps from tert-butylcalix[4]arene in an overall yields of <5% 
(Scheme 2.6).10,22-24 Formation of 1·2HCl were apparent by 1H NMR spectroscopy by the 
appearance of the characteristic high frequency NCHN resonances at δ 9.54 and 9.04 (CD3CN) 
for 1a.2HCl and 1b.2HCl, respectively.25 Strong parent ions with half-integer spacing were 
observed at 483.3018 m/z (cald. 483.3006 m/z) [M]2+ and 539.3631 m/z (cald.539.3632 m/z) 
[M]2+ by ESI-MS. A low-quality solid state structure (R1 = 15%) of 1b.2HCl was also determined 
by X-ray diffraction (Figure 2.1).  
 
Scheme 2.6: Synthesis of 1,3-substituted bis(imidazolinium)calix[4]arenes 1a.2HCl and 1b.2HCl. Conditions: 1) 
SnCl2.2H2O 2) DCC, HOBT, THF 3) i)BH3.THF ii) HCl, MeOH iii) HC(COEt)3 
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As well as the inclusion of the CH2Cl2 guest within the calix[4]arene cavity, the solid state of 
1b.2HCl is notable for the adoption of a distinct pinched-cone conformation, where the bulky 
and charged imidazolinium moieties are held at a NCH⋯NCH distance of 8.56(5) Å. Such 
pinched-cone conformations of upper rim substituted calix[4]arenes are well documented, 
can be driven by different factors, and have been shown to result in extensive deformation 
of the calix[4]arene scaffold.26 In order to quantify the extent of the calix[4]arene puckering 
in this thesis a ‘calix[4]arene puckering ratio’ (CPR) has been defined as the ratio of opposing 
upper rim carbon-carbon distances; CPR = r(CC)substituted/r(CC)unsubstituted (Figure 2.2).  
Figure 2.1: Solid state structure of 1b.2HCl in ball and stick view. Hydrogen atoms and anions are 
omitted for clarity. Selected bond lengths (Å ) and angles (°):C2⋯C16, 8.56(5); C50⋯C68, 6.55(3); 
C75⋯C57, 8.86(3); CPR = 0.739(4) 
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Figure 2.2: Calix[4]arene puckering ratio (CPR) definition 
 
For 1b.2HCl the CPR = 0.739(4), indicates that the calix[4]arene adopts a puckered 
conformation, driven by the steric repulsion of the tertbutyl groups rather than electrostatic 
interactions from the two charged imidazolium donors. Although the presence of the CH2Cl2 
guest can also be assumed to be a contributing factor.  
The preparation of 1·2HCl on a large scale, however proved problematic. In particular the 
literature nitration to form A81 resulted in inconsistent results and crude NMR spectra 
showed a variation in yield of the 1,3-product from 0-16% (cf. literature yields reported at 
24% (A81b)).22 Due to the inherent lack of selectivity of the direct nitration of p-
tertbutylcalix[4]arene A2, synthetic routes to selectively form A81 were investigated. For 
example 1,3-ditertbutylcalix[4]arene A86 can by synthesised by  exploitation of the benzoyl 
groups on the lower rim. Benzoyl chloride can be used to form the 1,3-substituted product, 
followed by selective dealkylation of the para positions.  The benzoyl groups are then easily 
hydrolysed and the lower rim alkylated. Nitration in this instance selectively proceeds via 
substitution of the bulky tertbutyl group. In this instance the increased number of steps 
resulted in only in a marginal increase in yield from 5 to 13% (Scheme 2.7).27, 28 
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Scheme 2.7: Nitration routes for the formation A81 a and b 
 
Alternative routes that could theoretically be adapted for the selective formation of 1,3-
dinitrocalix[4]arene products are known in literature, such as via isolation of boronic acid 
functionalised intermediates and reaction with bismuth nitrate (proposed route given in 
Scheme 2.8).29 However, due to the increased number of steps (five from A1) this route was 
not investigated during this project.  
Scheme 2.8: Proposed route for the formation of 1,3-dinitrocalix[4]arene 
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2.2.2 Imidazolium functionalised calix[4]arenes 2.2HI 
Given the low yielding preparation of 1.2HCl adaptions of known procedures for the 
preparation of 1,3-functionalised bis(imidazolium) calix[4]arene salts were targeted 
(Scheme 2.9). In this was the synthesis of new salt 2a.2HI was achieved using a six step 
synthesis starting from p-tertbutylcalix[4]arene A1 over ca. two weeks, with an overall yield 
of 7% (cf. <5% for 1·2HCl).30-33 Formation of A75 by Ullman-type coupling of imidazole and 
1,3-dibromocalix[4]arene A74 was achieved with an isolated yield of 62% (lit. 89 %).6 
Subsequent alkylation of A75 with MeI in THF gave 2a·2HI in 84% isolated yield. Formation 
of 2a.2HI was confirmed by 1H and 13C NMR spectroscopy, in particular a characteristic high 
frequency NCHN resonance was observed at δ 9.20 (CD2Cl2, Table 2.1). ESI-MS, which 
showed the expected parent dication peak  at 377.2220 m/z, [M]2+ (calcd 377.2224 m/z) with 
half integer spacing and microanalysis showed excellent agreement with calculated values.  
 
Scheme 2.9: Alkylation of 1,3-diimizadolcalix[4]arene A75 
 
Other alkylation reactions were assayed with a range of alkyl halides are summarised in 
Table 2.1Table 2.1. Alkylations involving nPrI, ICH2CH2OCH3 and BrCH2CH2CH=CH2 similarly 
proceeded with good conversion, however chloro containing (ClCH2CH2OCH3) and more 
bulky XiBu (X = Br, I) showed no conversion.  Due to the relatively high yield and structural 
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simplicity of the methyl product 2a.2HI, this salt was used for the synthesis of transition 
metal products.  
Table 2.1: Summary of alkylation reactions of A75  
Reagent Solvent Temp 
(°C) 
Time 
(h) 
Yield (%) δ NCHN 
 
ESI-MS 
[M] 2+¥ 
MeI THF 70 14 84 (isolated) 9.20 
(CD2Cl2) 
377.22 
nPrI THF 70 16 71 (isolated) 9.73 
(CD2Cl2) 
405.25 
BrCH2CH2CH=CH2 Dioxane 100 18 50 
(by NMR) 
10.35 
(CDCl3) 
 
417.3* 
ClCH2CH2OCH3 THF/ 
dioxane 
70-100 96 25 
(by NMR) 
10.55  
(CDCl3) 
- 
ClCH2CH2OCH3 Dioxane 100 24 Quantitative 
(by NMR) 
9.20 
(CDCl3) 
421.2* 
BriBu Dioxane 100 16 No reaction - - 
IiBu THF 80 16 No reaction - - 
*LR-ESI-MS ¥ All agree with calculated values 
 
The solid state structure of 2a.2HI was determined by X-ray diffraction (Figure 2.3). The 
calix[4]arene scaffold notably adopts a pinched cone conformation with a 
CPR = 2.247(9)/1.838(7) (two independent molecules observed). This puckering contrasts 
that found for 1b.2HCl (CPR = 0.739(4), (Figure 2.3), presumably a consequence of the 
reduced steric bulk on the upper rim (lack of tertbutyl groups). In this instance the distortion 
is presumably driven by columbic repulsion, resulting in NCHN⋯NCHN separations of 
13.43(2)/13.09(1). Although these large distances may superficially suggest that chelation of 
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2a.2HI may be difficult, it can be assumed that this geometry will not be retained in 
solution.34  
Figure 2.3: Solid-state structure of 2a·2HI Drawn in both thermal ellipsoids and stick for clarity. Ellipsoids drawn 
at the 30% probability level; only one of the two unique molecules shown (Z′ = 2); hydrogen atoms, anions and 
minor disordered components are omitted for clarity. Selected bond lengths (Å) and angles (°): C2⋯C8, 13.43(2); 
C102⋯C108, 13.09(2); C13⋯C27, 9.79(1); C20⋯C34, 4.27(2); C113⋯C127, 9.58(1); C120⋯C134, 5.22(2); 
CPR = 2.24(1), 1.838(7). 
 
Deprotonation of 2a.2HI was carried out using strong hindered bases K[OtBu] or K[N(SiMe3)2] 
in C6D6 or d8-THF at 298 K, resulting in quantitative formation of the free carbene 2a by 1H 
NMR spectroscopy (Scheme 2.10).  Although 2a is stable in solution under argon for 24 h, it 
could not be isolated and was therefore chatacterised in situ using 1H and 13C NMR 
spectroscopy in C6D6 or THF at 298 K. Formation of the free carbene 2a was confirmed by the 
loss of the high frequency NCHN resonance and the presence of a characteristic 13C carbenic 
resonance at δ 213.3 (C6D6)/ δ 216.0 (d8-THF). Both 1H and 13C{1H} spectra of 2a exhibit C2v 
symmetry with the NMe signals located at δ 4.17 and δ 37.8, respectively. The formation of 
the free carbene was also confirmed by a “trapping” experiment involving the addition of 
elemental sulfur and formation of a stable thione derivative which was subsequently isolated 
and fully characterised (vide infra).  
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2.2.3 Imidazol-2-thione functionalised calix[4]arene 3 
Synthesis of calix[4]arene imidazole-2-thione ligand 3 was initially achieved by reaction of 
2a, generated in situ from 2a.2HI and KOtBu in THF, with S8 as described above. The crude 
product was obtained with an apparent 88% yield, however, this material was later found to 
contain potassium salt impurities (see Chapter 4) and purification by column 
chromatography was necessary (silica, CH2Cl2, Et2O 3:1), ultimately leading to a low isolated 
yield of pure 3 (26 %). The synthesis of 3 was therefore adapted using inspiration from 
literature and prepared by deprotonation of 2a.2HI in the presence of S8 using the weak base 
K2CO3 in refluxing ethanol over 16 hours giving an improved yield of analytically pure 3 in 58 
% yield (Scheme 2.11).19, 35 
 
Scheme 2.11: Synthesis of 1,3-NHCS functinonalised calix[4]arene 3  
Scheme 2.10: Deprotonation of pro-ligand 2a.2HI to form free carbene 2a 
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The formation of 3 was fully corroborated by 1H and 13C NMR spectroscopy, ESI-MS, 
microanalysis and X-ray diffraction (Figure 2.4). Notably in CD2Cl2 solution, the NCN signal 
showed a significant downfield shift from δ 134.9 to 163.4  compared to 2a.2HI, but an 
upfield shift compared to 2a (δ 213.3, C6D6).  
 
 
 
 
 
 
 
As for 2a.2HI, the solid state structure of 3 (Figure 2.4) shows a pinching of the calix[4]arene 
scaffold. In this case the functionalised walls are contracted (NCSN-NCSN = 4.85(1), 
CPR = 0.419(1)) driven by apparent π-stacking of the imidazol-2-thione functionalities (Cnt-
Cnt – 3.460(9) Å). The thiones adopt an antiparallel arrangement resulting in an overall 
pseudo C2 symmetry. The structure was further corroborated by ESI-MS, where a [MH] + peak 
was observed, and by microanalysis.  
Figure 2.4: Solid state structure of 3 in ellipsoid view. Thermal ellipsoids drawn at the 50% probability level. 
Atoms denoted with * are generated from symmetry element 1+X,1-Y,1/2-Z Hydrogen atoms, anions and minor 
disordered units are omitted for clarity. Selected bond lengths (Å) and angles (°): S25⋯S25, 7.73(9); C50⋯C50*, 
4.235(11); C60⋯C60*, 10.118(12); C21⋯C21*, (4.4816(12), CPR = 0.419(1) 
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2.2.4 Model systems 
To help gain an insight into the role of the calix[4]arene scaffold in complexes derived from 
2a and 3, known "model" monodentate ligands, 1,3-diisopropyl-4,5dimethylimidazol-2-
ylidene (IiPr2Me2) and 1,3-diisopropyl-4,5-dimethylimidazol-2-thione (IiPr2Me2S), were 
prepared for comparison. The preparation of these model ligands was achieved using the 
procedure reported by Kuhn and Kratz (Scheme 2.12). Spectroscopic data of isolated 
materials showed excellent agreement with literature values.15 
 
Scheme 2.12: Synthesis of model ligands reported by Kuhn and Kratz 
 
The use of these mono-dentate ligands as models can be justified on the grounds of similar 
electronic and steric properties of the donor groups. For instance the good agreement of the 
carbenic and NCSN resonances can be noted:  δNCN 213.2 (C6D6, 2a) 205.9 (C6D6, IiPr2Me2), 
and δNCSN 163.4 (CD2Cl2, 3), 160.7 (CD2Cl2, IiPr2Me2S) (Table 2.2). Tolman’s electronic 
parameter (TEP), which is based on the A1 carbonyl stretching frequency of [Ni(CO)3(L)] 
complexes, can also be used to compare the electronic properties of the molecules.36 As can 
be seen from Table 2., substitution of the N or C4/C5 positions with alkyl or aryl substituents 
has little effect on this value.37 Moreover, the TEP value for IiPr2Me2 was found to be 
approximately the average value of those found for IMes and IDM (which can be used as an 
approximation for the unknown value for 2a). Percentage buried volume (%Vbur) represents 
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the percentage of a sphere around a metal which is occupied by the atoms of the ligand and 
can be used to approximate the steric effects of the NHC ligand.38 %Vbur values shown in 
Table 2. indicate that IiPr2Me2 is a suitable model for 2a, as the %Vbur is approximately the 
average of those of IMes and IDM.  
Overall it can be summarised that monodentate ligands IiPr2Me2 and IiPr2Me2S can provide 
a good representation of the donor characteristics of 2a and 3 and therefore differences in 
coordination chemistry are likely to be a result of the calix[4]arene scaffold. 
 
Table 2.2: Electronic and steric parameters of monodentate NHC and NHCS ligands and calix[4]arenes 2a and 3 
 
 
 
  
Ligand TEP /cm-1 %Vbur δ NCN /  δ 
NCSN 
IiPr2Me2 2051 28.0 205.9 (C6D6) 
IMes 2050 31.8 219.4  (C6D6)39 
IDM 2052 24.9 214.6 (C6D6)40 
2a - - 213.2 (C6D6)  
IiPr2Me2S - - 160.7 (CD2Cl2) 
3 - - 163.4 (CD2Cl2) 
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2.3 Conclusion  
Synthetic methodology for the preparation of 1·2HCl has been investigated. Formation of 
the 1,3-dinitrocalix[4]arene A82 proved to be a significant challenge and encumbered 
synthesis of meaningful quantities of 1·2HCl. Instead, adaption of literature procedures for 
closely related 1,3-substituted N-alkylimidazolium calix[4]arenes resulted in the reliable 
synthesis of satisfactory quantities of pro-ligand 2a.2HI. The corresponding free carbene 2a 
was readily formed in solution by addition of strong bases, characterised in situ and trapped 
by addition of elemental sulfur resulting in the formation of the imidazol-2-thione adduct 3. 
The donor characteristics of 2a and 3 are comparable to those of the mono-dentate ligands 
IiPr2Me2 and IiPr2Me2S, which will be used in parallel to assess the role of the calix[4]arene 
scaffold in the subsequent study of the coordination chemistry of 2a and 3.  
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2.4 Experimental section 
2.4.1 General considerations 
Unless otherwise stated all organic manipulations were carried out under a nitrogen 
atmosphere using standard Schlenk techniques. “Hi-dry” solvents were bought from Acros 
or Sigma Aldrich and unless otherwise stated used as received. THF and C6D6 were dried over 
Na, vacuum distilled, freeze-pump-thaw degassed three times and stored under argon. 
CD2Cl2 was distilled over CaH2, freeze-pump-thaw degassed three times under argon and 
stored over 3 Å molecular sieves under argon. d8-THF was dried over 3 Å molecular sieves 
and freeze–pump–thaw degassed three times before being placed under argon. A75 was 
synthesised by adaption of literature procedures.20, 27, 31-33 All other solvents and reagents are 
commercial products and were used as received. NMR spectra were recorded on Bruker DPX-
400, AV-400, AV-500 spectrometers at 298 K. Chemical shifts are quoted in ppm and coupling 
constants in Hz. ESI-MS were recorded on a Bruker MaXis mass spectrometer. Microanalysis 
were performed by Stephen Boyer at London Metropolitan University.  
2.4.2 Preparation of isolated products 
Pro-ligand (2a.2HI)  
A solution of A75 (1.00 g, 1.38 mmol) was stirred with iodomethane (0.84 mL, 13.8 mmol) in 
THF (30 mL) in a sealed J. Young’s flask 70°C for 14 hours. The resulting suspension was 
diluted with diethyl ether (ca. 20 mL), the solvent removed by filtration and the remaining 
precipitate washed with diethyl ether (2 x 20 mL). Volatiles were removed in vacuo. 
Yield = 1.17 g (84%, fine off-white powder). 1H NMR (CD2Cl2, 400 MHz) δ 9.20 (br, 2H, NCHN), 
8.04 (t, 3JHH = 1.8, 2H, Imid), 7.23 (d, 3JHH = 7.5, 4H, Ar), 7.05 (t, 3JHH = 7.5, 2H, Ar), 6.72 (t, 
JHH = 1.8, 2H, imid), 6.61 (s, 4H, Ar-imid), 4.54 (d, 2JHH = 13.5, 4H, ArCH2Ar), 4.17 (s, 6H, NCH3), 
4.03 – 4.09 (m, 4H, OCH2), 3.74 (t, 3JHH = 6.8, 4H, OCH2), 3.28 (d, 2JHH = 13.5, 4H, ArCH2Ar), 
1.87  –  2.06 (m, 8H, CH2CH3), 1.12 (t, 3JHH = 7.4, 6H, CH2CH3), 0.93 (t, 3JHH = 7.5, 6H, CH2CH3).  
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13C{1H} NMR (CD2Cl2, 101 MHz) δ 157.5 (COCH2), 157.3 (COCH2), 137.7 (Ar{CCH2}), 135.7 
(Ar{CCH2}), 134.9 (NCHN), 130.2 (Ar), 129.2 (Ar{CN}), 125.6 (Imid), 124.4 (Ar), 120.8 (Ar), 
119.9 (Imid), 78.1 (OCH2), 77.4 (OCH2), 37.8 (NCH3), 31.4 (ArCH2Ar), 23.9 (CH2CH3), 23.5 
(CH2CH3), 10.9 (CH2CH3), 10.2 (CH2CH3). ESI-MS (CH3CN, 180 °C, 3 kV) Positive ion 377.222 
m/z, [M]2+ (calc 377.222). Anal. Calcd. For C48H58I2N4O4 (1008.81 g∙mol-1): C, 57.13; H, 5.80; 
N, 5.55. Found: C, 56.88; H, 6.00; N, 5.55. 
General procedure for alkylation reactions of A75 
A solution of A75 and alkylhalide (5 equivalents) in THF or dioxane (5 mL) was heated. The 
resulting suspension was diluted with diethyl ether (ca. 20 mL), the solvent removed by 
filtration and the remaining precipitate washed with diethyl ether (2 x 20 mL). Volatiles were 
removed in vacuo. Yields and characterisation of products are summarised in Table 2.1. 
In situ generation of free carbene (2a) 
A suspension of 2a·2HI (10.2 mg, 0.0101 mmol) and K[OtBu] (3.1 mg, 0.0276 mmol) in d8-THF 
(0.5 mL) was agitated and sonicated for several minutes inside a sealed J. Young’s NMR tube. 
Analysis by NMR spectroscopy indicated quantitative formation of 2a with the concomitant 
formation of tBuOH (δ1H 5.33, OH; 1.15, CH3; δ13C 68.1, C̲CH3; 31.6, CH3). The reaction was 
repeated in C6D6 with the same outcome. The 1H NMR spectra remained unchanged on 
standing at 293 K for 24 h in both cases. 1H NMR (d8-THF, 500 MHz): δ 7.41 (s, 4H, Ar), 7.24 
(d, 3JHH = 1.6, 2H, imid.), 6.94 (d, 3JHH = 1.6, 2H, imid.), 6.40 (d, 3JHH = 7.5, 4H, Ar), 6.31 (app t, 
2H, J = 8, Ar), 4.51 (d, 2JHH = 13.1, 4H, ArCH̲2Ar), 4.00 – 4.04 (m, 4H, OCH2), 3.76–3.79 (m, 4H, 
OCH2), 3.76 (s, 6H, NCH3), 3.20 (d, 2JHH = 13.1, 4H, ArCH̲2Ar), 1.99 – 2.07 (m, 4H, CH̲2CH3), 
1.92–1.99 (m, 4H, CH̲2CH3), 1.10 (t, 3JHH = 7.4, 6H, CH2CH̲3), 0.98 (t, 3JHH = 7.5, 6H, CH2CH̲3). 
13C{1H} NMR (d8-THF, 126 MHz): δ 216.0 (s, NCN), 156.7 (s, C̲OCH2), 156.3 (s, C̲OCH2), 137.9 
(s, Ar{C̲N}), 137.6 (s, Ar{C̲CH2}), 134.5 (s, Ar{C̲CH2}),128.9 (s, Ar), 123.1 (s, Ar), 121.6 (s, Ar), 
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121.1 (s, imid.), 118.1 (s, imid.), 77.9 (s, OCH2), 77.7 (s, OCH2), 38.3 (s, NCH3), 32.0 (s, 
ArC̲H2Ar), 24.5 (s, C̲H2CH3), 24.2 (s, C̲H2CH3), 11.2 (s, CH2C̲H3), 10.7 (s, CH2C̲H3).  
1H NMR (C6D6, 500 MHz): δ 7.40 (s, 4H, Ar), 6.74 (d, 3JHH =7.5, 4H, Ar), 6.71 (br, 2H, imid.), 
6.61 (t, 3JHH = 7.5, 2H, Ar), 6.18 (br, 2H, imid.), 4.53 (d, 2JHH = 13.2, 4H, ArCH̲2Ar), 3.87 (t, 
3JHH = 7.6, 4H, OCH2), 3.76 (t, 3JHH = 7.4, 4H, OCH2), 3.42 (s, 6H, NCH3), 3.17 (d, 2JHH = 13.3, 4H, 
ArCH̲2Ar), 1.84–1.95 (m, 8H, CH̲2CH3), 0.93 (app. t, J = 7, 12H, CH2CH̲3). 13C{1H} NMR (C6D6, 
126 MHz): δ 213.2 (s, NCN), 156.7 (s, C̲OCH2), 155.5 (s, C̲OCH2), 137.1 (s, Ar{C̲N}), 136.4 (s, 
Ar{C̲CH2}), 134.7 (s, Ar{C̲CH2}), 128.8 (s, Ar), 123.0 (s, Ar),121.5 (s, Ar), 120.1 (s, imid.), 117.8 
(s, imid.), 77.1 (s, OCH2),77.0 (s, OCH2), 37.8 (s, NCH3), 31.6 (s, ArC̲H2Ar), 23.7 (s, C̲H2CH3), 
23.6 (s, C̲H2CH3), 10.6 (s, CH2C̲H3), 10.5 (s, CH2C̲H3). 
Deprotonation using K[N(SiMe3)2] in C6D6: 
Prepared in situ as described above. 
1H NMR (C6D6, 400 MHz) δ 7.45 (s, 4H, Ar), 6.77 (d, 3JHH = 1.6, 2H, Imid), 6.70 (d, 3JHH = 7.5, 
4H, Ar), 6.58 (t, 3JHH = 7.5, 2H, Ar), 6.21 (d, 3JHH = 1.6, 2H, Imid), 4.52 (d, 2JHH = 13.2, 4H, 
ArCH2Ar), 3.86 (t, 3JHH = 7.6, 4H, OCH2), 3.75 (t, 3JHH = 7.3, 4H, OCH2), 3.42 (s, 6H, NCH3), 3.14 
(d, 2JHH = 13.2, 4H, ArCH2Ar), 1.82 - 1.97 (m, 8H, CH2CH3), 0.92 (t, 3JHH = 7.4, 6H,CH2CH3). Co-
formation of HN(SiMe3)2 δ 0.1 (s, HN(SiMe3)2). 13C{1H} NMR (C6D6, 101 MHz) δ 215.8 (NCN), 
156.7 (COCH2), 155.4 (COCH2), 137.4 (Ar{CN}), 136.4 (Ar{CCH2}), 134.7 (Ar{CCH2}), 128.7 (Ar), 
123.0 (Ar), 121.3 (Ar), 120.0 (imid), 117.6 (imid), 77.1 (OCH2), 77.0 (OCH2), 37.9 (NCH3), 31.6 
(ArCH2Ar), 23.7 (CH2CH3), 23.6 (CH2CH3), 10.6 (CH2CH3), 10.5 (CH2CH3). 
Thione (3) 
A solution of 2a.2HI (495.0 mg, 0.4907 mmol), K2CO3 (400.0 mg, 0.894 mmol) and sulfur (40 
mg, 1.203 mmol) in ethanol (15 mL) was stirred at 90°C for 16 hours. The solvent was 
removed in vacuo and the resulting white powder extracted with CH2Cl2 and layered with 
pentane. Yield = 58% (231.0 mg, colourless crystals).  1H NMR (CD2Cl2, 400 MHz) δ 6.95 (s, 
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4H, Ar), 6.69 (d, 3JHH = 7.4 , 4H, Ar), 6.60 (m, 2H, Ar) , 6.57 (d, 3JHH =2.4 , 2H), 6.31 (d, 3JHH = 2.4 
, 2H), 4.51 (d, 2JHH = 13.3 , 4H, ArCH2Ar), 3.94, (t, 3JHH=7.5, 4H, OCH2), 3.87 (t, 3JHH =7.5, 4H, 
OCH2), 3.55 (s, 6H, CH3N), 3.24 (d, 2JHH= 13.4 , 4H, ArCH2Ar), 1.99 (m, 8H, CH2CH3), 1.02 (m, 
12H, CH2CH3).13C{1H} NMR (CD2Cl2, 101 MHz) δ 163.4 (NCN), 157.0 (COCH2), 156.6 (COCH2), 
136.4 (Ar{CCH2}), 135.2 (CCH2Ar), 132.9 (CNCH), 128.9 (Ar), 125.5 (Ar), 122.8 (Ar), 118.2 
(CHN), 118.0 (CHNCH3), 77.7 (OCH2), 77.5 (OCH2), 35.6 (CH3N), 31.4 (ArCH2Ar), 23.9 (CH2CH3), 
23.8 (CH2CH3), 10.7 (CH2CH3), 10.6 (CH2CH3). ESI-MS (CH3CN, 180°C, 4 kV) Positive ion: 
817.3818 m/z [MH]+ (calcd. 817.3816 m/z). Anal. Calcd. For C48H56N4O4S2 (MW 816.37 g mol-
1) (calc. C; 70.55, H; 6.91,N; 6.86) Found: C,70.69; H,6.74; N,7.71. 
 
2.4.2 Crystallography 
Structure determinations were carried out by Dr. A. B. Chaplin. Relevant crystallographic 
data are given in Table 2.3. Data were collected on an Oxford Diffraction Gemini Ruby CCD 
diffractometer using graphite monochromated CuKα radiation and a low-temperature 
device. Data were collected and reduced using CrysAlisPro. All non-hydrogen atoms were 
refined anisotropically using SHELXL,41 through the Olex2 interface. 
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Table 2.3: Crystallographic data for 1b·2HCl, 2a·2HI and 3 
 1b.2HCl 2a.2HI 3 
CCDC / ID 001abc12 1448987 0112abc14 
Figure Figure 2.2 Figure 2.5 Figure  
Formula C75H100Cl8N4O4 C51H64Cl6I2N4O4 C48H56N4O4S2 
M 1405.18 1263.56 817.08 
Crystal System Orthorhombic monoclinic tetragonal  
Space group P212121 P21/c I41/acd 
Radiation CuKα (λ = 1.54184) CuKα (λ = 1.54184) CuKα (λ = 1.54178) 
T [K] 100(2) 150(2) 150(2) 
a [Å] 16.8495(6) 24.1609(13) 30.2825(9) 
b [Å] 18.0909(7) 32.4937(10) 30.2825(9) 
c [Å] 25.3132(14) 16.4506(4) 20.5618(5) 
α[deg] 90 90 90 
 [deg] 90 101.091(4) 90 
γ [deg] 90 90 90 
V [Å3] 7716.0(6) 12673.8(9) 18855.8(12) 
Z [Z’] 4 8 16 
Density [gcm-3] 1.210 1.324 1.151 
 (mm-1) 3.040 10.439 1.375 
 range [deg] 12.712 to 79.934 12.712 to 133.202 12.798 to 120.022 
Reflns collected 8499 77500 40099 
Rint 0.0682 0.0837 0.0946 
Completeness 90.3% 99.8% 99.8 
No. of data/restr/param 4214/1222/777 22354/1339/1265 3497/0/265 
R1 [I > 2(I)] 0.1523 0.0843 0.1099 
wR2 [all data] 0.4269 0.2691 0.3304 
GoF 1.660 0.951 1.261 
Largest diff. pk and hole [eÅ-3] 0.95/-0.47 1.55/-0.79 0.99/-0.33 
Flack (x) 0.05(3) - - 
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3.0  Coordination chemistry of NHC pro-ligand (2a·2HI) 
Overview 
This chapter presents the coordination chemistry of the 1,3-bis(imidazolium)calix[4]arene 
pro-ligand 2a.2HI with rhodium(I) precursors [Rh(COD)Cl]2 and [Rh(CO)2Cl]2. In situ 
generation of the free carbene and reaction with Rh(I) precursors results in the formation of 
neutral bimetallic complexes, whereas transmetallation from an isolated silver transfer agent 
6a yields unusual µ2-Cl bridged dinuclear complexes (7a and 8a). The structures of the 
bimetallic products are supported by the synthesis and characterisation of model complexes 
bearing the monodentate IiPr2Me2 ligand. This comparison provides a platform for 
understanding the influence of the calix[4]arene backbone on the binding properties and 
reactivity of the NHC moieties (c.f. section 2.2.4).  
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3.1 Introduction 
 3.1.1 Complexes of NHC Ligands 
3.1.1.1 Deprotonation of azolium salts 
While many methods for the preparation of NHC complexes have been reported, the most 
common proceed via deprotonation of azolium salts at the most acidic C2 position. These 
and other notable synthetic routes for the formation of NHC complexes are outlined in 
Scheme 3.1.1 
Scheme 3.1: Common synthetic routes for the formation of NHC complexes  
 
Isolable free carbenes have been used to substitute relatively labile ligands such as THF, 
tmeda, py on monometallic precursors or fragment bimetallic metal precursors bridged by 
halides.1 In situ deprotonation of azolium salts followed by addition of metal precursors is a 
desirable alternative to the isolation of the free carbene as this route avoids the handling of 
potentially air and moisture sensitive carbenes.   
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In cases where the use of a strong base may result in deprotonation at multiple positions, 
weaker bases such as Cs2CO3 may be used in situ.2-5  Although the addition of a weak base to 
an azolium salt is unlikely to result in the formation of a high concentration of free carbene, 
metallation of these species in situ has been shown to proceed with good yields. This success 
has been attributed to thermodynamically favourable formation of the resulting NHC 
complexes.4, 6  
Another well-established synthetic route for the formation of NHC complexes is by the use 
of metal precursors containing basic ligands such as acetate, alkoxides or hyrides. Wanzlick 
and Öfele used this method in the synthesis of the first imidazolylidene complexes in the late 
1960s, using Hg(OAc)2 and [CrH(CO)5]-.7, 8  
 
3.1.1.2 Transmetallation reactions 
One of the most effective methods for the formation of late transition metal NHC complexes 
is by transmetallation from complexes containing a weak metal-carbene bond (Scheme 3.2). 
These so-called carbene transfer agents can be isolated or generated in situ.  The use of 
transfer agents is often favoured in order to avoid unwanted reactions resulting from the use 
of strong bases and storage of unstable free carbenes. 
Silver NHC complexes are the most common transfer agents and are typically formed by 
reaction between imidizolium salts and Ag2O.1, 4, 9 These complexes can be difficult to handle 
in some cases due to their instability in light.10-13 Previously reported products obtained in 
this manner include Au, Cu, Ni, Pd, Rh, Ir and Ru complexes.14-17 Typically bis-NHC2 complexes 
of Ag(I) adopt a linear conformation with Ag-NCN bond lengths of 2.05-2.15 Å and NCN-Ag-
NCN bond angles of 170-180°. 13C carbene resonances are typically observed between δ 170-
180, and 1JAgC coupling to both spin active, 107Ag and 109Ag isotopes can be observed (both 
spin = ½): coupling constants range from 180 to 234 Hz and 204 to 270 Hz, respectively.9 Ag-
carbene signals have not been observed for some complexes, this is speculated to be due to 
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dynamic behaviour on the NMR timescale.9 Imidazolinylidenes have been observed to be 
relatively inert to transmetallation compared to their unsaturated counterparts. This is 
thought to be a consequence of the relatively strong Ag-C bonds, which are not readily 
cleaved.  
 
 
Scheme 3.2: Transmetallation reactions of carbene transfer agents 
 
Although less common, copper(I), gold(I), nickel(I) and zirconium(IV)-NHC complexes can also 
be used as transfer agents (Scheme 3.2).13, 18-21 Copper complexes can result in cleaner 
formation of transition metal complexes and are more cost effective than the corresponding 
silver complexes (Cu2O £114/25 g cf. Ag2O £217/25 g, Sigma Aldrich 20/06/2016). Copper 
complexes are most commonly synthesised from the corresponding free carbene and 
therefore suffer from the issues described above, however, they can also be prepared from 
Cu2O in a method analogous to that described for Ag complexes, or by transmetallation from 
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isolated Ag complexes.18, 22 Transmetallation from Au(I) complexes is rare and requires the 
use of PPh3 and an oxygen free atmosphere.4, 18 The relative strength of NHC-M bonds 
decrease in order Au>Cu>Ag, and indeed Cu and Ag-NHC complexes have been used in the 
formation of Au-NHC complexes.19, 23 Nickel NHC-complexes can be formed by 
transmetallation from silver or copper complexes or by reaction of imidazolium salts with 
Raney Nickel powder.13, 17, 24 
 
3.1.1.3 Other routes 
Non-bulky imidazolinylidenes readily dimerize to form enetetramines. These dimers can be 
used as NHC precursors and a range of mono-, bis-, tris- and tetrakiscarbene complexes have 
been prepared in this way.25, 26 
As the isolation of a stable free carbene is not always viable, the reversible formation of NHC 
adducts of HY (Y = OR’, CCl3, C6F5) or CO2 can be exploited, these compounds are often 
referred to as “masked carbenes”. Oxidative addition of C2-X bonds (X = Me, H or halogen) 
to low valent transition metal complexes has been established since the 1970s as an operable 
route to NHC-M-X complexes. The majority of examples involve group 10 M(0) complexes, 
however, examples including Ir also exist.27, 28 
 
3.1.2 Rhodium complexes of NHC ligands 
A wide range of NHC complexes have been reported over the last 20 years and their 
synthesis, stability and catalytic applications are well reported.29-32 This introduction does not 
attempt to cover all of this vast quantity of work, but instead provide a brief overview to give 
an impression of known monodentate and polydentate Rh and Ir-NHC complexes.   
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3.1.2.1 Monodentate NHC ligands 
Monodentate NHC ligands have been used in a wide range of complexes, including bulky and 
fused ring structures which have been used to form low valent complexes featuring, agostic 
interactions or which undergo cyclometallation (Scheme 3.3).  
Raubenheimer et al. prepared a series of cationic and neutral Rh-NHC complexes by addition 
of isolated carbenes to [Rh(COD)Cl]2 (Scheme 3.3, A89 to A92).33 Use of an excess of 
[Rh(COD)Cl]2 resulted in the formation of neutral  mono-NHC chloride complexe A89, 
whereas addition of half an equivalent resulted in the formation of cationic bis-carbene 
complexes A91. Carbonyl species A90 and A92 were readily prepared by substitution of the 
COD by bubbling with CO and removal of free COD by pentane washing. Complexes A91 and 
A92 were tested for their activity in the catalytic hydroformylation of 1-hexene.  
Chaplin et al. have recently investigated a series of Rh and Ir complexes based on the 
conformationally rigid IBioxMe4 ligand first prepared by Glorius (Scheme 3.3, A93 to A100). 
34-37 Formation of mono-, bis- and tris- functionalised Rh and Ir complexes were described.34 
The rigid structure of the NHC ligand has enabled the formation of formally 14 valence 
electron rhodium(I) complex (Scheme 3.3, A98). The equivelent iridium(I) complex activates 
the C-H bonds of fluoroarenes resulting in the formation of 16 valance electron iridium(III) 
species.35 Nolans’ double C-H activated tertbutyl NHC Rhodium complexes A101 to A103 are 
also of particular interest due to their low coordination numbers and were formed by 
reaction of the ItBu ligand with a chloride bridged Rh(I)-olefin dimer (Scheme 3.3).38  
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Scheme 3.3: Preparation of selected Rh-NHC complexes 
 
Several groups have generated mixed NHC-phosphine complexes, for example Douglas et al. 
have studied the reaction of IiPr2Me2 with [HRh(PPh3)4], which results in the formation of a 
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mixture of mono and bis-NHC complexes (Scheme 3.4).39 By contrast reaction of 
[HRh(CO)(PPh3)3] with IiPr2Me2 resulted in a mixture of cis and trans bis-NHCcomplexes 
(A108 and A109) as well as the formation of an unsymmetrical µ-CO bridged dimer A110 
(Scheme 3.4).  
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Scheme 3.4: Synthesis of mixed NHC-Phosphine complexes reported by Douglas 
3.1.2.2 Multidentate NHC ligands  
Multidentate NHC ligands have been designed to adopt pincer, chain, ring and cage-based 
structures, which have been used to enhance catalytic selectivity, for stabilisation of low 
coordinate species and in the preparation of conjugated organometallic polymers with 
desirable electronic and mechanical properties.35, 40, 41  Pincer complexes are used extensively 
in catalysis due to their high stability under a range of catalytic conditions.42  
An excellent demonstration of the effect of co-ordination routes on complex geometry is the 
reactivity of the bis-NHC pincer ligand A111, reported by Hollis and co-workers (Scheme 
3.5).43 In this example a monometallic pincer type product was easily synthesised by 
transmetallation using a Zr(IV) transfer agent, providing a template for the pincer 
architecture (A112). Addition of the same rhodium based precursor to the free carbene 
generated in situ resulted in the direct formation of a bimetallic product A114. 
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Scheme 3.5: Synthesis of pincer and bimetallic Rh NHC complexes reported by Hollis and co-workers 
Veige and coworkers have reported the synthesis of rhodium(I) complexes based upon a 
chiral bis-NHC pro-ligand A115 (Scheme 3.6). Here they found that presence of an iPr group 
is sufficiently bulky to prevent the formation of an enetetramine structure, as evidenced by 
the NCN resonances observed at δ 226, A118 cf. 126, A116.44, 45 Reaction of the enetetramine 
with one equivalent of [Rh(NBD)2][BF4] under mild conditions resulted yielded the C1 
symmetric mononuclear complex A117. NBD was displaced by heating under a pressure of 
CO (100 bar) to yield cis-carbonyl species A120. Reaction of A116 or A118 with dinuclear 
[Rh(COD)Cl]2 yielded the C2 symmetric products A119. Complexes A117, A119 and A120 were 
found to be active in the hydroformylation of styrene.  
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Scheme 3.6: Synthesis of chiral Rh(I) complexes  
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3.2 Results and discussion 
3.2.1 Coordination of free carbene 2a 
Based on proceeding work (Chapter 2) the free carbene 2a was prepared in situ by 
deprotonation of 2a.2HI with K[OtBu] in THF and reacted with rhodium(I) dimers 
[Rh(COD)Cl]2 and [Rh(CO)2Cl]2 in the presence of excess KI, to avoid formation of mixed halide 
products (Scheme 3.7).  In the absence of excess KI mixed chloro and iodide species were 
observed. Halide exchange of this kind has been observed by Hollis and co-workers during 
the synthesis of bimetallic NHC complexes (Scheme 3.5).43  
 Use of 1 equivalent of [Rh(L2)Cl]2 (L2 = COD or (CO)2) per 2a resulted in the isolation of 
dinuclear complexes 4a and 5a. Reaction with 0.5 equivalents of dimer also resulted in the 
formation of these dimeric species, but alongside a significant quantity of 2a.2HI, formed by 
protonation of the carbene produced during work-up, as confirmed by the presence of a high 
frequency NCHN resonance at δ 8.81 (CD2Cl2) in the 1H NMR spectra of the crude reaction 
mixture.  
Complex 4a was purified over by column chromatography using a short alumina plug and 
isolated in good yield (53 % cf. similar bimetallic pincer-type products A114 isolated in 61 % 
yields).43 However, 5a isolated by the same method was obtained in a relatively low yield 
(17%).  An alternative synthesis of 5a was therefore developed via displacement of the COD 
ligand by CO (1 atm) in CH2Cl2. This reaction proved to be quantitative as determined by 1H 
NMR spectroscopy leading to an improved isolated yield of 37% (slightly improved yield of 
20 % over two steps from the starting 2a.2HI pro-ligand) with displaced COD removed by 
successive washings with pentane. The low isolated yield of 5a from 4a is attributed to non-
negligable solubility of 5a in pentane.  
Model complex 4b was readily synthesised in an analogous fashion by reaction of IiPr2Me2 
with [Rh(COD)Cl]2 and KI in THF. Subsequent purification over silica gave 4b in a 31% isolated 
yield. Model complex 5b was then easily formed by displacement of the COD ligand in 4b 
 78 
 
with CO (1 atm) and subsequent pentane washing and obtained in a good yield (59 %). The 
structure of complexes 4 and 5 were fully corroborated by 1H, 13C NMR and IR spectroscopy 
(for 5 vide infra) and microanalysis. NCN signals for 4a and 4b showed good agreement to 
those observed by Hollis and co-corkers for A114, δ 180.4 (4a), δ178.4 (4b) and 182.0 
(A114).43  
 
Scheme 3.7: Reactions of 2a and IiPr2Me2 with rhodium(I) dimers 
The structures of new complexes 4a and 4b were determined in the solid state by X-ray 
crystallography (Figure 3.1). In comparison to 2a.2HI, the calix[4]arene scaffold has 
undergone a conformational inversion in 4a, whereby the previously distant imidazolium 
groups of the pro-ligand are drawn together in an antiparallel arrangement, apparently 
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driven by π-stacking interactions between the imidazolyidene rings Cnt - Cnt = 3.608(5) Å, 
giving a CPR value of 0.4317(5) and pseudo C2 symmetry in the solid state.   
 
 
 
 
1H and 13C{1H} NMR spectra of 4a both exhibit a single resonance for the methyl moiety at 
δ 3.85 and 39.1, respectively. Together with the observation of the ArCH2Ar 1H resonances 
as two diastereotopic signals at δ 4.62, 4.50, 3.38, 3.19 (2JHH ~14 Hz) (Figure 3.2), it is apparent 
that C2 symmetry is retained in solution.  Moreover, the now inequivelent 1H resonances of 
the imidazolylidene functionalised aryl ring show a large divergence from that observed for 
the pro-ligand (δ 7.95 and 5.92 cf. 6.61 in 2.2HI). This is assumed to be a consequence of the 
proximity of the halogen atom CH∙∙∙I = 4.139(3)/4.295(3) Å. 
Figure 3.1: Solid state structures of 4a and 4b Thermal ellipsoids drawn at the 50% probability level. Hydrogen 
atoms, anions and minor disordered components are omitted for clarity. Selected bond lengths (Å)and angles 
(°):4a: Rh1–I3, 2.6905(3); Rh1–Cnt(C5,C6), 2.089(3); Rh1–Cnt(C9,C10), 2.001(3); Rh1–C21, 2.021(3); Rh2–I4, 
2.6934(3); Rh2–Cnt(C13,C14), 2.098(3); Rh1–Cnt(C17,C18), 1.990(4); Rh2–C27, 2.024(3); Rh1⋯Rh2, 8.5698(3); 
Cnt(C21–N25)–Cnt(C27–N31), 3.608(5); CPR = 0.3609(5) 4b: Rh1–I2, 2.6729(2); Rh1–Cnt(C3,C4), 2.109(2); Rh1–
Cnt(C7,C8), 2.00(3); Rh1–C11, 2.021(3) 
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Figure 3.2: 1H NMR spectra of 2a.2HI and 4a (CD2Cl2, 400 MHz, 298K) 
Adoption of square planar geometries, as expected for d8-metal complexes of this type, is 
seen in both 4a and 4b. The NHC binding is also in good agreement, with Rh-NCN bond 
lengths of 2.021(3)/2.024(3) Å and 2.021(3) Å, and CRhI bond angles of 89.8(6)/89.4(9)° and 
87.1(4)° for 4a and 4b, respectively. 13C NMR data resonances also show good agreement 
with the carbenes observed at δ 180.4 (1JRhC = 49 Hz) and δ 178.4 (1JRhC = 49 Hz) and diene 
signals at δ 95 (1JRhC = 7 Hz) and 72 (1JRhC = 14 Hz) for 4a and 4b respectively.  
Suitable samples of carbonyl complexes 5a and 5b have not yet been grown for structural 
elucidation by X-ray crystallography, however, solution data suggests that both adopt 
structures that are similar to 4a and 4b. The cis-configuration of the carbonyl ligands has 
been confirmed by the observation of two corresponding bands by IR spectroscopy (ν(CO)): 
2071, 2002 (5a) and 2072, 1998 cm-1 (5b)) and two high frequency doublets observed the 
13C{1H} NMR spectrum (δ 188.4 (1JRhC = 54 Hz) and 181.6 (1JRhC = 78 Hz); (5a) 188.7  (1JRhC ~53 
Hz) and 182.7 (1JRhC = 78 Hz)) (5b) The 1H and 13C NMR data of 5a also shows evidence for  C2 
symmetry as observed for the COD analogue. Both 5a and 5b show lower frequency 13C 
carbene resonances and reduction in coupling to 103Rh compared to 4a and 4b (e.g. δ 180.4  
(1JRhC ~49 Hz) (4a) cf. 171.5  (1JRhC ~44 Hz) (5a).  
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 3.2.2 Transmetallation reactions 
 In order to further investigate the coordination chemistry of pro-ligand 2a.2HI with 
rhodium(I) precursors, the silver calix[4]arene transfer agent 6a was synthesised (Scheme 
3.8). This was achieved by reaction between 2a.2HI, Ag2O and Na[BArF4], in a 1:1:0.99 ratio 
in CH2Cl2 . The resulting product was recrystallised from CH2Cl2/pentane to give 6a as 
colourless crystals in good yield (73 %). The use of an excess of Na[BArF4] per 2a.2HI resulted 
in the formation of a mixture of species, which could be bimetallic or multimetallic species 
or involve co-ordination of Na+ to the lower rim OnPr groups (Chapter 4).46, 47 Such species 
are evident by the presence of more than one equivalent of [BArF4]- per 2a by 1H NMR 
spectroscopy. Addition of a less than one equivalent of Na[BArF4] per 2a.2HI resulted in the 
formation of a mixture of products which were difficult to separate. The colourless crystalline 
6a was stored without decomposition in a glovebox under argon with the exclusion of light 
for several months. For comparison the model IiPr2Me2-based complex 6b was synthesised 
directly from the free carbene, Ag[OTf] and Na[BArF4] (Scheme 3.8). This biscarbene complex, 
bearing instead a tetrafluoroborate anion has been previously described by Abram (A121), 
however, for accurate comparison incorporation of the [BArF4]- counterion was more 
desirable.14  The solid-state structure of both 6a and 6b were obtained by X-ray diffraction 
(Figure 3.4). 
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Scheme 3.8: Synthesis of Ag(I) complexes 6a and 6b 
 
The structure of silver complex 6a was fully confirmed by 1H and 13C NMR spectroscopy, 
microanalysis and ESI-mass spectrometry, which showed a parent cation signal at 
859.3340 m/z [M]+ (calcd. 859.3347 m/z) with integer mass spacing and excellent agreement 
with the predicted isotope pattern (Figure 3.3). 
 
 
 
 
Figure 3.3: ESI-MS of 6a; observed [M] + ion (bottom) and predicted pattern (top) 
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Complex 6a was characterised in solution by the presence of two coincident doublet carbene 
13C resonances centred at δ 180.7, as a result of coupling to 107Ag and 109Ag. The observed 
coupling constants for Ag107 and Ag109 of 1JCAg = 183 Hz and 211 Hz, respectively, are in good 
agreement with literature values.9  However, the equivalent carbene signal could not be 
determined for 6b, presumably because it is too broad to be observed.14, 48 The X-ray 
structure of 6a shows a distorted linear geometry about the Ag centre of 170.00(14)° cf. 
176.81(15)° for 6b. The deviation from linearity in 6a is presumably a consequence of the 
chelating calix[4]arene scaffold. NCN-Ag bond lengths of 6a and 6b were in good agreement 
2.085(4)/2.083(4) Å (6a) cf. 2.078(11) Å (6b). The structure of 6a shows a near coplanar 
arrangement of the NHC donors and a puckering of the calix[4]arene scaffold as a result of 
chelation to the Ag centre, CPR = 0.5708(7). The solid-state structure of 6b is notable for a 
significantly more orthogonal orientation of the NHC ligands in comparison to 6a and A121, 
for example N6–C2–C8–N12 = 3.7(5)°, 6a; N3–C2–C15–N19 = 77.0(5)°, 6b; N–C–C–N = 
20.6(6)°, A121]. These differences are presumably due to crystal packing effects, induced by 
disparate anion sizes, and enabled through low-energy Ag– NHC bond rotation. 
 
 
 
Figure 3.4: Solid state structure of 6a and 6b. Thermal ellipsoids drawn at the 30% probability level. 
Hydrogen atoms, anions and minor disordered components are omitted for clarity. Selected bond 
lengths (Å) and angles (°) 6a: Ag1–C2, 2.085(4); Ag1–C8, 2.083(4); C2–Ag1–C8, 171.00(14); 6b: Ag1–C2, 
2.093(4); Ag1–C15, 2.092(4); C2–Ag1–C15, 176.81(15) CPR = 0.5708(7). 
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Transmetallation reactions of 6a with one equivalent of rhodium(I) dimers [Rh(COD)Cl]2 and 
[Rh(CO)2Cl]2 in 1,2-difluorobenzene resulted in the formation of bimetallic complexes 7a and 
8a respectively as the only isolable products in moderate yields of 63% and 59% (Scheme 
3.9). Reaction of 6a with 0.5 equivalents of the rhodium(I) dimer resulted in the formation 
of mixtures of 2a.2HI and 7a or 8a in equal measure, as determined by 1H NMR spectroscopy, 
showing that the bimetallic complexes are formed selectively. These products were difficult 
to purify due to low stability in solution, but were characterised in situ using 1H, 13C NMR and 
IR spectroscopy, and ESI-MS. A low resolution X-ray structure of 8a was also collected (Figure 
3.5). The monocationic character of both species was confirmed by integration of 1H NMR 
data which confirmed the presence of one equivalent of [BArF4] anion per calix[4]arene 
ligand. Parent cation signals were observed by ESI-MS with integer mass spacing and showed 
good agreement with calculated values (1209.3986 m/z [M] +, calcd. 1209.3973 m/z for 7a 
and 1105.1680 m/z [M] +, calcd. 1105.1891 m/z for 8a).  
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Scheme 3.9: Transmetallation reactions of 6a and 6b  
The presence of two inequivalent CO ligands can be identified in 8a from the observation of 
two 13C resonances at δ 182.7 (1JRhC = 53 Hz) and 181.0 (1JRhC = 80 Hz) (1,2-difluorobenzene). 
Inequivalent COD{CH} signals were observed by 13C NMR spectroscopy at δ 100.3, 96.4, 78.5 
and 71.8 for 7a. This data, alongside the presence of single 1H and 13C resonances for the N-
CH3 group and two sets of diastereotopic ArCH2Ar resonances, indicates the adoption of C2 
symmetry in solution for both 7a and 8a. The low quality solid state structure of 8a (R1 = 27%) 
shows pseudo C2 symmetry and pinching of the calix[4]arene scaffold with a CPR = 0.6371(4), 
a direct consequence of the presence of the µ-Cl bond.  
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In contrast to the selective transmetallation reactions of 6a, reactions of 6b with 
[Rh(COD)Cl]2 and [Rh(CO)2Cl]2 in 1,2-difluorobenzene resulted in the formation of 7b/9 (2:1 
ratio) and 8b/10 (5:2 ratio) respectively, as determined by 1H NMR spectroscopy (Scheme 
3.9).  
To authenticate the structures of the µ-Cl bridged IiPr2Me2 complexes 7b and 8b, these 
species were independently synthesised by reactions of known precursors A89 and A90,33 
with 0.5 equivalents of halide extractor Na[BArF4] in CH2Cl2 (Scheme 3.10). Complexes 7b and 
8b were subsequently isolated as single products in 69% and 66% yield, respectively, and 
fully characterised by 1H, 13C NMR and IR spectroscopy, ESI-MS, microanalysis and X-ray 
crystal diffraction (Figure 3.6).  
Complexes 7b and 8b were also used to help verify the structures of the calix[4]arene 
complexes 7a and 8a as their spectroscopic data showed excellent agreement. For instance, 
the carbene resonances for 7a and 7b were observed at δ 176.9 (1JRhC = 50 Hz) and 175.6 
(1JRhC = 50 Hz), and the carbonyl 13C signals and IR bands of 8a and 8b located at δ 182.7 (1JRhC 
= 53 Hz), 181.0 (1JRhC = 80 Hz) and δ 185.4 (1JRhC = 53 Hz), 181.0 (1JRhC = 84 Hz) and 2083/2016 
and 2090/2019 cm-1, respectively. Conformational differences, associated with the relative 
orientation of the NHC ligands about the Rh–Cl–Rh bridge, are evident by comparison of the 
Figure 3.5: Low resolution solid state structure of 8a in ellipsoid and stick view for clarity. Thermal 
ellipsoids drawn at the 50% probability level. Hydrogen atoms and anions are omitted for clarity. 
Selected bond lengths (Å) and angles (°):Rh1–Cl3, 2.353(5); Rh2–Cl3, 2.360(5); Rh1⋯Rh2, 3.861(3); 
Rh1–Cl3–Rh2, 110.0(3); CPR = 0.6371(4) 
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solid-state structures of 8a (anti) 7b (syn) and 8b (anti); 1H and 13C NMR data for 7a and 8a 
are consistent with anti-configurations in solution.  
 
 
 
 
 
 
Scheme 3.10: Synthesis of µ-Cl bridged IiPr2Me2 complexes 6b and 7b 
Reaction of 7b with CO (1 atm) resulted in the formation of a mixture of products, 
including A90, in agreement with reactivity observed for IDipp and IMes complexes 
reported by James et al.33 49 
Figure 3.6: Solid state structures of 7b and 8b. Thermal ellipsoids drawn at the 50% probability level. Hydrogen 
atoms, anions, minor disordered components and solvent molecules are omitted for clarity. Selected bond 
lengths (Å )and angles (°):7b: Rh1–Cl3, 2.3988(9); Rh1–Cnt(C4,C5), 2.092(5); Rh1–Cnt(C8,C9), 1.974(4); Rh1–
C20, 2.025(3); Rh2–Cl3, 2.4067(9); Rh2–Cnt(C12,C13), 2.101(4); Rh2–Cnt(C16,C17), 1.972(4); Rh2–C33, 
2.022(3); Rh1–Cl3–Rh2, 144.13(4); 8b: Rh1–Cl3, 2.4045(9); Rh1–C4, 1.915(4); Rh1–C6, 1.833(4); Rh1–C22, 
2.069(3); Rh2–Cl3, 2.3987(9); Rh2–C8, 1.920(4); Rh2–C10, 1.817(4); Rh2–C25, 2.069(3); Rh1–Cl3–Rh2, 
122.26(4). 
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bis-(IiPr2Me2) Complexes 9 and 10, formed during transmetallation reactions of 6b with 
Rh(I) dimers, containing the [BArF4] counter anions were independently prepared in 56% 
and 66% yields, respectively (Scheme 3.11). The structures of both compounds were fully 
characterised by 1H and 13C NMR spectroscopy, IR spectroscopy, ESI-MS, microanalysis 
and in the solid state by X-ray crystal diffraction (Figure 3.7). Complexes 9 and 10 show 
carbene NCN resonances were observed at δ 178.1 (1JRhC = 55.8 Hz) and 168.2 (1JRhC = 47 
Hz), respectively and ESI-MS showed parent ions at 571.3215 m/z [M]+ (calcd 571.3242 
m/z) for 9 and 519.2249 m/z [M]+ (calcd 519.2201 m/z) for 10. Additionally the IR 
spectrum of 10 showed carbonyl bands at 2077 and 2018 cm-1 (CH2Cl2), supporting the 
assertion that a cis complex was formed. X-ray structures showed the expected square 
planar binding and confirmed cis-binding of the CO ligands (Figure 3.7). 
 
Scheme 3.11: Synthesis of bis(IiPr2Me2) complexes 9 and 10 
 
 
Figure 3.7: Solid state structures of 9 and 10. Thermal ellipsoids drawn at the 50% probability level. 
Hydrogen atoms and anions are omitted for clarity. Selected bond lengths (Å) and angles (°): 8: Rh1–
C10, 2.086(3); Rh1–-C23, 2.073(3); Rh1–Cnt(C7,C6), 2.07(3); Rh1–Cnt(C2,C3) 2.06(9); 9: Rh1–C4, 
1.89(3); Rh1–C4, 1.893(3); Rh1–C6, 2.09(3); Rh1–C19, 2.08(3). 
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3.3 Conclusion 
A series of neutral and cationic calix[4]arene complexes have been synthesised from the 1,3-
bis(imidazolium) functionalised calix[4]arene proligand 2a.2HI described in Chapter 2, by in 
situ reactions of the free carbene or via transmetallation of the isolated monometallic 
silver(I) transfer agent (6a) with rhodium(I) dimers [Rh(COD)Cl]2 and [Rh(CO)2Cl]2. Both 
methods resulted in the formation of bimetallic structures, which have been characterised 
in solution using NMR and IR spectroscopy (CO derivatives), and ESI-MS (cationic complexes). 
Verification of their structural formulation was aided by excellent agreement with data from 
simpler and well-defined model complexes containing IiPr2Me2. Several solid-state 
structures, determined using X-ray diffraction, highlight the flexibility of the calix[4]arene 
scaffold, which can undergo significant conformational distortion as a result of charge 
repulsion (2a.2HI), π-stacking of the imidazolylidene rings (4a), trans-coordination to silver 
(6a), or presence of a bridging μ2-Cl ligand (8a). 
Comparisons of the transmetallation reactions of 2a and IiPr2Me2-based demonstrates the 
selectivity enforced by the presence of the calix[4]arene scaffold.  
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3.4 Experimental  
3.4.1 General Considerations 
All manipulations were performed under an atmosphere of argon, using Schlenk and glove 
box techniques unless otherwise stated. Glassware was oven dried at 150 °C overnight and 
flamed under vacuum prior to use. Anhydrous CH2Cl2, Et2O, and pentane (<0.005% H2O) were 
purchased from ACROS or Aldrich and freeze–pump–thaw degassed three times before 
being placed under argon. THF was dried over sodium/benzophenone, vacuum distilled, and 
freeze–pump–thaw degassed three times before being placed under argon. 1,2-C6H4F2 was 
stirred over neutral alumina, filtered, dried over CaH2, vacuum distilled, and freeze–pump–
thaw degassed three times before being placed under argon over 3 Å molecular sieves. 
CD2Cl2 was dried over CaH2, vacuum distilled, and freeze–pump–thaw degassed three times 
before being placed under argon. C6D6 was dried over Na, vacuum distilled, and freeze–
pump–thaw degassed three times before being placed under argon. [Rh(COD)Cl]2, 
[Rh(CO)2Cl]2, Na[BArF4], A89, and A90 were synthesised using adapted literature protocols.33, 
50-54 All other solvents and reagents are commercial products and were used as received. 
NMR spectra were recorded on Bruker AV spectrometers at 298 K unless otherwise stated. 
1H NMR spectra recorded in 1,2-C6H4F2 were referenced using the highest intensity peak of 
the highest (δ 6.865) frequency fluoro-arene multiplets. 13C{1H} NMR spectra recorded in 1,2-
C6H4F2 were referenced using an internal sealed capillary of C6D6. Chemical shifts are quoted 
in ppm and coupling constants in Hz. IR spectra were recorded on a PerkinElmer Spectrum 
One FT-IR spectrometer at 293 K. ESI-MS analyses were recorded on Bruker Maxis Impact 
instrument. Microanalyses were performed by Stephen Boyer at London Metropolitan 
University. 
3.4.2 Preparation of isolated complexes 
[2a(Rh(COD)I)2] (4a) 
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A solution of 2a·2HI (99.7 mg, 0.0987 mmol) and K[OtBu] (27.8 mg, 0.248 mmol) was stirred 
in THF (10 mL) for 1 hour then added to a flask charged with [Rh(COD)Cl]2 (51.6 mg, 0.105 
mmol) and KI (165.1 mg, 1.42 mmol). After a further hour the volatiles were removed in 
vacuo. The product was extracted with CH2Cl2 (2 × 10 mL) and purified by column 
chromatography (over alumina with 1 : 1 EtOAc/CH2Cl2, in air). Yield = 75.5 mg (53%, yellow 
powder). 1H NMR (CD2Cl2, 400 MHz): δ 7.95 (d, 4JHH = 2.8, 2H, Ar), 7.29–7.39 (m, 2H, Ar), 
7.04 – 7.14 (m, 2H, Ar), 6.97 (t, 3JHH = 7.4, 2H, Ar), 6.44 (d, 3JHH = 2.0, 2H, imid.), 6.19 (d, 3JHH = 
2.0, 2H, imid.), 5.92 (d, 4JHH = 2.8, 2H, Ar), 5.24 – 5.29 (m, 2H, COD{CH}), 4.92 – 5.09 (m, 2H, 
COD{CH}), 4.62 (d, 2JHH = 13.3, 2H, ArCH̲2Ar), 4.50 (d, 2JHH = 13.5, 2H, ArCH̲2Ar), 3.99 – 4.18 (m, 
4H, OCH2), 3.85 (s, 6H, NCH3), 3.65 – 3.82 (m, 4H, OCH2), 3.38 (d, 2JHH = 13.4, 2H, ArCH̲2Ar), 
3.21 – 3.26 (m, 2H, COD{CH}), 3.19 (d, 2JHH = 13.7, 2H, ArCH̲2Ar), 2.29 – 2.39 (m, 2H, COD{CH}), 
2.09–2.29 (m, 6H, COD{CH2}), 1.97 – 2.09 (m, 4H, CH̲2CH3), 1.83 – 1.97 (m, 6H, CH̲2CH3 + 
COD{CH2}), 1.58 – 1.79 (m, 4H, COD{CH2}), 1.27 – 1.46 (m, 4H, COD{CH2}), 1.15 (t, 3JHH = 7.4, 
6H, CH2CH̲3), 0.95 (t, 3JHH = 7.5, 6H, CH2CH̲3). 13C{1H} NMR (CD2Cl2, 101 MHz): δ 180.4 (d, 1JRhC 
= 49, NCN), 158.2 (s, C̲OCH2), 155.0 (s, C̲OCH2), 137.0 (s, Ar{C̲CH2}), 136.9 (s, Ar{C̲CH2}), 134.9 
(s, Ar{C}), 134.7 (s, Ar{C}), 134.3 (s, Ar{C}), 131.5 (s, Ar), 129.6 (s, Ar), 123.6 (s, Ar), 123.4 (s, 
imid.), 122.9 (s, Ar), 122.5 (s, imid.), 122.5 (s, Ar), 95.0 (d, 1JRhC = 7, COD{CH}), 95.0 (d, 1JRhC = 
7, COD{CH}), 77.7 (s, OCH2), 77.3 (s, OCH2), 71.4 (d, 1JRhC = 14, 2 × COD{CH}), 39.1 (s, NC̲H3), 
33.9 (s, COD{CH2}), 31.7 (s, CH2), 31.4 (s, CH2), 31.0 (s, CH2), 30.7 (s, CH2), 29.2 (s, COD{CH2}), 
23.8 (s, C̲H2CH3), 23.4 (s, C̲H2CH3), 11.3 (s, CH2C̲H3), 10.3 (s, CH2C̲H3). Anal. Calcd For 
C64H80I2N4O4 (1428.24 g mol−1): C, 53.79; H, 5.64; N, 3.92. Found: C, 53.71; H, 5.75; N, 4.04. 
[(IiPr2Me2)Rh(COD)I] (4b) 
A solution of IiPr2Me2 (61.2 mg, 0.336 mmol), [Rh(COD)Cl]2 (166.1 mg, 0.337 mmol) and KI 
(1072.2 mg, 6.46 mmol) in THF (10 mL) was stirred for 1 hour. The volatiles were removed in 
vacuo and the product obtained after purification by column chromatography (over silica, 
with CH2Cl2, in air) and subsequent recrystallisation from CH2Cl2/ pentane. Yield = 55.0 mg 
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(31%, yellow crystals). 1H NMR (CD2Cl2, 500 MHz): δ 5.97 (sept, 3JHH = 7.1, 2H,NCH), 5.03 – 
5.09 (m, 2H, COD{CH}), 3.50–3.57 (m, 2H, COD{CH}), 2.26–2.36 (m, 4H, COD{CH2}), 2.16 (s, 
6H, CCH̲3), 1.87 – 1.98 (m, 2H, COD1{CH2}), 1.73–1.83 (m, 2H, COD{CH2}), 1.56 (d, 3JHH = 7.1, 
6H, CHCH̲3), 1.50 (d, 3JHH = 7.1, 6H, CHCH̲3).13C{1H} NMR (CD2Cl2, 126 MHz): δ 178.4 (d, 
1JRhC = 49, NCN), 126.0 (s, C̲CH3), 95.2 (d, 1JRhC = 7, COD{CH}), 71.5 (d, 1JRhC = 14, COD{CH}), 
53.7 (s, NCH), 32.8 (s, COD{CH2}), 30.0 (s, COD{CH2}), 22.4 (s, CHC̲H3), 21.4 (s, CHC̲H3), 10.7 (s, 
CC̲H3). Anal. Calcd for C19H32I2N2Rh (518.29 g mol−1): C, 44.03; H, 6.22; N, 5.41. Found: C, 
44.11; H, 6.14; N, 5.47. 
[2a(Rh(CO)2I)2] (5a) 
Method A: A solution of 2a·2HI (102.1 mg, 0.101 mmol) and K[OtBu] (28.9 mg, 0.258 mmol) 
was stirred in THF (10 mL) for 1 hour then added to a flask charged with [Rh(CO)2Cl]2 (40.7 
mg, 0.105 mmol) and KI (165.4 mg, 0.996 mmol). After a further hour the volatiles were 
removed in vacuo. The product was extracted with CH2Cl2 (2 × 10 mL) and purified by column 
chromatography (over alumina, with 1 : 1 Et2O/CH2Cl2, in air). Yield = 22.4 mg (17%, yellow 
powder). 
Method B: A solution of 2a (121.2 mg, 0.0848 mmol) in CH2Cl2 (10 mL) was stirred under CO 
(1 atm) for 12 hours, resulting in a colour change from bright to pale yellow. The mixture was 
dried in vacuo and washed with pentane (3 × 5 mL). Yield = 42.1 mg (37%, yellow powder). 
1H NMR (CD2Cl2, 500 MHz): δ 7.26 (s, 2H, Ar), 7.02 (br, 4H, Ar), 6.82 (t, 3JHH = 7.4, 2H, Ar), 6.77 
(s, 2H, imid.), 6.46 (s, 2H, imid.), 6.41 (s, 2H, Ar), 4.51 (d, 2JHH = 13.3, 2H, ArCH̲2Ar), 4.48 (d, 
2JHH = 13.6, 2H, ArCH̲2Ar), 3.80 – 4.09 (m, 8H, OCH2), 3.77 (s, 6H, NCH3), 3.24 (d, 2JHH = 14.1, 
2H, ArCH̲2Ar), 3.22 (d, 2JHH = 14.1, 2H, ArCH̲2Ar), 1.79 – 2.16 (m, 8H, CH̲2CH3), 1.03 – 1.13 (m, 
6H, CH2CH̲3), 0.92 – 1.03 (m, 6H, CH2CH̲3). 13C{1H} NMR (CD2Cl2, 126 MHz): δ 188.4 (d, 1JRhC = 
54,CO), 181.6 (d, 1JRhC = 78, CO), 171.5 (d, 1JRhC = 44, NCN), 157.5 (s, C̲OCH2), 156.3 (s, C̲OCH2), 
136.2, 136.1, 135.9, 135.6, 130.6,129.4, 123.8, 123.4, 123.2, 122.8, 77.8 (OCH2), 77.4(OCH2), 
40.0 (s, NCH3), 31.5 (br, ArC̲H2Ar), 24.0 (C̲H2CH3), 23.7 (C̲H2CH3), 11.0 (s, CH2C̲H3), 10.4 (s, 
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CH2C̲H3). Not all signals were unambiguously identified. IR (CH2Cl2, cm−1): ν(CO) 2071, 2002. 
Anal. Calcd for C52H56I2N4O8Rh2 (1324.02 g mol−1): C, 47.15; H, 4.26; N, 4.23. Found: C, 46.91; 
H, 4.12; N, 4.25. 
[(IiPr2Me2)(Rh(CO)2I)] (5b) 
A solution of 4b (40.1 mg, 0.0774 mmol) in CH2Cl2 (10 mL) was placed under an atmosphere 
of CO (1 atm) for 2 hours. The volatiles were removed in vacuo to afford the product, which 
was washed with pentane (3 × 10 mL) and dried thoroughly under vacuum. Yield = 21.4 mg 
(59%, fine yellow powder).1H NMR (CD2Cl2, 500 MHz): δ 5.26 (sept, 3JHH = 7.1, 2H, NCH), 2.22 
(s, 6H, CCH3), 1.501 (d, 3JHH = 7.1, 6H, CHCH̲3), 1.496 (d, 3JHH = 2.7, 6H, CHCH̲3). 13C{1H} NMR 
(CD2Cl2, 126 MHz): δ 188.7 (d, 1JRhC = 53, CO), 182.7 (d, 1JRhC = 78, CO), 166.8 (d, 1JRhC = 41, 
NCN), 127.2 (s, C̲CH3), 54.3 (s, C̲HCH3), 22.2 (s, CHC̲H3), 21.1 (s, CHC̲H3), 10.7 (s, CC̲H3). IR 
(CH2Cl2, cm−1): ν(CO) 2072, 1998. Anal. Calcd for C13H20I2N2O2Rh (466.12 g mol−1): C, 33.50; H, 
4.33; N, 6.01. Found: C, 33.41; H, 4.25; N, 6.03. 
[(2a)Ag][BArF4] (6a) 
A suspension of 2a·2HI (79.5 mg, 0.0788 mmol), Ag2O (20.0 mg, 0.0862 mmol) and 
Na[BArF4]   (69.0 mg, 0.0778 mmol) in CH2Cl2 (20 mL) was sonicated periodically over 2 hours. 
The solution was filtered and the solvent was removed in vacuo to afford the product. Yield 
= 100.0 mg (73%, white crystals). 1H NMR (400 MHz, CD2Cl2): δ 7.72–7.76 (m, 8H, ArF), 7.57 
(br, 4H, ArF), 7.10 (d, 3JHH = 7.4, 4H, Ar), 6.92 (d, 3JHH = 1.7, 2H, imid.), 6.85 (t, 3JHH = 7.5, 2H, 
Ar), 6.81 (d, 3JHH = 1.7, 2H, imid.), 6.40 (s, 4H, Ar), 4.57 (d, 2JHH = 12.8, 4H, ArCH̲2Ar), 4.10–4.22 
(m, 4H, OCH2), 3.80 (s, 6H, NCH3), 3.74 (t, 3JHH = 7.1, 4H, OCH2), 3.24 (d, 2JHH 2JHH = 12.8, 4H, 
ArCH̲2Ar), 2.10–2.21 (m, 4H, CH̲2CH3), 1.99 (app. sex., J = 7, 4H, CH̲2CH3), 1.12 (t, 3JHH = 7.4, 
6H, CH2CH̲3), 0.98 (t, 3JHH = 7.5, 6H, CH2CH̲3). 13C{1H} NMR (CD2Cl2, 101 MHz): δ 180.7 (two 
coincident d,1J109AgC = 211, 1J107AgC = 183, NCN), 162.3 (q, 1JBC = 50.5, ArF), 157.8 (C̲OCH2), 156.7 
(s, C̲OCH2), 136.5 (s, 2 × Ar{C}), 135.4 (s, ArF), 134.3 (s, Ar{C}), 129.4 (qq, 2JFC = 32, 3JBC = 3, 
ArF),129.3 (s, Ar), 118.0 (sept, 3JFC = 4, ArF), 126.4 (s, Ar), 125.2 (q, 1JFC = 272, ArF), 124.7 (d, 
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3JAgC = 6, imid.), 123.4 (s, Ar), 121.9 (d, 3JAgC = 6, imid.), 118.0 (sept, 3JFC = 4, ArF), 78.7 (s, OCH2), 
77.2 (s, OCH2), 38.8 (d, 3JAgC = 3, NCH3), 31.4 (s, ArC̲H2Ar), 24.0 (s, C̲H2CH3), 23.5 (s, C̲H2CH3), 
11.0 (s, CH2C̲H3), 10.1 (s, CH2C̲H3). ESI-MS (CH3CN, 180 °C, 3 kV) positive ion: 859.3340 m/z, 
[M]+ (calcd 859.3347 m/z). Anal. Calcd For C80H68AgBF24N4O4 (1724.09 g mol−1):C, 55.73; H, 
3.98; N, 3.25. Found: C, 55.85; H, 4.08; N, 3.33. 
[(2a)Rh2(COD)2Cl][BArF4] (7a) 
A solution of 6a (29.9 mg, 0.0173 mmol) and [Rh(COD)Cl]2 (9.4 mg, 0.0191 mmol) in 1,2-
C6H4F2 (0.5 mL) was stirred for 1 hour with the exclusion of light. The solvent was removed 
in vacuo and the resulting crude material washed with pentane and dried in vacuo. 
Yield = 22.3 mg (63%, yellow powder). The product was characterised in situ, although has 
limited stability in solution. 1H NMR (1,2-C6H4F2/C6D6, 500 MHz): δ 8.09 – 8.15 (m, 8H, ArF), 
7.49 (br, 4H, ArF) 5.44 (br, 2H, COD{CH}), 5.38 (br, 2H, COD{CH}), 4.58 (d, 2JHH = 13.6, 2H, 
ArCH̲2Ar), 4.49 (d, 2JHH = 13.6, 2H, ArCH̲2Ar), 4.20 (s, 6H, NCH3), 3.96 – 4.24 (m), 3.67–3.76 
(m), 3.55 – 3.63 (m), 3.49–3.55 (m), 3.46 (d, 2JHH = 13.6, 2H, ArCH̲2Ar), 3.23 – 3.33 (m), 3.09 
(d, 2JHH = 13.6, 2H, ArCH̲2Ar), 1.35–2.50 (m, CH2), 1.03 (t, 3JHH = 6.9, 6H, CH2CH̲3), 0.85 (t, 3JHH 
= 6.9, 6H, CH2CH̲3), 0.7–1.1 (m, COD{CH2}). Not all signals unambiguously assigned and some 
signals obscured by solvent peak. 13C{1H} NMR (1,2-C6H4F2/C6D6, 126 MHz, selected signals 
only): δ 176.9 (d, 1JRhC = 50, NCN), 100.3 (br, COD{CH}), 96.4 (br, COD{CH}), 78.5 (d, 1JRhC = 14, 
COD{CH}), 71.8 (d, 1JRhC = 13, COD{CH}), 97.7 (d, 1JRhC = 7, COD{CH}), 70.2 (d, 1JRhC = 16, 
COD{CH}), 37.8 (s, NCH3). ESI-MS (CH3CN, 180 °C, 3 kV): positive ion: 1209.3986 m/z, [M]+ 
(calcd 1209.3973 m/z). 
[(IiPr2Me2)2Rh2(COD)2Cl]  (7b) 
A solution of A89 (23.6 mg, 0.0553 mmol) and Na[BArF4]   (24.5 mg, 0.0275 mmol) in CH2Cl2 
(10 mL) was stirred for 1 hour. The solution was then filtered and layered with pentane to 
afford the product on diffusion. Yield = 32.0 mg (69%, yellow crystals).  1H NMR (CD2Cl2, 500 
MHz): δ 7.70–7.74 (m, 8H, ArF), 7.56 (br, 4H, ArF), 5.91 (sept, 3JHH = 7.1, 4H, NCH), 4.75 (s, 4H, 
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COD{CH}), 3.51 (s, 4H, COD{CH}), 2.22–2.36 (m, 8H, COD{CH2}), 2.11 (s, 12H, CCH3), 1.81–1.93 
(m, 8H, COD{CH2}), 1.57 (d, 3JHH = 7.0, 12H, CHCH̲3), 1.36 (d, 3JHH = 7.0, 12H, CHCH̲3). 
13C{1H}NMR (CD2Cl2, 126 MHz): δ 175.6 (d, 1JRhC = 50, NCN), 162.3 (q, 1JBC = 51, ArF), 135.4 (s, 
ArF), 129.4 (qq, 2JFC = 31, 3JBC = 3, ArF), 126.3 (s, C̲CH3), 125.2 (q, 1JFC =272, ArF), 118.0 (sept, 
3JFC = 4, ArF), 97.7 (d, 1JRhC = 7, COD{CH}), 70.2 (d, 1JRhC = 16, COD{CH}), 54.3 (s, NCH), 33.1 (s, 
COD{CH2}), 29.1 (s, COD{CH2}), 22.5 (s, CHC̲H3), 22.2 (s, CHC̲H3), 10.5 (s, CC̲H3). ESI-MS (CH3CN, 
180 °C, 3 kV) positive ion: 817.2872 m/z, [M]+ (calcd 817.2924 m/z). Anal. Calcd For 
C70H76BF24N4Rh2Cl (1434.39 g mol−1): C, 49.97; H, 4.56; N, 3.33. Found: C, 50.18; H, 4.52; N, 
3.23. 
[2a·Rh2(CO)4Cl][BArF4] (8a) 
A solution of 6a (32.0 mg, 0.0186 mmol) and [Rh(CO)2Cl]2 (7.8 mg, 0.0201 mmol) in 1,2-C6H4F2 
(10 mL) was stirred for one hour with the exclusion of light. The cloudy yellow solution was 
filtered, reduced to dryness and the resulting residue washed with pentane. Yield = 21.4 mg 
(31%, yellow powder). The product was characterised in situ, although has limited stability 
in solution. 1H NMR (1,2-C6H4F2/C6D6, 500 MHz): δ 8.11 – 8.15 (m, 8H, ArF), 7.49 (br, 4H, ArF), 
4.52 (d, 2JHH = 12.6, 2H, ArCH̲2Ar), 4.51 (d, 2JHH = 12.6, 2H, ArCH̲2Ar), 4.05 – 4.19 (m, 2H, OCH2), 
3.88 – 3.99 (m, 2H, OCH2), 3.84 (s, 6H, NCH3), 3.51 – 3.65 (m, 4H, OCH2), 3.18 (d, 2JHH = 12.6, 
2H, ArCH̲2Ar), 3.15 (d, 2JHH = 12.6, 2H, ArCH̲2Ar), 2.11 – 2.23 (m, 4H, CH̲2CH3), 1.79 – 1.92 (m, 
4H, CH̲2CH3), 0.94 (t, 3JHH = 7.5, 6H, CH2CH̲3), 0.93 (t, 3JHH = 7.5, 6H, CH2CH̲3). Some signals 
obscured by solvent peak. 13C{1H} NMR (1,2-C6H4F2/C6D6, 126 MHz, selected signals only): δ 
182.7 (d, 1JRhC = 53, CO), 181.0 (d, 1JRhC = 80, CO), 168.1 (d, 1JRhC = 43, NCN), 36.3 (s, NCH3). 
ESI-MS (CH3CN, 180 °C, 3 kV) positive ion: 1105.1680 m/z, [M]+ (calcd 1105.1891 m/z). IR 
(CH2Cl2, cm−1): ν(CO) 2083, 2016. 
[(IiPr2Me2)2Rh2(CO)4Cl][BArF4] (8b) 
A solution of A90 (26.5 mg, 0.709 mmol) and Na[BArF4] (32.6 mg, 0.368 mmol) in CH2Cl2 (5 
mL) was stirred for 1 hour. The solution was then filtered and layered with pentane to afford 
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the product on diffusion. Yield = 37.1 mg (66%, yellow crystals). 1H NMR (CD2Cl2, 400 MHz): 
δ 7.67 – 7.77 (m, 8H, ArF), 7.56 (br, 4H, ArF), 5.20 (sept, 3JHH = 7.1, 4H, NCH), 2.18 (s, 12H 
CCH̲3), 1.55 (d, 3JHH = 7.1, 12H, CHCH̲3), 1.50 (d, 3JHH = 7.0, 12H, CHCH̲3).13C{1H} NMR (CD2Cl2, 
101 MHz): δ 185.4 (d, 1JRhC = 53, CO), 181.0 (d, 1JRhC = 84, CO), 162.3 (q, 1JBC = 50, ArF), 135.4 
(s, ArF), 129.4 (qq, 2JFC = 32, 3JBC = 3, ArF), 128.0 (s, CCH3), 125.2 (q, 1JFC = 272, ArF), 54.8 (s, 
NCH), 22.8 (s, CHC̲H3), 22.4 (s, CHC̲H3)2, (s, 10.6 CC̲H3). The carbene resonance was not 
located. ESI-MS (CH3CN, 180 °C, 3 kV) positive ion: 713.0829 m/z, [M]+ (calcd 713.0843 m/z). 
IR (CH2Cl2, cm−1): ν(CO) 2090, 2019. Anal. Calcd For C58H52BClF24N4O4Rh2Cl (1577.11 g mol−1): 
C, 44.17; H, 3.32; N, 3.55. Found: C, 44.51; H, 3.57; N, 3.49. 
[(IiPr2Me2)2Rh(COD)][BArF4] (9) 
A solution of IiPr2Me2 (50.8 mg, 0.282 mmol), [Rh(COD)Cl]2 (34.3 mg, 0.0696 mmol) and 
Na[BArF4] (123.4 mg, 0.139 mmol) was stirred in 1,2-C6H4F2 (5 mL) for 2.5 h. The solution was 
then filtered and layered with pentane to afford the product on diffusion. Yield = 114.0 mg 
(56%, yellow crystals). 1H NMR (CD2Cl2, 500 MHz): δ 7.71 – 7.75 (m, 8H, ArF), 7.56 (br, 4H, 
ArF), 5.56 (sept, 3JHH = 7.1, 4H, NCH), 4.27 (s, 4H, COD{CH}), 2.31 – 2.40 (m, 4H, COD{CH2}), 
2.16 (s, 12H, CCH3), 2.01 – 2.11 (m, 4H, COD{CH2}), 1.55 (d, 3JHH = 7.1, 12H, CHCH̲3), 1.22 (d, 
3JHH = 7.1, 12H, CHCH̲3). 13C{1H} NMR (CD2Cl2, 126 MHz): δ 178.1 (d, 1JRhC = 55.8, NCN), 162.3 
(q, 1JBC = 50, ArF), 135.4 (s, ArF), 129.4 (qq, 2JFC = 32, 3JBC = 3, ArF), 127.1 (s, C̲CH3), 125.2 (q, 1JFC 
= 272, ArF), 118.0 (sept, 3JFC = 4, ArF), 87.2 (d, 1JRhC = 8, COD{CH}), 54.5 (s, NCH), 31.8 (s, 
COD{CH2}), 22.9 (s, CHC̲H3), 21.6 (s, CHC̲H3), 10.9 (s, CC̲H3). ESI-MS (CH3CN, 180 °C, 3 kV) 
positive ion: 571.3215 m/z [M]+ (calcd 571.3242 m/z). Anal. Calcd For C62H64BF24N4Rh 
(1434.39 g mol−1): C, 51.96; H, 4.49; N, 3.90. Found: C, 52.05; H, 4.59; N, 3.93. 
[(IiPr2Me2)2Rh(CO)2][BArF4] (10) 
A solution of 9 (113.9 mg, 0.0794 mmol) in 1,2-C6H4F2 (5 mL) was stirred under an 
atmosphere of CO (1 atm) for 24 hours. The solvent was removed in vacuo and the resulting 
crude material washed with pentane and recrystallised from CH2Cl2/ pentane. Yield = 72.4 
 97 
 
mg (66%, orange powder). 1H NMR (CD2Cl2, 500 MHz): δ 7.71–7.75 (m, 8H, ArF), 7.56 (br, 4H, 
ArF), 5.05 (sept, 3JHH = 7.1, 4H, NCH), 2.20 (s, 12H, CCH3), 1.46 (d, 3JHH = 7.1, 12H, CHCH̲3), 1.19 
(d, 3JHH = 7.1, 12H, CHCH̲3). 13C{1H} NMR (CD2Cl2, 126 MHz): δ 186.9 (d, 1JRhC = 57, CO), 168.2 
(d, 1JRhC = 47, NCN), 162.3 (q, 1JBC = 50, ArF), 135.3 (s, ArF), 129.4 (qq, 2JFC = 32, 3JBC = 3, ArF), 
128.2 (s, C̲CH3), 125.2 (q, 1JFC = 272, ArF), 118.0 (sept, 3JFC = 4, ArF), 55.3 (s, NCH), 22.0 (s, 
CHC̲H3), 21.1 (s, CHC̲H3), 10.9 (s, CC̲H3). ESI-MS (CH3CN, 180 °C, 3 kV) positive ion: 519.2249 
m/z [M]+ (calcd 519.2201 m/z). IR (CH2Cl2, cm−1): ν(CO) 2077, 2018. Anal. Calcd For 
C56H52BF24N4Rh (1382.29 g mol−1): C, 48.64; H, 3.79; N, 4.05. Measured: C, 48.51; H, 3.63; N, 
4.15. 
3.4.3. In situ reactions 
 Generation of [(IiPr2Me2)2Ag][BArF4] (6b) 
A suspension of IiPr2Me2 (9.9 mg, 0.0549 mmol), Ag[OTf] (7.2 mg, 0.0277 mmol) and 
Na[BArF4]   (24.0 mg, 0.0271 mmol) in 1,2-difluorobenzene (0.5 mL) was agitated for several 
minutes. Analysis in situ by NMR spectroscopy indicated quantitative formation of 6b (data 
below). Solutions of 6b, prepared in this way, was then filtered onto either [Rh(COD)Cl]2 (13.6 
mg, 0.0276 mmol) or [Rh(CO)2Cl]2 (10.8 mg, 0.0278 mmol), resulting in the formation of 5b : 
7 (2 : 1) and 6b/8 (5:2). 1H NMR (1,2-C6H4F2, 500 MHz): δ 8.11–8.13 (m, 8H, ArF), 7.49 (br, 4H, 
ArF), 4.20 (sept, 3JHH = 6.8, 4H, NCH), 1.87 (s, 12H, CCH3), 1.31 (d, 3JHH = 6.8, 24H, 
CHCH̲3).13C{1H} NMR (1,2-C6H4F2, 126 MHz): δ 162.5 (q, 1JBC = 50, ArF), 135.1 (s, ArF), 129.7 
(qq, 2JFC = 32, 3JBC = 3, ArF), 124.9 (q, 1JFC = 272, ArF), 124 (obscured, C̲CH3), 117.6 (sept, 3JFC = 
4, ArF), 50.1 (s, NCH), 23.3 (s, CHCH̲3), 8.1 (s, CC̲H3). The carbene resonance was not located. 
19F{1H} NMR (1,2-C6H4F2, 282 MHz): δ-62.25 (ArF). No signal for [OTf]− detected. ESI-MS 
(CH3CN, 180 °C, 3 kV) positive ion: 467.2297 m/z, [M]+ (calcd 467.2298 m/z). 
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3.4.4 Crystallography 
Structure determinations were carried out by Dr. A. B. Chaplin. Relevant crystallographic 
data are given in Table 3.1. Data were collected on an Oxford Diffraction Gemini Ruby CCD 
diffractometer using graphite monochromated Mo K (λ = 0.71073 Å) radiation and a low-
temperature device. Data were collected and reduced using CrysAlisPro. All non-hydrogen 
atoms were refined anisotropically using SHELXL,55 through the Olex2 interface. 
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Table 3.1: Key crystallographic data for structures 3 - 9 
 4a 4b 6a 6b 8a 7b 8b 9 10 
CCDC / ID 1448988 1448989 1448990 1448991 1448993 1448992 1448994 1448995 1448996 
Figure Figure 3.1 Figure 3.1 Figure 3.4 Figure 3.4 Figure 3.5 Figure 3.6 Figure 3.6 Figure 3.7 Figure 3.7 
Formula C64H80I2N4O4Rh
2 
C19H32IN2Rh C80H68AgBF24N4
O4 
C54H52AgBF24N4 C84H68BClF24N4O
8Rh2 
C71H78BCl3F24N4
Rh2 
C58H52BClF24N4
O4Rh2 
C62H64BF24N4Rh C56H52BF24N4O2
Rh 
M 1428.94 518.27 1724.06 1331.67 1969.50 1766.35 1577.11 1433.89 1382.73 
Crystal System monoclinic monoclinic triclinic monoclinic monoclinic monoclinic triclinic monoclinic triclinic 
Space group P21/n P21/c P-1 P21/c P21/c P21/n P-1 P21/n P-1 
Radiation Mo K 
(λ = 0.71073 
Å) 
Mo K 
(λ = 0.71073 Å) 
Mo K 
(λ = 0.71073 Å) 
Mo K 
(λ = 0.71073 Å) 
Mo K 
(λ = 0.71073 Å) 
Mo K 
(λ = 0.71073 
Å) 
Mo K 
(λ = 0.71073 
Å) 
Mo K 
(λ = 0.71073 
Å) 
Mo K 
(λ = 0.71073 
Å) 
T [K] 200(2) 150(2) 250(2) 150(2) 150(2) 150(2) 150(2) 150(2) 150(2) 
a [Å] 13.07898(15) 10.94671(13) 11.5261(8) 10.29827(16) 19.6345(4) 14.1084(4) 12.2319(3) 12.8630(2) 17.0878(3) 
b [Å] 27.7640(3) 13.02535(13) 19.1677(9) 20.4557(3) 22.6778(5) 25.7959(7) 13.2693(3) 24.2781(5) 18.9928(3) 
c [Å] 17.30754(19) 14.51455(15) 20.4328(7) 29.5742(4) 20.0799(4) 21.8486(7) 21.7143(4) 20.3511(4) 19.5695(4) 
α[deg] 90 90 85.952(3) 90 90 90 100.9872(15) 90 79.1970(13) 
 [deg] 99.4834(11) 96.9118(10) 77.095(5) 95.6910(14) 109.352(3) 105.666 94.9257(17) 90.0784(15) 87.6582(15) 
γ [deg] 90 90 80.605(5) 90 90 90 91.7507(12) 90 76.2505(14) 
V [Å3] 6198.92(12) 2054.51(4) 4338.4(4) 6199.34(16) 8435.8(3) 7656.2(4) 3443.08(12) 6381.6(2) 6062.41(18) 
Z [Z’] 4 4 2 4 4 4 2 4 4 
Density [gcm-3] 1.531 1.676 1.320 1.427 1.551 1.532 1.521 1.493 1.515 
 (mm-1) 1.577 2.336 0.331 0.435 0.533 0.637 0.628 0.380 0.399 
  range [deg] 5.87 to 52.744 5.864 to 52.744 6.714 to 
51.364 
6.348 to 
52.742 
5.82 to 50.054 6.582 to 
52.744 
6.62 to 52.744 6.686 to 
52744 
6.612 to 
52.744 
Reflns collected 75467 25165 38190 89535 46355 65779 133482 66093 124137 
Rint 0.0376 0.0343 0.0584 0.0512 0.0801 0.0369 0.0764 0.0388 0.0494 
Completeness 99.9% 99.9% 99.8% 99.8% 99.8% 99.8% 99.8% 99.8% 99.8% 
No. of 
data/restr/para
m 
12663/262/71
3 
4192/0/214 16436/883/12
69 
12657.714/879 14873/1923/12
24 
15632/633/10
42 
14061/760/10
01 
13011/324/89
7 
24757/1056/1
806 
R1 [I > 2(I)] 0.0304 0.0183 0.0618 0.0586 0.2744 0.0446 0.0429 0.0534 0.0445 
wR2 [all data] 0.0943 0.0636 0.1860 0.1672 0.6304 0.1139 0.1152 0.1240 0.1161 
GoF 1.165 1.231 1.010 1.020 2.559 1.052 1/037 1.154 1.019 
Largest diff. pk 
and hole [eÅ-3] 
1.05/-1.03 0.7/-0.85 1.02/-0.46 1.19/-0.66 17.15/-1.80 0.74/-1.16 0.73/-0.52 0.58/-0.42 0.81/-0.58 
Flack (x) - - - - - - - - - 
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4.0  Coordination chemistry and potassium binding of 
calix[4]arene NCHS ligand 3 
Overview 
This chapter presents the synthesis, characterisation and reactivity of rhodium and iridium 
complexes based on imidazol-2-thione functionalised calix[4]arene 3, and IiPr2Me2S ligands. 
Their ability to host potassium guests within the central cavity, despite, in some cases, 
unfavourable coulombic repulsion is then detailed. For comparison the potassium binding of 
calix[4]arenes bearing 0, 1 and 2 imidazol-2-thione donor groups have been studied in 
solution and the solid state. 
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4.1 Introduction  
4.1.1 Imidazol-2-thione complexes  
In addition to their role as NHC precursors, imidazol-2-thiones find applications in the 
pharmaceutical industry (in particular 1-methylimidazol-2-thione and carbimazole are used 
for their antithyroid activity)1, 2 and have received attention as ligands for the formation of 
transition metal complexes. An array of thione complexes of transition metals, such as Cu, 
Fe, Pd and Rh have been prepared, in addition to main-group elements such as Bi, Sb and 
alkali metals.3-8 This section will describe the binding properties of imidazole-2-thione ligands 
and provide representative examples of their complexes. 
4.1.1.1 Structure and binding 
The coordination of thiones to metal centres occurs via donation of one or two filled p-
orbitals on sulfur. This can result in dymanic behaviour in solution, observed by broadening 
of resonances observed by 1H NMR spectroscopy, and is reflected by small C-S-M angles 
observed in the solid state (Figure 4.1, Table 4.1).  NHCS ligands show quite different steric 
and electronic donor properties to their parent carbenes (Table 4.1) including increased S/C-
M bond lengths and a distinct upfield shift of the NC(S)N resonance.9, 10 Notably NHCS ligands 
can be used to bridge transition metal centres (vide infra). 
 
 
 
 
 
Figure 4.1: [Rh(L)(COD)Cl] complexes L = IMe2Me2S (left), IMe2Me2 (right) 
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Table 4.1: Comparison of bond lengths (Å) and angles (°) and 13C NMR data of [Rh(L)(COD)Cl] complexes 
L = IMe2Me2 or IMe2Me2S 
 
 
 
 
 
4.1.1.2 Complexes of monodentate NHCS ligands 
 A range of complexes of monodentate imidazol-2-thione complexes have been reported. 
Raubenheimer et al. have reported the synthesis of rhodium(I) complexes by reaction 
between [Rh(COD)Cl]2 and IiPr2Me2S (A122), subsequent displacement of the cyclooctadiene 
ligand with CO affords A123, which is also a precursor to complex A124 (Scheme 4.1).4 The 
authors have also reported the synthesis of mixed thione-NHC Rh(I) complexes such as A125 
(Figure 4.2).4 Monodentate imidazole-2-thione ligands have also been used in the synthesis 
of di- and tetra- substituted complexes (A126 and A127),8 and µ-halide bridged complexes 
(A128) (Figure 4.2) which, upon transmetallation, form a µ-S bridged complex (A129).11 
Bridging thione ligands, notably show an increase in M=S bond length compared to terminal 
modes (2.331(2) and 2.335(2) Å cf. 2.318(2) Å) respectively.  
 
L C-S S/C-Rh C-S-Rh S/C-Rh-Cl δ NCN/NCSN 
IMe2 Me2S 1.725(2) 2.3602(7) 108.81(7) 92.95(2) 156.3 (CD2Cl3) 
IMe2Me2 - 2.016(2) - 166.00(4) 178.8  (CD2Cl2) 
Scheme 4.1: Rh(I) imidazol-2-thione complexes reported by Raubenheimer 
 106 
 
 
 
4.1.1.3 Complexes of multidentate NHCS ligands 
A number of complexes containing multidentate imidazole-2-thione ligands, including pincer 
type ligands are known (A130 and A131, Figure 4.3).6, 12    Miecznikowski et al. used the zinc 
pincer complex of an SNS pincer ligand as a model for the zinc active site in liver 
dehydrogenase (that adopts a pseudo-tetrahedral geometry). The gold-based SNS pincer has 
been used in the reduction of 4-nitrophenol by Jia.6 The tri-dentate 
hydrotris(methimazolyl)borate ligand A132 has been reported in the formation of a large 
range of transition metal and main group complexes. These adopt a variety of motifs 
including mono metallic complexes such as A133 to A138 which adopt a sandwich motif. The 
indium complex A133 in particular forms an almost regular S6 octohadral complex (S-In-S 
angles found between 86.1 and 87.7°).  µ-Halide bridged bimetallic complexes based on the 
ligand A132 have also been reported e.g. A139 to A141.13, 14 
Figure 4.2: Monodentate imidazole-2-thione complexes 
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Figure 4.3 Multidentate imidazol-2-thione complexes  
 
4.1.2 Alkali metal binding 
Alkali metal cations, in particular Na+ and K+, play vital roles in many physiological systems 
including modulating enzyme activity.15 As such, development of supramolecular systems 
which are able to bind to alkali metal cations by non-covalent interactions have been a focus 
of investigation. Such investigations have led to the development of cation sensors, 
molecular switches and methods for disposal of radioactive 137Cs.16-20 A plethora of 
supramolecular species have therefore been developed with complementary cavity sizes and 
chelating structures resulting in highly selective binding properties.15,21-23 
One of the most common groups of alkali metal hosts are crown ethers (Figure 4.4). These 
simple macrocylic structures form well defined complexes with alkali metals by coordination 
of the ether functionalities: the hydrophobic ring exterior also results in good solubility in 
non-polar solvents.24-26 Variation of the ring size allows selective binding for example 15-
crown-5 binds most strongly to Na+, whereas 16-crown-8 shows a greater affinity for K+ 
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cations. Increased binding strengths have been found for cryptands, initially developed by 
Lehn.27 Cryptands typically contain two bridging nitrogen atoms joined by three oligo oxa 
chains of different lengths, resulting in spherical, ellipsoidal or cylindrical supramolecular 
capsules. The increased number of ligating atoms relative to that in crown ethers results in 
higher binding affinity for cation guests although the cage structure results in slower kinetics  
(Table 4.2).28,29 
 
 
Figure 4.4: Structures of common crown ethers and cryptands 
Table 4.2: 18-crown-6 and cryptand Na+ and K+ binding constants 
Host Cavity size 
Å 
Na+ 
Log10 KS 
K+ 
Log10 KS 
18-crown-6 2.60 4.35 6.07 
[2.1.1] 1.6 6.4 2.3 
[3.2.2] 3.6 4.8 >7 
[3.3.2] 4.2 3.2 6.0 
(a) KS (log10) for anhydrous methanol at 25°C. (b) Na+ ~ 2.0 Å and K+~2.8 Å  
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Spherands, rigid macrocycles consisting of sp2 hybridised atoms show higher selectivity for 
alkali metal cations than crown ether and cryptands due to their pre organised and more 
rigid structures. Many other species have been adapted for the coordination of alkali metal 
cations by functionalisation with crown-ether type chains.30-33 
 
4.1.3 Alkali metal binding by calix[4]arene hosts 
The ability of calix[4]arenes to bind alkali metals has been well explored,  this largely consists 
of variants bearing donor appendages, most commonly oxygen-based substituents, 
supported by π-donation from the calix[4]arene scaffold.21, 22, 34 Calix[4]arenes bearing no 
formally donating functionality in the upper rim,  for example A1 or A2 have also been shown 
to bind alkali metal cations, presumably stabilised by cation-π interactions.35 Binding of alkali 
metal cations has been shown to be highly dependent on the calix[4]arene conformation, for 
example extraction of aqueous alkali metal picrates into CH2Cl2 has been used to determine 
the selectivity of the isomers of bisethoxycarbonylmethoxycalix[4]arene A142 (Figure 4.4), 
the results of which are outlined in Table 4.2.36 
 
 
Figure 4.4: Structure of bisethoxycarbonylmethoxycalix[4]arene 
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Table 4.2: Percent extraction of alkali metal picrates reported by Shinkai et al. 
Isomer 
Li+ 
/% extr. 
Na+ 
/% extr. 
K+ 
/% extr. 
Cs+ 
/% extr. 
cone 17.6 100 86.1 24.6 
partial cone 5.2 62.1 94.3 49.9 
1,2-alternate 0 22.1 70.0 54.0 
1,3-alternate 1.5 88.8 100 98.9 
 
Calix[4]tubes were first introduced by Beer and co-workers in 1997 and consist of rigid ether-
bridged bis-calix[4]arene structures (A143, Figure 4.5).37 These calix[4]tubes show a high 
selectivity for the coordination of potassium ions over other alkali metal ions (O⋯K bond 
distances of 2.8 Å cf. 2.8 Å observed in [K∙18-crown-6], vide infra). Binding of the potassium 
cation within the ether channel was observed by 1H NMR spectroscopy and in the solid state 
by X-ray diffraction.  Molecular mechanics calculations showed the preference for the 
potassium to pass through the tube along the main axis. This directionality was presumed to 
be a result of weak complexation within the calix[4]arene cavities.  
 
 
Figure 4.5: Calix[4]tube reported by Beer et al. 
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1,3-Alternate scaffolds have been exploited by a large number of groups for example, Beer 
et al. have appended 1,3-alternate calix[4]arenes with amide functionalities in order to form 
inclusion complexes with one or two equivalents of potassium cation.38, 39 Cone and 1,3-
calix[4]arene structures are also readily adapted to include crown and azocrown species, for 
example the synthesis of 1,3-dialkoxy-p-tertbutylcalix[4]arenes in both cone and 1,3-
alternate conformations have been described by Rheinhoudt et al. resulting in the selective 
coordination of potassium along the lower rim (A144, Figure 4.6).40 Wu et al. have also 
developed a number of calix[4]crown complexes based upon phenolate ligands which allow 
free rotation of the phenol units.41 Both 1,2- and 1,3-functionalised calix[4]arene complexes 
A145 and A146 are obtained upon deprotonation one of the phenolic groups. The resulting 
anionic phenolate donor is therefore able to stabilise of the potassium cation within the 
calix[4]arene cavity.  
 
 
Figure 4.6: Calix[4]crown potassium complexes  
 
The presence of charged phenolate groups has also been shown to promote binding of alkali 
metals within calix[4]arene cavites. For example, the caesium complex A147 has been 
reported by White et al. The solid state structure of A147 was determined by X-ray 
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diffraction, where short Cs-C distances of 3.57 Å, indicative of strong stabilisation from the 
calix[4]arene scaffold, were observed (Figure 4.7).42 Another example, A148, reported by Wu 
et al. features two coordinated potassium cations, one within the calix[4]arene cavity and 
one coordinated to the lower rim with or without further stabilisation from an 18-crown-6 
auxiliary ligand.41  
 
 
Figure 4.7: Anionic calix[4]arene host-guest complexes 
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4.2 Results and discussion 
4.2.1 Synthesis and characterisation of NHCS complexes 
Reaction of ligand 3 with [M(COD)Cl]2 dimers (M = Rh or Ir) in CH2Cl2 at room temperature in 
the presence of Na[BArF4] as a halide extractor resulted in the formation of mononuclear 
complexes 11a and 12a in acceptable yields (52% and 45% respectively, Scheme 4.2). 
IiPr2Me2S was found to react in an analogous fashion and 11b and 12b were formed in 74% 
and 67% yields, respectively.  All of these new complexes were fully characterised by 1H, 13C 
NMR spectroscopy, ESI-MS, microanalysis and X-ray diffraction (Figure 4.8). 
 
 
Scheme 4.2: Synthesis of Rh and Ir complexes of 3 and IiPr2Me2S 
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The solid state structures of 11a and 12a determined by X-ray diffraction, are less puckered 
than the free ligand 3. This clear from the increased CPR values of = 0.5500(3) and 0.5500(6) 
for 11a and 12a respectively, compared to 3 (0.419(1)). Rotation of the imidazole-2-thione 
appendages from their antiparallel positions in 3 and the “bent” coordination mode of the 
thione donors (M-S-C ca. 100°) results in the positioning of the transition metal to one side 
of the calix[4]arene cavity (Figure 4.9, Table 4.3). Very similar bonding metrics are observed 
for the model complexes 11b and 12b, as seen in Table 4.3, although S-M-S and C-S-M bond 
angles are slightly larger, than in 11a and 12a, presumably because the latter thione donors 
are partially constrained by the calix[4]arene scaffold.  
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Figure 4.8: Solid-state structures of 11a (top left), 12a (bottom left), 11b (top right) and 12b (bottom right). Thermal 
ellipsoids for selected atoms drawn at the 50% probability level. Hydrogen atoms, anions, minor disordered components 
and solvent molecules are omitted for clarity. Selected bond lengths (Å) and angles (°): S25∙∙S35, 3.1572(6); C21∙∙C31, 
4.621 ; Rh1-S25, 2.3515(5); Rh1-S35, 2.3756(5); Rh1-C10, 2.158(2); Rh-C11, 2.120(2); Rh1-C14, 2.132(2); Rh1-C15, 
2.132(2); S25-C21, 1.705(2); S35-C31, 1.720(2); S25-Rh1-S35, 83.808(18), C21-S25-Rh1, 109.72(7); C31-S35-Rh1, 
108.76(6); CPR = 0.5500(3) . 11b Rh1-S25, 2.3706(6); Rh1-S35, 2.3671(7); Rh1-C10, 2.120(3); Rh1-C11, 2.130(3); Rh1-C14, 
2.133(3); Rh1-C15, 2.137(3); S25-C21, 1.727(3); S35-C31, 1.729(3); S35-Rh1-S25, 89.06(2);C11-Rh1-S35, 158.90(11); C11-
Rh1-C14, 81.12(13); C21-S25-Rh1, 111.44(8); C31-S35-Rh1, 110.23(9). 12a S25∙∙S35, 3.1568(12); C21∙∙C31, 4.618(4); Ir1-
S25, 2.3390(8); Ir1-S35, 2.3604(8); Ir1-C10, 2.150(3); Ir1-C11, 2.122(3); Ir1-C14, 2.124(3); Ir1-C15, 2.131(3); S25-C21, 
1.709(3), S35-C31, 1.732(3); S25-Ir1-S35, 84.40(3); C10-Ir1-S25, 101.71(10); C10-Ir1-S35, 165.21(10); C11-Ir1-S25, 
97.24(9); C11-Ir1-S35, 154.99(11); C11-Ir1-C10, 38.45(13); C11-Ir1-C14, 81.51(13); C11-Ir1-C15; 96.95(13); C14-Ir1-S25, 
160.36(10); C14-Ir1-S35, 88.66(10); C14-Ir1-C10, 89.53(14); C14-Ir1-C15, 39.05(13); C15-Ir1-S25, 158.50(10); C15-Ir1-S35, 
89.51(10); C15-Ir1-C10, 79.91(13); C21-S25-Ir1, 109.63(11); C31-S35-Ir1, 108.46(11) CPR = 0.5500(6). 12b Ir1-S25, 
2.3496(8); Ir1-S35, 2.3459(9); Ir1-C10, 2.109(3); Ir1-C11, 2.117(4); Ir1-C14, 2.119(3); Ir1-C15, 2.129(3); S25-C21, 1.728(3); 
S35-C31, 1.732(3); S35-Ir1-S25, 89.50(3); C21-S25-Ir1, 111.20(10); C31-S35-Ir1, 110.02(11). 
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Figure 4.9: Comparison of partial crystal structures of 11a and 11b 
 
Table 4.3: Bond lengths and angles of complexes 11a, 11b, 12a and 12b observed in the solid state structures 
 
In solution 11a and 12a show Cs  symmetry, most likely due to dynamic interconversion of the 
C-S-M angle about the sulfur atom at room temperature. This symmetry is evidenced by the 
two sets of diastereotopic ArCH2Ar methylene bridge resonances by 1H NMR spectroscopy 
(4.60, 4.56, 3.34, 3.22, 2JHH = ca. 13 Hz, 11a; Ir: 4.59, 4.57, 3.35, 3.29, 2JHH = ca. 13 Hz, 12a) 
and single 1H and 13C{1H}resonances for the NMe group observed at δ 3.76 and 37.2 (11a) 
Complex S-M-S /° C-S-M /° S-M /Å C-S/Å 
M-CCnt(COD) 
 / Å 
NCSN/δ δ CH {COD} 
11a 
 
83.808(18) 109.72/108.7
6 
2.3515(5)/ 
2.3756(5) 
1.705(2)/
1.720(2) 
1.720(2) 
2.030(2)/2.)15(2) 156.4 82.9/81.4 
11b 
 
89.06(2) 111.44/110.2
3 
2.3706(6)/ 
2.3671(7) 
1.727(3)/
1.729(3)   
1.729(3) 
2.010(3)/2.020(3) 151.8 81.1 
12a 84.40(3) 109.63/108.4
6 
2.3390(8)/ 
2.3604(8) 
1.709(3)/
1.732(3) 
1.732(3) 
2.017(3)/2.005(3) 156.6 66.2/63.0 
12b 
 
89.50(3) 111.20/110.0
2 
2.3496(8)/ 
2.3459(9) 
1.728(3)/
1.732(3) 
1.732(3) 
1.994(4)/2.005(3) 149.2 64.6 
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and δ 3.73, δ 37.1 (12a) respectively. Similar dynamics and C2v symmetry is observed in 
solution for model complexes 11b and 12b, which have only one 13C COD{CH} resonance due 
to fluxional behaviour of IiPr2Me2S in solution Table 4.4. NCSN and COD{CH} resonances for 
11b and 12b show a slight upfield shift with respect to 11a and 12a.  
 
4.2.2 Reactivity of NHCS complexes 
Reactivity of the isolated thione complexes 11 and 12 was then followed, primarily by 1H 
NMR spectroscopy (Scheme 4.3). No notable reactions were observed on placing 11 and 12 
under H2 at room temperature. The COD ligand, however, was easily displaced by stirring 
under an atmosphere of CO (1 atm). In this way, bis-carbonyl derivatives 13 and 14 were 
isolated, with excess COD removed by subsequent washings with hydrocarbon (yields: 53% 
(13a) and 58% (14a), 77% (13b) and 77% (14b)). Although the cis-carbonyl adducts could not 
be crystallised for analysis in the solid state, the cis-geometry of the carbonyl ligands was 
confirmed by IR spectroscopy 13a: 2068, 2001 14a: 2055, 1984 13b: 2067, 2002 14b: 2052, 
1983 cm-1. The remarkable similarity of these stretching frequencies is demonstrative of their 
electronic similarities of the calix[4]arene and model complexes.   
Addition of two equivalents of IiPr2Me2S to 11a and 12a in CD2Cl2 was used to determine the 
relative binding strengths of 3 to the transition metal centre. This resulted in approximate 
1:6 11a:11b and 1:2.4 12a:12b ratios observed in solution by 1H NMR spectroscopy. This 
suggests that despite the chelating nature of 3, the IiPr2Me2S binds significantly more 
strongly to the rhodium(I) or iridium(I) centres. It is possible that this equilibrium is driven by 
relief of the strain about the S-M-S bonds observed in the calix[4]arene complexes 11a and 
12a. Similarly, addition of bipyridine to 11a or 11b resulted in the rapid and quantitative 
formation of [Rh(bipy)(COD)][BArF4] (15a) by 1H NMR spectroscopy, the structure of which 
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was confirmed by independent synthesis in the Chaplin group.‡ The 1H NMR resonances of 3 
were found to be slightly shifted, presumably due to binding of bipy in solution; data showed 
good agreement with that obtained from mixing free 3 and bipy in solution. Intriguingly 
neither 12a nor 12b showed the same reactivity with bipy but instead single products that 
could not be attributed to either 3, 12a or [Ir(bipy)(COD)][BArF4]. Further scrutiny suggests 
that in fact the adduct 16a or 16b (Scheme 4.3) was formed. This product independently 
formed, as observed by 1H NMR spectroscopy, by addition of 3 to [Ir(COD)(bipy)][BArF4] in 
CD2Cl2.  
                                                             
‡ Synthesis from [Rh(COD)Cl]2/[Ir(COD)Cl]2, bipy, Na[BArF4] in CH2Cl2 at r.t. by Jack Emerson-King, PhD 
student University of Warwick 
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Scheme 4.3: Reactivity of 11, 12 
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4.2.3 Potassium binding studies 
Early synthesis of the 11a and 12a, synthesised by deprotonation of 1a·2HI using KHMDS in 
THF, resulted in the formation of crystalline products which confirmed the presence of 
potassium cations within the calix[4]arene cavity. Calix[4]arenes bearing potassium cations 
within the central cavity were then systematically produced by reaction of A2, 3, 18, 11a and 
12a with K[BArF4] in CH2Cl2 at room temperature (Scheme 4.4). Analysis by 1H NMR 
spectroscopy indicated the formation of potassium adducts in each case, notably by the 
appearance of 1H resonances for the [BArF4] counter anion, at δ 7.71 – 7.75 and 7.56. 1:1 
stochiometry for potassium binding was confirmed by 1H NMR experiments with addition of 
0.5, 1.1 and 5.0 equivalents of K[BArF4] per calix[4]arene, which indicated slow exchange and 
formation of adducts in a 1:1 ratio as determined by integration of BArF resonances. Further 
confirmation of the presence of these complexes were observed by ESI-MS (not observable 
for [11a·K][BArF4] or [12a·K][BArF4]), and in the solid state by X-ray diffraction (Table 4.4). 
Bulk purity in each case was confirmed by microanalysis and reactions of the isolated product 
with an excess of 18-crown-6. This resulted in the reformation of the potassium free 
calix[4]arene host and K[18-crown-6]. The 1:1 ratio of the calix[4]arene host and K guest 
could therefore be monitored integration of BArF4- signals measured by 1H NMR 
spectroscopy. 
 
 
 121 
 
 
 
 
Scheme 4.4: Reactions of A2, 3, 18, 11a and 12a with K[BArF4] 
 
 
 
 
 122 
 
Table 4.4: Summary of characteristic 1H resonsances and bond lengths (Å) observed by X-ray diffraction 
   
 [A2·K][BArF4] [18·K][BArF4] 18 [3·K][BArF4] 3 [11a·K][BArF4] 11a [12a·K][BArF4] 12a 
δ 1H NCSN - 163.8 163.3 164.2 163.4 158.5 156.4 158.9 156.6 
δ 1H  NCH3 - 35.6 35.5 35.4 35.6 37.4 37.2 37.3 37.1 
δ 1H NCH3 - 3.41 3.51 3.22 3.55 3.75 3.76 3.77 3.74 
S···S (Å) - - - 3.9644 7.739 2.9897 3.1572(6) 2.9933 3.1568(12) 
C=S (Å) - 1.686(2) - 
1.681(2)/1.6
79(2) 
1.688(6) 
1.718(4)/1.71
7(4) 
1.720(2)/1.7
05(2) 
1.729(5)/1.72
0(5) 
1.709(3)/1.7
32(3) 
K-ArCnt (Å) 2.791(11) 2.825(2) - 2.712(2) - 3.084(4) - 3.068(5) - 
K-ArCnt (Å) - 2.788(2) - 2.711(2) - 3.078(4) - 3.065(5) - 
K-O56 (Å) 3.929(8) 3.9056(12) - 4.001(15) - 4.264(3) - 4.245(4) - 
K-O66 (Å) 2.832(7) 2.8471(13) - 2.8451(13) - 3.149(3) - 3.087(4) - 
K-O76 (Å) - 3.9239(13) - 3.9512(15) - 4.212(3) - 4.184(4) - 
K-O86 (Å) - 2.8826(14) - 2.8069(16) - 3.534(3) - 3.514(4) - 
K-S25 (Å) - 3.2083(6) - 3.4019(7) - 3.4722(14) - 3.5207(19) - 
K-S35 (Å) - - - 3.4102(6) - 3.5854(15) - 3.6324(19) - 
K-M (Å) - - - - - 3.7153(10) - 3.6901(13) - 
SMS (°) - - - - - 77.99(3) 83.808(18) 78.80(4) 84.40(3) 
CPR 0.5827(20) 0.6092(4) - 0.5536(4) 0.419(1) 0.7156(8) 0.5500(3) 0.7113(10) 0.5500(6) 
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18-crown-6 was chosen to probe the bulk purity of the calix[4]arene complexes due to its 
strong and selective binding to potassium. For comparison the unknown 18-crown-6 adduct 
of K[BArF4] was isolated by recrystalisation from DCM/pentane. The colourless crystals were 
analysed by 1H and 13C NMR spectroscopy, ESI-MS, microanalysis and in the solid state by X-
ray diffraction (Figure 4.10).  
 
 
 
 
Figure 4.10: [18-crown-6·K][BArF4] Thermal ellipsoids for selected atoms drawn at the 50% probability level. 
Hydrogen atoms, disordered components and anions omitted for clarity. Selected bond lengths (Å) and angles 
(°): K1-O2, 2.774(7); K1-O5, 2.747(7); K1-O8, 2.774(8); K1-O11, 2.783(7); K1-O14, 2.770(7); K1-O17, 2.778(7). 
 
4.2.3.1 Calix[4]arene (A2) 
[A2·K][BArF4] was readily formed by addition of K[BArF4] to A2, despite its lack of stabilising 
functionalities such as phenolate or thione donors. 1H NMR spectra showed a downfield shift 
of all resonances, but most notably the aryl, ArCH2Ar and OCH2 resonances, consistent with 
binding through cation-π and ether functionalities (Figure 4.11).  
 
Figure 4.11: 1H NMR spectra of A2 (top) and isolated [A2.K][BArF4] (CD2Cl2, 600 MHz) 
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In the solid-state structure of [A2∙K][BArF4] the potassium cation is observed well within the 
calix[4]arene cavity, with short K-Cnt bond distances of 2.791(11) Å for two opposing aryl 
rings (Figure 4.12). K-O bond of lengths 3.929(8) Å and 2.832(7) Å indicate only two of the 
phenol-ether groups bind strongly to the potassium. C4V symmetry is observed in solution by 
1H and 13C NMR spectroscopy indicating that the interactions observed in the solid state (C2v) 
are dynamic in solution.  
 
 
 
 
 
 
 
 
 
Figure 4.12: Solid-state structure of [A2·K][BArF4] in ball and stick representation. Structure is disordered 
equally over special positions, anion, solvent and minor disordered components are omitted for clarity. Atoms 
denoted * are generated using the symmetry operation 3-X,3/2-Y,+Z Selected bond lengths (Å) and angles (°): K-
Cnt(C50C55), 2.791(11); K-O56, 3.929(8); K-O66, 2.832(7), CPR = 0.5899(3). 
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4.2.3.2.1 Synthesis of CalixImidMe1S 18 and potassium binding of 3 and 18 
For comparison of potassium binding strengths of 3 and A2, mono-functionalised 
calix[4]arene 18 was synthesised. This synthesis proceeded in a similar way to 2a·2HI, from 
the alkylation of known imidazole* A149 to give imidazolium salt 17, which was characterised 
by 1H, 13C NMR spectroscopy, ESI-MS and microanalysis (Scheme 4.5).43-45 Thione ligand 18 
was then prepared using an analogous procedure to that used for the formation of 3 (Chapter 
2) and was isolated in 71% yield and fully characterised by 1H, 13C NMR spectroscopy, ESI-MS 
and microanalysis.                                                                                        
Scheme 4.5: Preparation of of 18 
 
Compounds 3 and 18 readily form potassium complexes, which were isolated by 
recrystalisation as colourless crystalline products. Coordination of the potassion cation was 
observable by 1H NMR spectroscopy, for example in 3 by the downfield shift of one set of 
OCH2 resonances (δ 3.94 to 4.41) and an upfield shift of the NCH3 resonance (δ 3.55 to 3.22) 
(Figure 4.13).  
                                                             
* Synthesised my Jack Emerson-King, PhD student, University of Warwick. 
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Figure 4.13: 1H NMR spectra of 3 (top) and isolated [3·K][BArF4] (bottom) (CD2Cl2, 600 MHz) 
 
In the solid state [18·K][BArF4] and [3·K][BArF4] show strong potassium binding, with S-K bond 
lengths of 3.2083(6) Å and 3.4019(7)/3.4102(6) Å, and CPR values of 0.6092(4) and 0.5536(4), 
respectively (cf.CPR 3 = 0.419(1)) (Figure 4.14). The binding of potassium is associated with 
the shortening of the interspacial S∙∙∙S distances that drop from 7.739(3) Å in 3 to 3.9644(8) Å 
for [3·K][BArF4]. The monofunctionalised calix[4]arene complex [18·K][BArF4] shows a CPR 
value which is comparable with that found for [A2·K][BArF4] (0.6092(4) cf. 0.5827(20)). The 
CPR value for the bis-imidazol-2-thione complex [3·K][BArF4] shows a dramatic decrease of 
S∙∙∙S distance (7.739 to 3.9644 Å) and shift in CPR from 0.419(1) to 0.5536(4)), reflecting the 
inclusion of potassium guest and breaking of the thione-thione π-stacking interactions 
observed in 3. As observed for complex [A2·K][BArF4], only two of the phenol-ether moieties 
participate in the binding of potassium with interspatial  K∙∙∙O distances of 
3.9056(12)/3.9239(13)/2.8471(13)/2.8826(14) and 
4.001(15)/3.9512(15)/2.8451(13)/2.8069(16) for [18·K][BArF4] and [3·K][BArF4] respectively.  
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4.2.3.3 Rhodium and iridium complexes 11a and 12a 
Both 11a and 12a appear to bind potassium less strongly than 3 or 18. Coordination is 
observed in solution, however, both the “free” host complexes and host-guest complexes 
were observable by 1H NMR spectroscopy upon the addition of five equivalents of K[BArF4] 
(0.13:1 11a:[11a·K][BArF4] and 0.17:1 12a:[12a·K][BArF4] ratios) (Figure 4.15). Pure materials 
were obtained however, by reaction of 11a or 12a with K[BArF4] and subsequent 
recrystalisation from CH2Cl2/pentane, presumably aided by the highly charged nature of the 
potassium adducts. 
 
Figure 4.14: Solid-state structures of [18·K][BArF4] (left) and [3·K][BArF4] (right). Thermal ellipsoids for selected 
atoms drawn at the 50% probability level. Hydrogen atoms, anions and minor disordered components are omitted 
for clarity. Selected bond lengths (Å) and angles (°):[18·K][BArF4] S25-K2, 3.2083(6); K2-O66, 2.8472(13); K2-O86, 
2.8826(15); K2-C52, 3.1288(17); K2-C53, 3.1288(17); K2-C54, 3.0928(17); K2-C63, 3.0698(18); K2-C71, 3.116(2); K2-
C72, 3.0748(19); K2-C73, 3.0951(18); K2-C74, 3.0873(19); K2-C75, 3.142(2); K2-C83, 3.1005(18); S25-C21, 
1.6857(19). [3·K][BArF4] S25-K2, 3.4019(7); S35-K2, 3.4102(6);  K2-O66, 2.8451(14); K2-O86, 2.8069(15); K2-C50, 
3.0124(18); K2-C51, 3.0037(18); K2-C52, 3.0515(18); K2-C54, 3.0568(17); K2-C55, 3.0383(18); K2-C70, 3.0214(18); 
K2-C71, 3.0080(19); K2-C72, 3.0566(19); K2-C74, 3.0631(18); K2-C75, 3.0440(18); S25-C21, 1.679(2); S35-C31, 
1.681(2). 
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Figure 4.15: 1H NMR specta of 11a + 5.0 eq. K[BArF4] (top) 12a + 5.0 eq. K[BArF4] (CD2Cl2, 400 MHz) 
 
Solid state analysis of [11a·K][BArF4] and [12a·K][BArF4] both show inclusion of the potassium 
cation within the calix[4]arene cavity, mediated by interaction with the thione donors, arene 
rings and adjacent oxygen atoms (Figure 4.16).  The presence of the included potassium 
inside the calix[4]arene cavity also results in the shift of CPR values from 0.5499(3) to 
0.7156(8) [11a·K][BArF4] and 0.5500(6) to 0.7114(10) [12a·K][BArF4] and subsequently a 
decrease in SMS bond angles from 83.808(18) to 77.99(3) and 84.40(3) to 78.80(4)°. The 
M∙∙∙K (M = Rh or Ir) contacts are 3.7153(10) Å and 3.6903(13) Å for 11a and 12a respectively, 
this is unusually close given the cationic nature of the species although greater than the sum 
of their ionic/covalent radii (K+ = 1.40, Rh = 1.34 Ir = 1.36).46, 47 
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Relatively few examples of Rh/Ir∙∙∙K distances distances <4 Å have been reported.48-51 Anionic 
rhodium complex A150 has been described by Grutzmacher, in which the [K(THF)3]+ fragment 
is embedded in the anionic ligand resulting in a Rh∙∙∙K distance of 3.36 Å (Figure 4.17). The 
Figure 4.16: Solid-state structures of [11a·K][BArF4] (top) and [12a·K][BArF4] (bottom).  Thermal ellipsoids for 
selected atoms drawn at the 50% probability level. Hydrogen atoms, anions, minor disordered components and 
solvent molecules are omitted for clarity. Selected bond lengths (Å) and angles (°) [11a·K][BArF4]:Rh1-K2, 
3.7153(10); Rh1-S25, 2.3662(10); Rh1-S35, 2.3850(9); Rh1-C10, 2.137(4); Rh1-C11, 2.140(4); Rh1-C14, 2.141(4); 
Rh1-C15, 2.146(4); K2-O66, 3.149(3); K2-C50, 3.415(3); K2-C51, 3.307(4); K2-C52, 3.299(4); K2-C53, 3.419(4); K2-
C54, 3.421(4); K2-C55, 3.433(4); K2-C72, 3.398(4); K2-C73, 3.373(4); K2-C74, 3.276(4); K2-C75, 3.328(4); K2-C83, 
3.252(4); S25-C21, 1.716(4); S35-C31, 1.718(4); S25-Rh1-K2, 65.30(3); S25-Rh1-S35, 77.99(3); S35-Rh1-K2, 
68.01(3); CPR = 0.7156(8). [12a·K][BArF4]: Ir1-S35, 2.3640(12); Ir1-S25, 2.3516(12); Ir1-C15, 2.131(5); Ir1-C10, 
2.130(5); Ir1-C11, 2.135(5); Ir1-C14, 2.130(5); Ir1-K2, 3.6903(13); S35-C31, 1.729(5); S35-K2, 3.6324(19); S25-C21, 
1.720(5); S25-K2, 3.5207(18); C70-K2, 3.445(5); C75-K2, 3.337(5); C71-K2, 3.432(5); C72-K2, 3.359(5); C74-K2, 
3.275(5); C55-K2, 3.400(5); C54-K2, 3.386(5); C51-K2, 3.319(5); C50-K2, 3.409(4); C73-K2, 3.344(5); C52-K2, 
3.295(5); C53-K2, 3.398(5); C82-K2, 3.498(5); 83-K2, 3.266(5); S35-Ir1-K2, 69.84(4); S25-Ir1-S35, 78.80(4); S25-Ir1-
K2, 67.10(4); C15-Ir1-S35, 98.55(15); C15-Ir1-S25, 160.83(16); CPR = 0.7114(10). 
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iridium complex , A151, reported by Balch and co-workers features a crown ether receptor 
which binds K+. X-ray crystallography showed an Ir∙∙∙K distance of 3.33 Å (Figure 4.17). 
 
Figure 4.17: Previously reported Rh and Ir complexes with potassium binding characteristics 
 
To the authors’ knowledge no structures of bearing positively charged Rh/Ir centres within 
4 Å of a potassium cation have been reported. † 
 
4.2.3.4. IiPr2Me2S and 11b/12b 
Attempts to prepare potassium complexes of the IiPr2Me2S ligand through reaction with 
K[BArF4] in CH2Cl2 resulted in no observable reaction by 1H NMR spectroscopy at room 
temperature. Addition of an excess of K[BArF4] at room temperature resulted in the 
appearance of weak [BArF4]- signals in the 1H NMR spectra indicative of the formation of an 
adduct, however in a 1:40 ratio (IiPr2Me2S:[BArF4]-). Addition of 0.5 equivalents of K[BArF4] to 
IiPr2Me2S and heating at 50°C for 24 hours resulted in the formation of a single complex in 
solution. This was attributed to the formation of 19. This unexpected adduct was 
characterised by X-ray diffraction (Figure 4.18) and fully characterised by 1H and 13C NMR 
spectroscopy.  
                                                             
† Based on search for Ir/Rh(I) K distances <4 Å using ICSD Web and Conquest (I. J. Bruno, J. C. Cole, P. 
R. Edgington, M. Kessler, C. F. Macrae, P. McCabe, J. Pearson and R. Taylor, Acta Cryst., B58, 389-
397, 2002) 
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Figure 4.18: Solid-state structures of 19. Ball and stick representation. Hydrogen atoms and anion ([BArF4]-) 
omitted for clarity. Selected bond lengths (Å) and angles (°): Cl2-C1, 1.742(6); S25-C1, 1.810(6); S25-C21, 
1.739(5); C21-S25-C1, 100.9(3); N20-C21-N22, 108.3; Cl2-C1-S52, 114.3(3). 
 
The model complexes 11b and 12b complexes showed no reactivity with 0.5, 1 or 5 
equivalents of K[BArF4] in CD2Cl2 at room temperature.  
Dichloromethane behaving as a non-innocent ligand in the presence of imidazole-2-thione 
ligands has previously been described be Hill.14, 52 For example, addition of ligand A132 to 
CH2Cl2 resulted in the slow formation of a heterocyclic salt [A132.CH2][Cl] (Scheme 4.6).  
 
 
 
 
 
Scheme 4.6: Addition of CH2Cl2 to thione ligrand reported by Hill14 
4.2.2.5 Na+ Binding  
In addition to experiments with potassium, reactivity of 3 with 1 equivalent of Na[BArF4] was 
monitored by 1H NMR spectroscopy. Binding of the Na+ was observed by solvation of the 
Na[BArF4], complexation induced chemical shift changes and presence of the characteristic 
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[BArF4]- resonances by 1H NMR spectroscopy at δ 7.70 – 7.74 and 7.56. Despite multiple 
attempts, no crystals suitable for analysis by X-ray diffraction were obtained. Upon addition 
of excess Na[BArF4] 1H NMR spectra indicated binding stoichiometries of greater than one 
[BArF4]- per calix[4]arene, presumably a result of binding through the lower rim of the 
calix[4]arene.  
4.2.2.6 Competition experiments 
In order to help quantify the potassium binding strengths of 18, 3, 11a and 12a relative to 
A2, a series of competition experiments were carried out using a 10 mM solution of hosts 
and [A2·K][BArF4] in CD2Cl2 (Scheme 4.6).‡ Solvents such as THF and 1,2-difluorobenzene 
were found to be competitive cation binders and therefore unsuitable for analysis. The 
resulting mixtures were in slow exchange and analysed using 1H NMR spectroscopy 
(600 MHz) at 298 K with long relaxation delays (d1 = 10s). The corresponding mixtures were 
assigned by integration of the 1H NMR spectra and equilibrium constants calculated and 
given in Table 4.5. 
 
 
 
Table 4.5: Equilibrium constants calculated from 1H NMR spectra at 298 K 
Host Equilibrium constant 
18 10 
3 14 
11a 3 × 10-3 
12a 3 × 10-3 
 
What is immediately clear from these results is that, binding strength increases in order  
12a ≈ 11a << A2 < 18 < 3. This trend is in line with expectation; the binding of potassium by 
                                                             
‡ Competition NMR experiments carried out and equilibrium constants calculated by Dr Richard 
Knighton, Post Doctoral Research Fellow, University of Warwick. 
Scheme 4.6: Competition experiment equilibrium 
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11a and 12a is presumably destabilised by the electrostatic repulsion from the rhodium and 
iridium centres. Binding strength is then broadly proportional to the number of thione 
donors. No significant difference in binding strength between 11a or 12a was found, within 
error, suggesting that there is no meaningful stabilising interaction between the transition 
metal and potassium ion (no Z-type bonding) as a greater interaction would be expected for 
the heaver congener. VT 1H NMR experiments were also recorded in attempt to probe the 
role of the thermodynamic parameters, however, the changes observed were too small to 
draw meaningful conclusions.  
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4.3 Conclusion 
Monometallic rhodium(I) and iridium(I) complexes 11a and 12a were readily synthesised 
from 1,3-bis(imidazole-2-thione) functionalised calix[4]arene ligand 3. These complexes 
were analysed in solution by 1H, 13C NMR spectroscopy, ESI-MS and in the solid state by 
microanalysis and X-ray diffraction. The solid-state structures of 11a and 12a demonstrate 
loss of π-stacking between the imidazole-2-thione donors compared to the free ligand 3. 
Model complexes 11b and 12b, containing IiPr2Me2S were synthesised in parallel, and 
highlighted the flexibility of the calix[4]arene scaffold, which only results in relatively small 
changes to the S-M-S bond angles.   
Reactivity of 11 and 12 with CO, H2, bipy and IiPr2Me2S shed light into the binding of 3 and 
COD, in both cases the chelating COD ligand was easily displaced by CO and showed no 
reaction under 1 atm H2. Addition of bipy revealed the reactivity differences between the Ir 
and Rh products, reaction of 11a and 11b both resulted in the subsititution of their respective 
ligands however reaction with Iridium analogues 12a and 12b resulted in the formation of 
adducts 16a and 16b. Imidazol-2-thione ligand 3 can be displaced by IiPr2Me2S in 11a and 
12a, perhaps driven by relief of SMS bond strain, while the addition of bipy highlights the 
stronger binding of Ir compared to Rh and bipy compared to 3.  
Calix[4]arene species A2, 18, 3, 11a and 12a were all found to bind potassium cations, by 
reaction with K[BArF4] and the resulting host-guest complexes were analysed in solution by 
1H and 13C NMR spectroscopy and in the solid state by X-ray diffraction. Interrogation of 
crystallographic data demonstrated the potassium binding is mediated by interactions with 
S, O and arene donors. Despite electrostatic repulsion the cationic hosts 11a and 12a could 
bind K+. Solution data indicated that potassium binding strength increases 11a ~ 12a < A2 < 
18 < 3 with no host-guest adducts observed for IiPr2Me2S or 11b or 12b. The formation of 
potassium adducts of 11a and 12a highlight the ability of calix[4]arene ligand scaffolds host 
to support otherwise unstable metal-metal systems.   
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4.4 Experimental 
4.4.1 General considerations 
Unless otherwise stated all manipulations were performed under an atmosphere of argon, 
using Schlenk and glove box techniques. Glassware was oven dried at 150 °C overnight and 
flame dried under vacuum prior to use. Anhydrous CH2Cl2, Et2O, and pentane (<0.005% H2O) 
were purchased from ACROS or Aldrich and freeze–pump–thaw degassed three times before 
being placed under argon. THF was dried over sodium/benzophenone, vacuum distilled, and 
freeze–pump–thaw degassed three times before being placed under argon. 1,2-C6H4F2 was 
stored over neutral alumina for 12 hours, filtered, dried vacuum distilled from CaH2 and 
freeze–pump–thaw degassed three times before being placed under argon over 3 Å 
molecular sieves. CD2Cl2 was dried over activated 3 Å sieves and freeze–pump–thaw 
degassed three times before being placed under argon. C6D6 was dried over Na, vacuum 
distilled, and freeze–pump–thaw degassed three times before being placed under argon. 
[Rh(COD)Cl]2, Na[BArF4], K[BArF4] were synthesised using literature protocols.53, 54 A118 was 
prepared by Jack Emerson-King by adaption of literature protocols.55, 56 All other solvents and 
reagents are commercial products and were used as received. NMR spectra were recorded 
on Bruker 300, 400, 600 Avance III HD, 400 Avance AV, 500 Avance III HD, 500 Avance AV and 
700 Avance II HD spectrometers at 298 K unless otherwise stated. 1H NMR spectra recorded 
in 1,2-C6H4F2 were referenced using the highest intensity peak of the highest (δ 6.865) 
frequency fluoro-arene multiplets. 13C{1H} NMR spectra recorded in 1,2-C6H4F2 were 
referenced using an internal sealed capillary of C6D6. Chemical shifts are quoted in ppm and 
coupling constants in Hz. IR spectra were recorded on a PerkinElmer Spectrum One FT-IR 
spectrometer at 293 K. ESI-MS analyses were recorded on Bruker Maxis Impact instrument 
or Brucker MicroTOF. Microanalyses were performed by Stephen Boyer at London 
Metropolitan University or Brian Addison at Elemental Microanalysis Ltd. 
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4.4.2 Preparation of isolated complexes 
Synthesis of [(3)Rh(COD)][BArF4] (11a) 
A solution of 3 (201.8 mg, 0.2479 mmol), [Rh(COD)Cl]2 (61.2 mg, 0.1241 mmol) in 
CH2Cl2 (10 mL) was stirred for one hour at RT, added to Na[BArF4] (217.1 mg, 0.02450 mmol) 
stirred for a further hour, filtered, and layered with pentane (30 mL) for several days at RT. 
The mixture was filtered and the product dried in vacuo. Yield = 240.2 mg (52 %, yellow 
powder). 1H NMR (CH2Cl2, 600 MHz) δ 7.69 – 7.75 (m, 8H, ArF), 7.56 (s, 4H, ArF), 7.50 (s, 2H, 
Ar), 7.33 (d, 3JHH = 7.5, 2H, Ar), 7.15 (d, 3JHH = 7.5, 2H, Ar), 7.12 (t, 3JHH = 7.5 , 1H, Ar), 6.91 (t, 
3JHH = 7.5, 1H, Ar), 6.85 (d, 3JHH = 2.3 , 2H, imid.), 6.78 (d, 3JHH = 2.3 , 2H, imid.), 6.11 (d, 
3JHH = 2.8, 2H, Ar), 4.60 (d, 2JHH = 13.2, 2H, ArCH2Ar), 4.56 (d, 2JHH = 13.2, 2H, ArCH2Ar), 4.16 
– 4.19 (m, 4H, OCH2), 4.11 (s, 2H, COD{CH}), 3.86 (s, 2H, COD{CH}), 3.76 (s, 6H, NCH3), 3.69 
– 3.73 (m, 4H, OCH2), 3.34 (d, 2JHH = 13.2, 2H, ArCH2Ar), 3.22 (d, 2JHH = 13.3, 2H, ArCH2Ar), 2.60 
(s, 2H, COD{CH}), 2.41 (s, 2H, COD{CH}), 2.02 – 2.11 (m, 4H, CH2CH2), 1.92 – 2.11 (m, 8H, 
CH2CH2, COD57), 1.11 (t, 3JHH = 7.4 , 6H, CH2CH3), 0.95 (app. q, 6H, CH2CH3). 13C{1H} NMR 
(CD2Cl2, 151 MHz) δ 162.3 (q, 1JBC = 50, ArF), 158.2 (Ar), 158.0 (Ar), 156.4 (C=S), 136.9 (Ar), 
136.5 (Ar), 135.4 (ArF), 131.7, 130.2 (Ar), 129.4 (qq, 2JFC = 32, 3JBC = 3, ArF) 129.6 (Ar), 125.2 
(q, 1JFC = 272, ArF) 124.8 (Ar), 123.6 (Ar), 123.1 (Ar), 121.1 (imid.), 118.0 (s, ArF), 82.9 (d, 
1JRhC = 10, COD{CH}), 81.4 (d, 1JRhC = 12, COD{CH}), 78.6 (OCH2), 77.2 (OCH2), 77.1 (OCH2), 37.2 
(NCH3), 32.3 (COD{CH2}), 32.0 (COD{CH2}), 31.6 (COD{CH2}), 31.3 (COD{CH2}), 24.1 (CH2CH3), 
23.4 (CH2CH3), 11.1 (CH2CH3), 10.1 (CH2CH3). ESI-MS (CH3CN, 180°C, 4 kV) Positive ion: 
1027.3469 m/z, [M]+ (calc. 1027.3732 m/z). Anal. Calcd. For C88H80BF24N4O4RhS2 (1890.4386 
g∙mol-1): C,55.88; H, 4.26; N, 2.96. Found: C, 55.76; H, 4.18; N, 3.13. 
Cis-[(3)Rh(CO)2][BArF4] (13a) 
A solution of 11a (100.9 mg, 0.05334 mmol) in CH2Cl2 (10 mL) was stirred under CO (1 atm) 
for 2 hours. The solvent was removed in vacuo and the product washed with pentane and 
dried under vacuum. Yield = 24.6 mg (53 %, yellow powder).1H NMR (CD2Cl2, 500 MHz) 
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δ 7.71– 7.73 (m, 8H, ArF), 7.56 (s, 4H, ArF), 7.26 (d, 3JHH = 2.8, 2H, imid.), 7.18 (d, 3JHH = 7.5, 
2H, Ar), 7.12 (d, 3JHH = 7.4, 2H, Ar), 7.03 (s, 4H, Ar), 6.95 (t, 3JHH = 7.5, 1H, Ar), 6.87 (t, 3JHH = 7.5, 
1H, Ar), 6.46 (d, 3JHH = 2.9, 2H, imid.), 4.58 (d, 2JHH = 12.7, 4H, ArCH2Ar), 4.04– 4.25 (m, 4H, 
OCH2), 3.71– 3.81 (m, 4H, OCH2), 3.71 (s, 6H, NCH3), 3.32 (d, 3JHH = 12.7, 2H, ArCH2Ar), 3.24 
(d, 2JHH = 12.8, 2H, ArCH2Ar), 1.92 – 2.18 (m, 4H, CH2CH3), 1.92– 2.00 (m, 4H, CH2CH3), 1.09 (t, 
3JHH = 7.4, 6H, CH2CH3), 0.99 (q, 3JHH = 7.7, 6H, CH2CH3). 13C{1H} NMR (CD2Cl2, 126 MHz) 183.3 
(d, 1JRhC = 69.7, CO), 162.3 (q, 1JBC, 50, ArF), 135.4 (ArF), 130.0 (Ar) 129.4 (qq, 2JFC=32, 3JBC=3, 
ArF), 125.2 (q, 1JFC=272, ArF), 125.0 (imid.), 121.9 (Ar), 121.7 (Ar), 118.1 (ArF), 78.9 (OCH2), 
77.3 (OCH2), 77.1 (OCH2), 37.1 (NCH3), 23.7 (CH2CH3),24.0 (ArCH2Ar), 23.7 (ArCH2Ar), 23.5 
(CH2CH3), 11.0 (CH2CH3), 10.2 (CH2CH3). ESI-MS (CH3CN, 180°C, 3 kV) Positive ion: 
976.2997 m/z, [M]+ (calc. 976.2980 m/z). IR (CH2Cl2, cm-1): ν(CO) 2068, 2001. Anal. Calcd. For 
C82H68BF24N4O6RhS2 (1838.33 g∙mol-1): C, 53.55; H, 3.73; N, 3.05. Found: C, 53.52; H, 3.62; N, 
3.28. 
 [(3)Ir(COD)][BArF4] (12a) 
A solution of 3 (149.8 mg, 0.1835 mmol), [Ir(COD)Cl]2 (62.8 mg, 0.09345 mmol) in CH2Cl2 
(10 mL) was stirred for one hour, added to Na[BArF4] (161.0 mg, 0.1817 mmol) stirred for a 
further hour, filtered, and layered with pentane (30 mL) for several days at RT. The mixture 
was filtered and the product dried in vacuo. Yield = 163.2 mg (45 %, yellow crystals). 1H NMR 
(CD2Cl2, 600 MHz) δ 7.70 – 7.74 (m, 8H, ArF), 7.56 (s, 4H, ArF), 7.43 (s, 2H, Ar), 7.28 (d, 
3JHH = 7.5, 2H, imid.), 7.14 (d, 3JHH = 7.5, 2H, imid.), 7.08 (t, 3JHH = 7.5, 1H, Ar), 6.98 – 6.91 (m, 
4H, Ar), 6.89 (t, 3JHH = 7.5, 1H, Ar), 6.18 (d, 3JHH = 2.9, 2H, Ar), 4.59 (d, 2JHH = 12.9, 2H, ArCH2Ar), 
4.57 (d, 2JHH = 13.0, 2H, ArCH2Ar), 4.25 – 4.12 (m, 4H), 3.73 (s, 4H), 3.73 – 3.69 (m, 2H), 
3.66 – 3.43 (m, 2H), 3.32 (d, 2JHH = 13.0, 2H, ArCH2Ar), 3.23 (d, 2JHH = 13.2, 2H, ArCH2Ar), 2.40 
(s, 2H, COD{CH}), 2.21 (s, 2H, COD{CH}), 2.05 – 2.11 (m, 4H, CH2CH3), 1.93 – 1.98 (m, 4H, 
CH2CH3), 1.69 (s, 2H, COD{CH2}), 1.53 (s, 2H, COD{CH2}), 1.11 (t, 3JHH = 7.4, 6H, CH2CH3), 0.95 
(app. q., 6H, CH2CH3). 13C{1H} NMR (CD2Cl2, 151 MHz) δ 162.3 (q, 1JBC= 50, ArF), 158.1, 157.8, 
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156.6 (NCN), 154.5, 136.7, 136.4, 136.10, 135.6, 135.4 (ArF), 131.6, 130.2, 129.6, 129.4 
(qq, 2JFC = 32, 3JBC = 3, ArF) 125.2 (q, 1JFC = 272, ArF), 124.8, 123.9, 123.2, 121.8, 118.0 (ArF), 
78.7 (OCH2), 77.2 (OCH2), 77.1 (OCH2), 37.1 (NCH3), 32.3 (ArCH2Ar), 31.6 (ArCH2Ar), 
24.1(CH2CH3), 23.4 (CH2CH3), 11.1 (CH2CH3), 10.1 (CH2CH3). ESI-MS (CH3CN, 180°C, 4 kV) 
Positive ion: 1117.4331 m/z, [M]+ (calc. 1117.4307). Anal. Calcd. For C88H80BF24N4O4IrS2 
(1980.4960 g mol-1): C, 53.36; H,4.07; N,2.83. Found: C, 53.33; H, 3.90; N, 2.91. 
Synthesis of cis-[(3)Ir(CO)2][BArF4] (14a) 
A solution of 12a (26.0 mg, 0.01313 mmol) in CH2Cl2 (10 mL) was stirred for 16 hours under 
CO (1 atm) the solvent removed in vacuo. The residue was washed with pentane (3 × 10 mL) 
filtered and dried in vacuo. Yield = 14.6 mg (58 %, yellow powder). 1H NMR (CH2Cl2, 500 MHz) 
δ 7.83 – 7.73 (m, 8H, ArF), 7.60 (s, 4H, ArF), 7.26 – 7.22 (m, 2H), 7.20 (d, 3JHH = 7.5 , 2H, imid.), 
7.16 (d, 3JHH = 7.5, 2H, Ar), 7.09 (s, 4H, Ar), 6.99 (d, 3JHH = 7.5, 1H, Ar), 6.91 (t, 3JHH = 7.5, 1H, 
Ar), 6.53 (d, 3JHH = 2.8, 2H, imid.), 4.62 (app. d, 4H, ArCH2Ar), 4.23 – 4.09 (m, 4H), 3.86 – 3.69 
(m, 17H), 3.81 (s, 6H, NCH3), 3.35 (d, 2JHH = 12.7, 2H, , ArCH2Ar), 3.29 (d, 2JHH = 12.8, 2H, 
ArCH2Ar), 2.20 – 2.23 (m, 4H, CH2CH3), 1.96 – 2.03 (m, 4H, CH2CH3), 1.13 (t, 3JHH = 7.4, 6H, 
CH2CH3), 1.04 (app. q, 6H, CH2CH3). 13C{1H} NMR (CD2Cl2, 126 MHz) δ 172.5 (CO), 162.3 (q, 
1JBC = 50, ArF), 157.7 (Ar), 157.5 (Ar), 156.9 (NCN), 152.7 (Ar), 136.2 (Ar), 136.1 (Ar), 136.0 (Ar), 
135.4 (ArF), 130.8, 130.0 (Ar), 129.4 (Ar), 129.4 (qq, 2JFC = 32, 3JBC = 3, ArF), 125.3 (imid), 125.2 
(q, 1JFC = 272, ArF), 124.9 (Ar), 124.6 (imid), 123.5 (Ar), 122.1 (Ar), 121.7 (Ar), 118.0 (ArF), 79.0 
(OCH2), 77.3 (OCH2), 77.1 (OCH2), 37.1 (NCH3), 31.7 (ArCH2Ar), 31.5 (ArCH2Ar), 24.0 (CH2CH3), 
23.7 (CH2CH3), 23.5 (CH2CH3), 11.0 (CH2CH3), 10.2 (CH2CH3), 10.2 (CH2CH3). ESI-MS (CH3CN, 
180°C, 4 kV) Positive ion: 1065.3267 m/z, [M]+ (calc. 1065.3265 m/z). IR (CH2Cl2, cm-1): ν(CO) 
2055, 1984. Anal. Calcd. For C82H68BF24N4O6IrS2 (1928.3919 g∙mol-1): C,51.07; H,3.55; N,2.91. 
Found: C,50.87; H,3.37; N,3.01. 
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[(IiPr2Me2S)2Rh(COD)][BArF4] (11b) 
Adapted from procedure reported by Raubenheimer et al.4 
A solution of IiPr2Me2S2 (101.3 mg, 0.4775 mmol) and [Rh(COD)Cl]2 (58.3 mg, 0.1182 mmol) 
was stirred in CH2Cl2 (10 mL) for one hour. The mixture was filtered onto Na[BArF4] (231.4 mg, 
0.2611 mmol) and stirred for a further two hours. The mixture was filtered, washed with 
heptane and dried in vacuo. Yield = 260.4 mg (74%, yellow powder).1H NMR (CD2Cl2, 
400 MHz) 1H NMR δ 7.71 – 7.72 (m, 8H, ArF), 7.56 (s, 4H, ArF), 5.46 (s, 4H, CHCH3), 3.78 (s, 4H, 
COD{CH}), 2.27 – 2.38 (m, 4H, COD{CH2}), 2.22 (s, 12H, CCH3), 1.77 – 1.91 (m, 4H, COD{CH2}), 
1.51 (d, 3JHH = 7.1, 24H, CHCH3). 13C{1H} NMR (CD2Cl2, 101 MHz) δ 162.3 (q, JBC = 50, ArF), 152.2 
(NCN), 135.4 (ArF4), 129.4 (qq, 2JFC  = 32, 3JBC = 3, ArF), 126.2 (CCH3), (q, 1JFC = 272, ArF), 118.0 
(ArF), 81.1, (d, 1JRhC = 12.0, COD{CH}), 54.6 (CHCH3), 31.6 (COD{CH2}), 21.4 (CHCH3), 10.9 
(CCH3). ESI-MS (CH3CN, 180 °C, 4 kV) Positive ion: 637.2509 m/z [M]+ (Calculated 
637.2839 m/z). Anal. Calcd. For C62H64BF24N4RhS2 (1498.3337 g mol-1): C, 49.68; H, 4.30; N, 
3.74. Found: C, 49.83; H,4.16; N,3.75. 
cis-[(IiPr2Me2S)2Rh(CO)2][BArF4] (13b) 
A solution of 11b (100.8 mg, 0.0673 mmol) in CH2Cl2 (10 mL) was stirred under an atmosphere 
of CO (atm) for 4 hours the solvent was removed in vacuo, the product washed with pentane 
(3 × 10 mL) and dried in vacuo. Recrystallised from CH2Cl2/pentane Yield= 15.1 mg (77%, 
orange powder). 1H NMR (CD2Cl2, 400 MHz) δ 7.80 – 7.66 (m, 8H, ArF ), 7.56 (s, 4H, ArF), 5.48 
(s, 4H, CHCH3), 2.27 (s, 12H, CCH3), 1.55 (d, 3JHH = 7.1, 24H, CHCH3). 13C{1H}  NMR (CD2Cl2, 
101 Hz) δ 183.7 (d, 1JRhC = 69, CO), 162.3 (q, 1JBC  = 50, ArF), 146.8 (NCN), 135.4 (ArF), 129.4 (qq, 
ArF), 126.5 (imid), 118.0 (sept, 3JFC = 4, ArF), 52.4 (CH(CH3)2), 21.1 (CH(CH3)2), 10.9 (CCH3). ESI-
MS (CH3CN, 180°C, 4 kV) 583.1429 m/z [M]+ positive ion (calc. 583.1642 m/z [M]+). IR 
(CH2Cl2, cm-1): ν(CO) 2067, 2002. Anal. Calcd. For C56H52BF24N2O2RhS2 (1446.2297 g mol-1): 
C,46.49; H,3.62; N,3.87. Found: C,46.52; H,3.71; N,3.87. 
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[(IiPr2Me2S)2Ir(COD)][BArF4] (12b) 
IiPr2Me2S (100.2 mg, 0.4718 mmol), [Ir(COD)Cl]2 (74.6 mg, 0.1111 mmol) were stirred in 
CH2Cl2 (10 mL) and filtered onto Na[BArF4] (232.0 mg, 0.2618 mmol) and stirred for a further 
hour. The yellow mixture was filtered, dried in vacuo, washed with heptane (2 x 10 mL) and 
recrystallised from CH2Cl2/pentane. Yield = 251.0 mg (67%, orange crystals). 1H NMR 
(400 MHz, CD2Cl2) δ 7.70 – 7.74 (m, 8H, ArF), 7.57 (s, 4H, ArF), 5.34 – 5.51 (m, 4H, CHCH3), 3.33 
(s, 4H, COD{CH}), 2.25 (s, 12H, CCH3), 2.06 – 2.20 (m, 4H, COD{CH2}), 1.50 (d, 3JHH = 7.1, 24H, 
CHCH3).13C{1H} NMR (101 MHz, CD2Cl2) δ 162.3 (q, ArF) , 149.2 (NCN), 135.4 (s, ArF), 129.4 
(qq, ArF), 126.5 (NCC), 125.2 (q, 1JFC= 272, ArF), 118.0 (sept, 3JFC = 4, ArF), 64.6 (COD{CH}), 52.1 
(s, NCH), 32.0 (s, COD{CH2}), 21.5 (s, CCH3), 10.9 (s, CCH3). ESI-MS (CH3CN, 180 °C, 4 kV) 
725.3248 m/z (calc. 725.3255 m/z). Anal. Calcd. For C62H64BF24IrN4 (1588.39 g mol-1): C, 46.88; 
H, 4.06; N, 3.53 Found: C,47.02;H,4.17;N,3.58.  
cis-[(IiPr2Me2S)2Ir(CO)2][BArF4] (14b) 
A solution of 12b (100.3 mg, 0.06316 mmol) in CH2Cl2 (20 mL) was stirred for 4 hours under 
an atmosphere of CO (1 atm). The solvent was removed in vacuo, the solid washed with 
pentane (3 ×10 mL) and dried in vacuo. Yield = 15.1 mg (77%, yellow powder). 1H NMR 
(500 MHz, CD2Cl2) δ 7.71-7.73 (m, 8H, BArF), 7.56 (s, 4H, BArF), 5.48 (s, 4H, CHCH3), 2.31 (s, 
12H, CCH3), 1.56 (d, J = 7.1 Hz, 20H, CHCH3).13C{1H} NMR (126 MHz, CD2Cl2) δ 173.0 (s, CO), 
162.3 (q, 1JBC = 50, ArF), 147.5 (s, C=S), 135.4 (s, ArF), 129.4 (qq, 2JFC = 32, 3JBC = 3, ArF), 127.5 
(s, CCH3) , 125.1 (q, 1JFC = 272, ArF), 118.0 (sept, 3JFC = 4, ArF), 52.6 (s, CHCH3), 21.1 (CHCH3), 
10.8 (CCH3). ESI-MS (CH3CN, 180 °C, 4 kV) 673.2215 m/z [M] + (Calc. 673.2214 m/z). 
IR (CH2Cl2, cm-1): ν(CO) 2052, 1983. Anal. Calcd. For C62H64BF24IrN4S2 (1588.39 g∙mol-1): 
C, 43.79;H, 3.41;N, 3.65 Found: C, 43.52; H, 3.29; N 3.71.  
[A2·K][BArF4] 
A solution of A2 (101.2 mg, 0.1707 mmol) and K[BArF4] (170.1 mg, 0.1885 mmol) in CH2Cl2 
(10 mL) was stirred for 16 hours at room temperature. The colourless solution was filtered 
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and layered with pentane (30 mL) and stored at RT overnight. Yield = 203.2 mg (78 %, 
colourless crystals). 1H NMR (CD2Cl2, 400 MHz) δ 7.72 (s, 8H, BArF), 7.55 (s, 4H, BArF), 
7.01 - 7.07 (m, 8H, Ar), 6.86-6.93 (m, 4H, Ar), 4.53 (d, 2JHH = 13.3, 4H, ArCH2Ar), 4.12 (t, 
3JHH = 7.9, 8H, OCH2), 3.47 (d, 2JHH = 13.4, 4H, ArCH2Ar), 1.88-2.01 (m, 8H, CH2CH3), 0.98-1.06 
(m, 12H, CH2CH3).  13C{1H} NMR (CD2Cl2, 101 MHz) 162.3 (q,1JBC= 51, ArF), 155.2 (Ar), 135.9 
(Ar), 135.4 (s, ArF), 130.9 (Ar), 129.4 (qq, 2JFC = 32, 3JBC = 3, ArF), 128.4 (Ar), 126.2 (Ar), 125.2 
(q, 1JFC = 272, ArF), 121.9 (Ar), 118.0 (sept, 3JFC = 4, ArF), 78.4 (OCH2), 31.5 (ArCH2Ar), 23.4 
(CH2CH3), 10.3 (CH2CH3). ESI-MS (CH3CN, 180°C, 4 kV) 631.3186 m/z [M]+ (calc. 631.3184 
m/z). Anal. Calcd. For C72H60BF24KO4 (1494.38 g∙mol-1): C, 57.84; H, 4.05. Found: C, 57.69; H, 
3.86. 
[18-crown-6·K][BArF4] 
A solution of 18-crown-6 (155.0 mg, 0.5871 mmol) and K[BArF4] (553.1 mg, 0.6131 mmol) 
were stirred in CH2Cl2 (20 mL) for 2 hours. The mixture was filtered and the colourless 
solution was layered with pentane resulting in the formation of large white crystals, which 
were dried in vacuo. Yield = 412.0 mg (60 %, white crystals). 1H NMR (400 MHz, CD2Cl2) δ 7.73 
(s, 8H, BArF4), 7.58 (s, 4H, BArF4), 3.58 (s, 24H, OCH2). 13C{1H} NMR (CD2Cl2, 101 MHz): δ 162.3 
(q, 1JBC = 50, ArF 135.4 (s, ArF), 129.4 (qq, 2JFC = 32, 3JBC = 3, ArF), 125.2 (q, 1JFC = 272, ArF), 118.0 
(sept, 3JFC = 4, ArF), 70.7 (s, OCH2). ESI-MS (CH3CN, 180°C, 4 kV) Positive ion: 303.1189 m/z, 
[M]+ (calc. 303.1204 m/z). Anal. Calcd.For C44H36BF24KO6 (1166.1859 g mol-1): C, 45.30; H, 
3.11; Found: C,45.33; H,2.94.  
1-methylimidazolcalix[4]arene (17) 
A mixture of A148 (167.0 mg, 0.2537 mmol) and iodomethane (0.1 mL, 1.606 mmol) in THF 
(1 mL) was heated at 80°C for 30 h. The product was precipitated by the addition of ethanol 
(10 mL), filtered and washed with diethyl ether (2 x 10 mL) and dried in vacuo. Yield = 181.0 
mg (89 %, white solid). 1H NMR (CD2Cl2, 500 MHz) δ 9.88 (s, 1H, imid), 7.36 (m, 1H, imid), 7.01 
– 7.09 (m, 4H, Ar), 6.85 (t, 3JHH = 7.5, 1H, Ar)., 6.46 (s, 2H, imid), 6.26 (d, 3JHH = 7.5, 2H, Ar), 
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6.08 (t, 3JHH = 7.5, 1H, Ar), 4.52 (d, 2JHH = 13.6, 2H, ArCH2Ar), 4.46 (d, 2JHH = 13.3, 2H, ArCH2Ar)., 
4.12 (s, 3H, NCH3), 3.89  – 4.08 (m, 4H, OCH2), 3.81 (t, 3JHH = 6.9, 2H, OCH2), 3.72 (t, 3JHH = 6.9, 
2H, OCH2), 3.27 (d, 2JHH = 13.6, 2H), 3.17 (d, 2JHH = 13.4, 2H, ArCH2Ar)., 1.87 – 2.01 (m, 8H, 
CH2CH3), 1.10 (t, 3JHH = 5.8, 3H, CH2CH3), 1.07 (t, 3JHH = 5.8, 3H, CH2CH3), 0.93 (t, 3JHH = 7.4, 6H, 
CH2CH3).13C NMR (CD2Cl2, 126 MHz) δ 158.0 (Ar), 156.6 (Ar), 137.76 (Ar), 137.2 (Ar), 136.0 
(Ar), 135.6 (imid), 134.8 (Ar), 129.8 (Ar), 129.4 (Ar), 128.9 (Ar), 127.8 (Ar), 124.0 (imid), 122.8 
(Ar), 121.8 (imid), 121.7 (Ar), 121.3 (Ar), 77.9 (OCH2), 77.6 (OCH2), 77.3 (OCH2), 37.7 (NCH3), 
31.5 (ArCH2Ar), 31.4 (ArCH2Ar), 24.0 (CH2CH3), 23.9 (CH2CH3), 23.6 (CH2CH3), 11.0 (CH2CH3), 
11.0 (CH2CH3), 10.3 (CH2CH3).ESI-MS (CH3CN, 180°C, 3 kV) positive ion 637.4002 m/z, [M]+ 
(calc 673.4000 m/z). Anal. Calcd. For C44H53IN2O4 (800.31 g∙mol-1): C,65.99; H,6.67; N,3.50. 
Found: C, 65.90; H, 6.64; N, 3.58. 
imidazol-2-thione calix[4]arene (18) 
A mixture of 17 (614.2 mg, 0.9121 mmol), K2CO3 (161.2 mg, 1.1663 mmol) and S8 (34.4 mg, 
0.1344 mmol) in ethanol (20 mL) was stirred at reflux for 16 hours. Solvent was removed in 
vacuo and the product extracted with CH2Cl2 (2 x 10 mL) and precipitated with excess 
pentane/hexane. Yield = 459.3 mg (71 %, white powder). 1H NMR (CD2Cl2, 500 MHz) δ 6.93 
(d, 3JHH = 7.5, 4H, Ar), 6.77 (t, 3JHH = 7.5, 2H, Ar), 6.62 (d, 3JHH = 2.4, 1H, imid), 6.46 (s, 2H, Ar), 
6.37 (d, 3JHH = 7.4, 2H, Ar), 6.29 – 6.32  (m, 6.5, 1H, Ar), 6.13 (d, 2JHH = 2.4, 1H, imid), 4.48 (app. 
t, 3JHH = 14, 4H, ArCH2Ar), 3.90 – 4.06 (m, 4H, OCH2), 3.84 (t, 3JHH = 7.0, 2H, OCH2), 3.74 (t, 
3JHH = 7.1, 2H, OCH2), 3.51 (s, 3H, NCH3), 3.23 (d, 2JHH = 13.5, 2H, ArCH2Ar), 3.16 (d, 2JHH = 13.3, 
2H, ArCH2Ar), 1.85 – 2.06 (m, 8H, CH2CH3), 1.08 (m, 1.05 – 1.11, 6H, CH2CH3), 0.94 (t, 3JHH = 7.5, 
6H, CH2CH3). 13C{1H} NMR (CD2Cl2, 126 MHz) δ 163.32 (NCN), 160.46 (imid), 157.87 (Ar), 
156.59 (Ar), 156.03 (Ar), 136.89 (Ar), 136.40 (Ar), 135.51 (Ar), 134.86 (Ar), 133.01 (Ar), 129.32 
(Ar), 129.13 (Ar), 128.01 (Ar), 125.54 (Ar), 122.53 (Ar), 122.34 (Ar), 118.54 (imid), 117.96 
(imid), 77.76 (OCH2), 77.64 (OCH2), 77.29 (OCH2), 35.52 (NCH3), 31.44 (ArCH2Ar), 24.03 
(CH2CH3), 23.65 (CH2CH3), 11.01 (CH2CH3), 10.36 (CH2CH3). ESI-MS (CH3CN, 180°C, 3 kV) 
 143 
 
positive ion 704.3364 m/z [M]+ (calc. 704.3642 m/z). Anal. Calcd. For C44H51N4O4S 
(704.36 g∙mol-1): C, 74.97; H, 7.44; N, 3.97. Found: C, 74.77; H, 7.29; N, 4.15. 
[18·K][BArF4] 
A solution of 18 (20.2 mg, 0.02865 mmol) and K[BArF4] (29.2 mg, 0.03236 mmol) in CH2Cl2 
(10 mL) was stirred for 16 h. The mixture was filtered and the product was precipitated by 
addition of pentane (10 mL) and recrystallised from CH2Cl2/pentane and dried in vacuo. Yield 
= 25.4 mg (55 %, white crystals). 1H NMR (CD2Cl2, 500 MHz) δ 7.72 – 7.76 (m, 8H, ArF), 7.56 
(s, 4H, ArF), 7.35 (d, 3JHH = 7.6, 1.7, 2H, Ar), 7.27 (d, 3JHH = 7.7, 2H, Ar), 7.14 (t, 3JHH = 7.6 , 2H, 
Ar), 6.73 – 6.82 (m, 3H, Ar), 6.70 – 6.71(m, 3H, Ar, imid), 6.63 (d, 3JHH = 2.4, 1H, imid), 4.57 
(app. t, 4H, ArCH2Ar), 4.39– 4.49 (m, 4H, OCH2), 3.86 (t, 3JHH = 7.1, 2H, OCH2), 3.81 (t, 3JHH = 7.1, 
2H, OCH2), 3.48 (app. t, 4H, ArCH2Ar), 3.41 (s, 3H, NCH3), 1.87 – 2.05 (m, 8H, CH2CH3), 1.10 
(app. q , 6H, CH2CH3), 0.96 (t, 3JHH = 7.4, 6H, CH2CH3).  13C{1H} NMR (CD2Cl2, 126 MHz) δ 163.8 
(NCN), 162.3 (q, 1JBC = 50, ArF), 157.4 (Ar), 157.2 (Ar), 153.4 (Ar), 136.8 (Ar), 136.2 (Ar), 136.1 
(Ar), 135.4 (s, ArF), 134.8 (Ar), 134.5 (Ar), 131.9 (Ar), 131.4 (Ar), 130.2 (Ar), 129.6 (Ar), 129.4 
(qq, 2JFC = 32, 3JBC = 3, ArF), 126.7 (Ar), 126.2 (Ar), 126.2 (Ar), 125.2 (Ar), (q, 1JFC = 272, ArF), 
124.1 (Ar), 121.9 (Ar), 119.6 (imid), 118.0 (sept, 3JFC = 4, ArF), 117.9 (imid), 79.6 (OCH2), 79.4 
(OCH2), 77.5 (OCH2), 35.6 (NCH3), 31.6 (ArCH2Ar), 31.6 (ArCH2Ar), 24.0 (CH2CH3), 23.9 
(CH2CH3), 23.0 (CH2CH3), 10.9 (CH2CH3), 10.9 (CH2CH3), 9.8 (CH2CH3). ESI-MS (CH3CN, 180°C, 
4 kV) positive ion: 743.2924 m/z [M]+ (calc. 743.3279 m/z). Anal. Calcd. For C73H55BF24KN2O4S 
(1561. 32g∙mol-1): C, 56.79; H, 4.01; N, 1.74. Found: C, 56.56; H, 3.90; N, 1.84. (56.13; H, 3.55; 
N, 1.79.) 
[3·K][BArF4] 
A solution of 3 (51.2 mg, 0.0627 mmol) and K[BArF4] (61.4 mg, 0.0680 mmol) in CH2Cl2 (10 mL) 
was stirred for 16 hours at RT. The colourless solution was filtered and layered with pentane 
(20 mL) at RT overnight. Yield = 92.4 mg (82 %, colourless crystals). 1H NMR (CD2Cl2, 400 MHz) 
δ 7.72 (s, 8H, ArF), 7.56 (s, 4H, ArF), 7.30 (d, 3JHH = 7.6, 4H, Ar), 7.12 (t, 3JHH = 7.6, 2H, Ar), 7.00 
 144 
 
(s, 4H, Ar), 6.73 (d, 3JHH=2.5, 2H, imid), 6.67 (d, 3JHH = 2.5, 2H, imid), 4.59 (d, 2JHH = 13.5 , 4H, 
ArCH2Ar), 4.32 – 4.50 (m, 4H, OCH2), 3.86 (t, 3JHH = 7.0 , 4H, OCH2), 3.49 (d, 2JHH = 13.6 , 4H, 
ArCH2Ar), 3.22 (s, 6H, NCH3), 1.92 – 2.04 (m, 8H, CH2CH3), 1.12 (t, 3JHH = 7.4, 6H, CH2CH3), 0.96 
(t, 3JHH = 7.4, 6H, CH2CH3).  13C{1H} NMR (CD2Cl2, 101 MHz) δ 164.16 (NCN), 162.3 (q, 1JBC = 50, 
ArF), 156.6 (Ar), 153.7 (Ar), 136.1 (Ar), 135.4 (s, ArF), 134.9, 134.1 (Ar), 132.0 (Ar), 129.4 
(qq, 2JFC = 32, 3JBC = 3, ArF), 128.6 (Ar), 126.7 (Ar), 125.2 (q, 1JFC = 272, ArF), 118.8 (imid), 118.0 
(sept, 3JFC = 4, ArF), 117.0 (imid), 79.5 (OCH2), 77.5 (OCH2), 35.4 (NCH3), 31.9 (ArCH2Ar), 24.0 
(CH2CH3), 23.0 (CH2CH3), 10.9 (CH2CH3), 9.9 (CH2CH3). ESI-MS (CH3CN, 180°C, 4 kV) Positive 
ion 855.3381 m/z, [M]+ (calc 855.3375 m/z). Anal. Calcd. For C80H68BF24KN4O4S2 
(1718.4029 g∙mol-1): C, 55.88; H, 3.99; N, 3.26 Found: C, 55.91;H, 3.91; N, 3.22.  
 
[11a·K][BArF4] 
A solution of 11a (50.0 mg, 0.0252 mmol) and K[BArF4] (113.6 mg, 0.126 mmol) in CH2Cl2 
(10 mL) was stirred for 16 hours. The mixture was filtered and the solvent was removed in 
vacuo. The product washed with pentane and dried under vacuum. Yield = 32 % (9.0 mg, 
yellow powder).  1H NMR (CD2Cl2, 500 MHz) δ 7.70 – 7.74 (m, 16H, ArF), 7.56 (br, 8H, ArF), 
7.46 (d, 3JHH = 7.6, 2H, Ar), 7.34 (d, 3JHH = 2.9, 2H, imid), 7.23 – 7.3(m, 3H, Ar), 7.06 (t, 3JHH = 
7.6, 1H, Ar), 6.94 – 7.02 (m, 4H, Ar), 6.70 (d, 3JHH = 2.7 Hz, 2H, imid), 4.61 – 4.71 (m, 6H, 
ArCH2Ar, COD{CH}), 4.41-4.46 (m, 2H, OCH2), 33.82-3.97 (m, 4H, OCH2), 3.75 (s, 6H, NCH3), 
3.69 (s, 1H, COD{CH}), 3.63 (d, 2JHH = 13.7 , 2H, ArCH2Ar), 3.53 (d, 2JHH = 13.3, 2H, ArCH2Ar), 
3.20-3.25 (m, 2H, COD{CH}), 2.28-2.36 (m, 2H, COD{CH}), 2.04 – 1.63 (m, 14H, COD{CH2}, 
CH2CH3), 1.10 (t, 3JHH = 7.4, 6H, CH2CH3), 1.01 (dt, 3JHH = 10.1, 7.4, 6H, CH2CH3). 13C{1H} NMR 
(CD2Cl2, 126 MHz) δ 162.3 (q, 1JBC = 50, ArF), 135.4 (s, ArF), 1, 129.4 (qq, 2JFC = 32, 3JBC = 3, ArF), 
125.2 (q, 1JFC = 272, ArF) 118.0 (sept, 3JFC = 4, ArF), 158.5 (NCN), 155.29 (Ar), 153.71(Ar), 137.37 
(Ar), 136.69 (Ar), 136.30 (Ar), 135.97 (Ar), 135.36 (Ar), 132.70, 132.29, 131.44, 128.39, 
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127.88, 127.34, 127.17, 126.40, 126.23, 124.06, 123.05, 121.13, 84.15, 84.06, 80.21, 77.85, 
76.67, 54.44, 37.4 (NCH3), 32.78, 31.34, 23.96 (COD{CH2}), 23.15 (COD{CH2}), 22.26 
(COD{CH2}), 9.99 (CH2CH3), 9.88 (CH2CH3). Anal. Calcd. For C82H68BF24KN4O4RhS2 (1934.24 
g∙mol-1): C,51.59; H, 3.32; N, 2.01 Found: C, 51.63; H, 3.39; N, 2.13. 
[12a·K][BArF4] 
A solution of 12a (50.0 mg, 0.0252 mmol) and K[BArF4] (113.6 mg, 0.126 mmol) in CH2Cl2 
(10 mL) was stirred for 16 hours. The mixture was filtered and the solvent was removed in 
vacuo and the product washed with pentane and dried under vacuum. Yield = 9.0 mg (32 %, 
yellow powder). 1H NMR (CD2Cl2, 400 MHz) δ 7.70 – 7.74 (m, 8H, ArF), 7.56 (br, 4H, ArF), 7.37 
(d, 3JHH  = 7.6, 2H), 7.30 (d, 3JHH  = 7.6, 2H, Ar), 7.14 (td, 3JHH = 7.6, 2.3, 2H, Ar), 7.06 (d, 3JHH = 2.3, 
2H, Ar), 7.04 (d, 3JHH = 2.7, 2H, imid), 7.01 (d, 3JHH = 2.3, 2H, Ar), 6.86 (d, 3JHH = 2.7, 2H, imid), 
4.73 – 4.81 (m, 2H, OCH2), 4.68 (app.t, 2JHH = 13, 4H, ArCH2Ar), 4.41 – 4.30 (m, 2H, OCH2), 3.81 
– 4.00 (m, 4H, OCH2), 3.77 (s, 6H, NCH3), 3.59 (d, 2JHH = 9.6, 2H, ArCH2Ar), 3.55 (d, 2JHH = 9.6, 
2H, ArCH2Ar), 2.99 (s, 2H, COD{CH}), 2.44 (s, 2H, COD{CH}), 2.16 – 1.92 (m, 8H, CH2CH3), 1.73 
– 1.86 (m, 2H, COD{CH}), 1.44 (d, 3JHH = 8.5, 2H, COD{CH}), 1.14 – 1.34 (m, 4H, COD{CH}), 0.94 
– 1.13 (m, 12H, CH2CH3).13C{1H} NMR (CD2Cl2, 126 MHz) δ 162.3 (q, 1JBC = 50, ArF), 158.8 9 
(NCN), 137.3 (Ar), 137.2 (Ar), 135.7 (Ar), 135.4 (s, ArF), 132.3 (Ar), 132.1 (Ar), 131.3 (Ar), 129.4 
(qq, 2JFC = 32, 3JBC = 3, ArF), 129.6 (Ar), 129.3 (Ar), 129.2 (Ar), 127.5 (Ar), 127.4 (Ar), 126.5 
(imid), 126.0 (Ar), 125.2 (q, 1JFC = 272, ArF) 123.8 (Ar), 123.3 (Ar), 122.7 (Ar), 118.0 
(sept, 3JFC = 4, ArF), 80.3 (OCH2), 78.3 (OCH2), 76.1 (OCH2), 67.8 (COD{CH}), 65.9 (COD{CH}), 
54.6, 37.3 (NCH3), 33.0 (COD{CH}), 32.0 (COD{CH}), 31.6 (COD{CH}), 31.2 (COD{CH}), 24.0 
(COD{CH}), 23.6 (COD{CH}), 21.9 (COD{CH}), 10.7 (CH2CH3), 10.1 (CH2CH3), 9.9 (CH2CH3). Anal. 
Calcd. For C82H68BF24KN4O6IrS2 (2882.52 g∙mol-1): C, 49.99; H, 3.22; N, 1.94. Found: C, 49.86; 
H, 3.31; N, 2.02. 
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Synthesis of [IiPr2Me2S·CH2Cl][BArF4] (19) 
A solution of IiPr2Me2 (20.0 mg, 0.0942 mmol), K[BArF4] (42.5 mg, 0.471 mmol) in 
CH2Cl2 (10 mL) was stirred for 16 hours at 50°C, filtered, and layered with pentane. The 
mixture was filtered and dried in vacuo. Yield = 31.4 mg (62 %, colourless crystals). 1H NMR 
(CH2Cl2, 400 MHz) δ 7.69 – 7.75 (m, 8H, ArF), 7.56 (s, 4H, ArF), 5.3 (m, 1H, CHCH3), 4.8 (s, H, 
CH2Cl), 2.4 (s, 6H, CCH3), 1.6 (d, 12H CHCH3). 13C{1H} NMR (CD2Cl2, 101 MHz) δ 162.3 
(q, 1JBC = 50, ArF), 135.4 (ArF), 131.7 (CCH3), 129.4 (qq, 2JFC = 32, 3JBC = 3, ArF) 125.2 (q, 1JFC = 272, 
ArF), 54.7 (CHCH3), 49.8 (CHCH3), 21.7 (CHCH3), 11.6 (CCH3).  
4.4.3 NMR Experiments 
Potassium binding stoichiometry 
A mixture of 0.005 mmol reagent and incremental quantities of K[BArF4] (0.5 equivalents; 
0.0025 mmol, 2.3 mg; 1 equivalent; 0.005 mmol, 4.6 mg and 0.05 equivalents; 25 mmol, 
23.0 mg) in CD2Cl2 (0.5 mL) under argon were agitated vigorously for 30 seconds and analysed 
by 1H NMR spectroscopy. The ratio of host and complex was determined by integration of 
the 1H NMR data. 
Table 4.6: Potassium binding stoichiometry’s determined by integration of 1H NMR spectra : 
Host 0.5 eq.s of K[BArF4] 
Host:[Host·K][BArF4] 
1.0 eq.s of K[BArF4] 
Host:[Host·K][BArF4] 
5.0 eq.s of K[BArF4] 
Host:[Host·K][BArF4] 
A2 49:51 0:1 0:1 
18 1.0:0.9 0.18:1.00 0:1 
3 1.0:1.3 0.16:1.00 0:1 
11a 1:1 0.22:1.00 0.13:1.00 
12a 1.0:1.3 0.19:1.00 0.17:1.00 
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Potassium complexes of A2, 3, 17, 11a, 12a and 18-crown-6 general procedure 
A solution of 0.005 mmol potassium was analysed by 1H NMR spectroscopy. An excess of 18-
crown-6 (~2 eq) was added which unanimously showed decoordination of the calix[4]arene 
binder and coordination of 18-crown-6 to K[BArF4] observable by integration of the [BArF4] 
resonance observed by 1H NMR spectroscopy. These were in good agreement with expected 
values.  
11a + IiPr2Me2 
A solution of 11a (9.5 mg, 5.00 mmol) and IiPr2Me2 (2.1 mg, 10.00 mmol) in CD2Cl2 (0.5 mL) 
was analysed by 1H NMR spectroscopy. The resulting mixture was analysed by 1H NMR 
spectroscopy (400 MHz) which showed a ratio of 1:6 11a:11b 
 12a + IiPr2Me2 
A solution of 12a ( mg, 5.00 mmol) and IiPr2Me2 (2.1 mg, 10.00 mmol) in CD2Cl2 (0.5 mL) 
was analysed by 1H NMR spectroscopy. The resulting mixture was analysed by 1H NMR 
spectroscopy (400 MHz) which showed a ratio of 1: 2.4 12a:12b 
Reaction with bipyridine 
[(3)Rh(COD)][BArF4] or [(IiPr2Me2S)2Rh(COD)][BArF4]  
A solution of IiPr2Me2S complex (0.005 mmol) and bipy (0.8 mg, 0.005 mmol) in CD2Cl2 (0.5 
mL) was analysed by 1H NMR spectroscopy. This showed quantitative formation of 
[Rh(COD)(bipy)][BArF4] and free 3.  
[(3)Ir(COD)][BArF4]  
A solution of IiPr2Me2S complex (0.005 mmol) and bipy (0.8 mg, 0.005 mmol) in CD2Cl2 (0.5 
mL) was analysed by 1H NMR spectroscopy. This showed quantitative formation of a single 
product thought to be [(3) Ir(COD)bipy][BArF4] by observation of 1H NMR and COSY NMR 
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spectroscopy. This product was also formed by reaction of [Ir(COD)(bipy)][BArF4] (6.6 mg, 
0.005 mmol) and 3 (4.1 mg, 0.005 mmol) in CD2Cl2 (0.5 mL).  
 
Hydrogenation attempt 
A solution of IiPr2Me2S complex 11a/11b/12a/12b (0.005 mmol) in CD2Cl2 (0.5 mL) was 
placed under an atmosphere of H2 and monitored by 1H NMR spectroscopy over 24 hours. A 
resonance indicating the presence of H2 gas in solution was observed at 4.60 ppm however 
no reaction was observed in any case.  
 
[(3)Ir(COD)][BArF4] + 2 IiPr2Me2S 
A solution of [(3)Ir(COD)][BArF4] ( 9.9 mg, 0.005 mmol) and IiPr2Me2S (2.1 mg, 0.010 mmol) 
in CD2Cl2 (0.5 mL) was monitored by 1H NMR spectroscopy Resulting in a mixture of 3: 
[(3)Ir(COD)][BArF4]:NHCS: [(NHCS)2Ir(COD)][BArF4] over time a fifth species was observed this 
has been attributed to the formation of [(3)Ir(COD)(NHCS)][BArF4]. 
[(3)Rh(COD)][BArF4] + 2 IiPr2Me2S 
A solution of [(3)Rh(COD)][BArF4] ( 9.5 mg, 0.005 mmol) and IiPr2Me2S (2.1 mg, 0.010 mmol) 
in CD2Cl2 (0.5 mL) was monitored by 1H NMR spectroscopy for 24 hours. Resulting in a mixture 
of 3: [(3)Rh(COD)][BArF4]: IiPr2Me2S: [(IiPr2Me2S)2Rh(COD)][BArF4] 1: 8:8:1. 
4.4.4 Crystallography 
Structure determinations were carried out by Dr. A. B. Chaplin. Relevant crystallographic 
data are given in Table 4.7 and Table 4.8. Data were collected on an Oxford Diffraction 
Gemini Ruby CCD or SuperNova AtlasS2 CCD diffractometer using graphite monochromated 
Mo K (λ = 0.71073 Å) or CuKα (λ = 1.54184 Å) radiation and a low-temperature device. Data 
were collected and reduced using CrysAlisPro. All non-hydrogen atoms were refined 
anisotropically using SHELXL,58 through the Olex2 interface. 
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Table 4.7: Crystallographic data for 11a, 12a, 11b, 12b and 19 
 
 
 
 
 
 
 
 
 
 
 
 11a 12a 11b 12b 19 
CCDC/ID 0229abc16s 0107abc14 0113abc14 0065abc14 0233abc16s 
Figure Figure 4.8 Figure 4.8 Figure 4.8 Figure 4.8 Figure 4.18 
Formula C88H80BF24N4O4Rh
S2 
C88H80BF24N4O4IrS2 C62H64BF24N4RhS2 C62H64BF24N4IrS2 C44H34BClF24N2S 
M 1891.40 1980.69 1499.01 1588.30 1125.05 
Crystal System monoclinic monoclinic Triclinic Triclinic orthorhombic 
Space group P21/c P21/c P-1 P-1 Pbca 
Radiation Mo K (λ = 
0.71073 Å) 
Mo K (λ = 0.71073 
Å) 
Mo K (λ = 0.71073 
Å) 
Mo K (λ = 0.71073 
Å) 
CuKα  
(λ = 1.54184 Å) 
T [K] 150(2) 150(2) 150(2) 150(2) 150(2) 
a [Å] 17.0807(2) 17.0555(3) 12.15660(17) 12.1169(4) 21.0239(6) 
b [Å] 13.79936(17) 13.80514(17) 15.5551(2) 15.5279(6) 19.1761(4) 
c [Å] 36.0546(10) 36.0149(6) 19.1376(3) 19.0942(6) 24.2192(6) 
α[deg] 90 90 71.5985(13) 71.555(3) 90 
 [deg] 94.3486(10) 94.4520(15) 79.1459(12) 79.098(3) 90 
γ [deg] 90 90 79.6587(12) 79.588(3) 90 
V [Å3] 8473.10(17) 8454.3(2) 3344.28(9) 3318.2(2) 9764.1(4) 
Z [Z’] 4 4 2 2 8 
Density [gcm-3] 1.483 1.556 1.489 1.590 1.531 
 (mm-1) 0.357 1.735 0.426 2.184 2.255 
  range [deg] 6.196 to 52.744 6.438 to 52.744 5.97 to 52.742 5.986 to 52.7444 13.022 to 120.028 
Reflns collected 84435 184417 79957 34737 68139 
Rint 0.0441 0.1134 0.0371 0.0279 0.2197 
Completeness 99.8 99.8 99.9 99.8 99.7 
No. of 
data/restr/param 
17305/504/1225 17259/405/1197 13665/532/952 13561/532/960 7224/639/804 
R1 [I > 2(I)] 0.0350 0.0365 0.0410 0.0323 0.0734 
wR2 [all data] 0.0848 0.0766 0.1142 0.0714 0.2292 
GoF 1.018 1.016 1.051 1.038 0.985 
Largest diff. pk and 
hole [eÅ-3] 
0.48/-0.68 0.64/-0.61 0.74/-0.69 1.45/-1.02 0.43/-0.44 
Flack (x) -0.024(5) - - - - 
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Table 4.8: Crystallographic data for potassium complexes for 18-crown-6, A2, 17, 3, 11a, 12a 
 
 [18-crown-6·K] 
[BArF4] 
[A2·K][BArF4] [17·K][BArF4] [3·K][BArF4] [11a·K][BArF4] [12a·K][BArF4]  
CCDC/ID 0184abc15 0182abc15a 0217abc16 0148abc15 0108abc14 0106abc14  
Figure Figure 4.10 Figure 4.12 Figure 4.14 Figure 4.14 Figure 4.16 Figure 4.16  
Formula C44H31BF24KO6 C72H60BF24KO4 C76H64BF24KN2O4S C80H68BF24KN4O4S2 C120H92B2F48KN4O4RhS
2 
C120H92B2F48KN4O4IrS2  
M 1161.60 1495.11 1607.26 1719.41 2793.72 2883.01  
Crystal System tetragonal  tetragonal  monoclinic monoclinic Monoclinic Monoclinic  
Space group P41 I41/a P21/n P21/c Cc Cc  
Radiation CuKα  
(λ = 1.54178 Å) 
CuKα  
(λ = 1.54178 Å) 
Mo K 
 (λ = 0.71073 Å) 
CuKα  
(λ = 1.54178 Å) 
Mo K 
 (λ = 0.71073 Å) 
Mo K 
 (λ = 0.71073 Å) 
 
T [K] 150(2) 150(2) 150(2) 150(2) 150(2) 150(2)  
a [Å] 10.35845(7) 18.2071(3) 21.8843(3) 19.56163(10) 21.1080(2) 21.0354  
b [Å] 10.35845(7) 18.2071(3) 13.02630(12) 18.55522(11) 30.0680(2) 30.0638(2)  
c [Å] 46.9994(5) 20.3230(4) 27.6180(3) 21.98471(12) 20.1929(2) 20.2173(2)  
α[deg] 90 90 90 90 90 90  
 [deg] 90 90 108.4047(12) 97.5122(5) 109.3759(12) 109.3840(14)  
γ [deg] 90 90 90 90 90 90  
V [Å3] 5042.92(9) 6737.0(3) 7470.40(15) 7911.31 12090.1(2) 12060.7(2)  
Z [Z’] 4 4 4 4 4 4  
Density [gcm-3] 1.530 1.474 1.429 1.444 1.535 1.588  
 (mm-1) 2.157 1.729 0.209 2.047 0.339 1.205  
  range [deg] 12.658 to 133.18 13.056 to 133.14 5.948 to 52.436 12.968 to 149.004 6.694 to 52.742 6.696 to 52.744  
Reflns collected 29477 13213 183708 66723 130874 116009  
Rint 0.0259 0.0286 0.0466 0.0369 0.0392 0.0472  
Completeness 99.8 99.8 99.9 99.8 99.8 99.8  
No. of 
data/restr/param 
8753/1600/987 2982/427/403 15254/610/1109 16145/441/1133 24663/1358/1924 24628/1145/1852  
R1 [I > 2(I)] 0.0532 0.0949 0.0458 0.0473 0.0347 0.0303  
wR2 [all data] 0.1205 0.3268 0.1251 0.1287 0.0891 0.0718  
GoF 1.023 1.122 1.037 1.030 1.030 1.023  
Largest diff. pk and 
hole [eÅ-3] 
0.35/-0.28 0.45/-0.50 0.74/-0.53 0.62/-0.48 0.64/-0.26 0.64/-0.40  
Flack (x) 0.008(4) - - - 0.024(5) -0.0162(13)  
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5.0  Summary and outlook 
Despite the long period of investigation since the elucidation of their structure in the 1940s 
relatively few calix[4]arene complexes bearing transition metals over the calix[4]arene cavity 
have been reported. In particular there are few examples of NHC and no examples of NHCS- 
calix[4]arene complexes have been reported.  
This thesis describes the preparation of bi- and mono-metallic calix[4]arene-NHC complexes 
(4a, 5a, 7a and 8a) and calix[4]arene–thione complexes (11a and 12a). Their structural 
properties have been studied by NMR spectroscopy and X-ray analysis and by comparison to 
model complexes containing the IiPr2Me2 and IiPr2Me2S ligands.  
Synthesis of 1,3-imidazolinium functionalised calix[4]arenes proved challenging due to the 
low selectivity for the synthesis of the 1,3-dinitrocalix[4]arene A82 by nitration of p-
tertbutylcalix[4]arene A2 or calix[4]arene A19. However, adaption of literature procedures 
resulted, in the synthesis of 1,3-imidazolium pro-ligand 2a.2HI over a six step synthesis 
pathway with an overall yield of 7%.   
Reaction of 2a with Rh(I) precursors [Rh(COD)Cl]2 and [Rh(CO)2Cl]2 resulted in the formation 
of bimetallic complexes, featuring discrete Rh(COD)I and Rh(CO)2I centres (4a and 5a). 
Transmetallation from the isolated silver complex 6a resulted in the formation of µ-Cl 
bridged complexes 7a and 8a (Scheme 5.1). These structures highlight the flexibility of the 
calix[4]arene scaffold, which underwent significant conformational distortion as a result of 
charge repulsion (2a.2HI), π-stacking of the imidazolylidene rings (4a), trans-coordination to 
silver (6a), or presence of a bridging μ2-Cl ligand (8a). 
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Imidazole-2-thione functionalised calix[4]arene 3 was synthesised by deprotonation using a 
weak base and addition of elemental sulfur. Ligand 3 was subsequently used in the formation 
of mononuclear Rh and Ir COD complexes 11a and 12a which were fully characterised in 
solution and in the solid state (Scheme 5.2). These showed excellent agreement with the 
IiPr2Me2S model complexes. 3 was found to bind more weakly to the transition metal centres 
than their IiPr2Me2S based analogues; this was presumed to be a result of the strain 
associated with the S-M-S bonds angles, which were slightly smaller in 11a and 12a than 
those for the corresponding complexes of IiPr2Me2S (11b and 12b).  
 
 
 
 
 
 
 
Scheme 5.1: Formation of bimetallic calix[4]arene complexes from 2a.2HI 
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Scheme 5.2: Synthesis of imidazole-2-thione complexes 11a and 12a 
Isolated calix[4]arene species, most interestingly the rhodium(I) and iridium(I) complexes 
11a and 12a showed a good affinity for the binding of potassium cations, and could be 
formed easily by the addition of K[BArF4]. These potassium complexes were all analysed in 
solution and the solid state, which confirmed the presence of the potassium guest within the 
calix[4]arene cavity. Evidence for π-dontation from calix[4]arene scaffold, donation from 
ether functionalities and chelation from thione donors, where present, were evident from X-
ray diffraction and NMR spectra. Although encapsulation of potassium cations with 
calix[4]arene species have been previously reported, few examples exist with the cation is 
bound deeply inside the cavity, and to the writers knowledge no previous examples with 
potassium cations held in close proximity to a transition metal cation have been reported. 
Formation of the potassium adducts of 11a and 12a highlight the potential for encapsulation 
of otherwise weakly binding substrates within the calix[4]arene cavity in order to probe 
interactions with transition metal centres bound on the upper rim.  
Current work is being carried out in the Chaplin group to achieve this by functionalization of 
the upper rim with phosphinomethyl donors and subsequent coordination with rhodium 
precursors. Calix[4]arene ligands adapted with pincer functionalities on the upper rim to 
minimise distortion of the calix[4]arene scaffold may also be targeted as a means to favour 
the formation of monometallic chelated complexes (Figure 5.1). 
 
Figure 5.1: Calix[4]arene ligands being developed in the Chaplin group 
